var title_f40_50_41760="Optotype recognition tests";
var content_f40_50_41760=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Optotype recognition tests for visual acuity testing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 241px; height: 502px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Snellen letters, (B) tumbling E game, (C) HOTV test, (D) Landolt ring test, (E) Lea figures, (F) Allen figures, (G) single optotypes surrounded by crowding bars.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission of American Academy of Ophthalmology. Coats DK, Jenkins RH. Refinements: Vision assessment of the patient 1:1. San Francisco: American Academy of Ophthalmology 1997.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41760=[""].join("\n");
var outline_f40_50_41760=null;
var title_f40_50_41761="Left ventricular hypertrophy short axis echocardiogram";
var content_f40_50_41761=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/80552/shaxlvhy_conv.mp4?title=Left+ventricular+hypertrophy+short+axis+echocardiogram\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left ventricular hypertrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 237px; height: 376px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The short axis view from a 2-D echocardiogram shows concentric hypertrophy of entire left ventricular myocardium and the papillary muscle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41761=[""].join("\n");
var outline_f40_50_41761=null;
var title_f40_50_41762="Course of the superficial temporal artery";
var content_f40_50_41762=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F82875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F82875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Course of the superficial temporal artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 471px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHXAhMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKRmCKWYgKOpJ6UALRWTc+ILCIlYpGuXHaAbh/wB9dP1rNn8QXkmRbW8UK9mlYufyGB+tQ6kVuzSNKctkdRRXGPf6hKCJLyTB7Iqr+RAz+tUpYFmP+kb5/wDrs5k/9CJqHXXRGqw0urOzn1XT4GKzX1sjj+Eyru/LOaqyeItOX7skzn/Zgc5/HGK5mOJUUKihVHYDAp2yodZ9EaLCx6s3X8SwD7tneMPUBB/NqjPiUnOyxf8A4HIB/LNY22jbS9rIr6vA1T4mn7WEf/gQf/iKT/hJrj/nwi/8CD/8RWUVppSl7WRXsKfY2R4nk/isB/wGbP8ANRUi+KIuN9jdg/7JjI/9CFYJSk2Ue2kL6vTOlTxNYf8ALUXMR94Wb/0HNWY9d0tzj7dAh/uyt5Z/JsVx5WkK8U1XfVCeEj0Z6DG6yIGjZXU9CpyDTq82W2iRy8aCOT+/H8jfmOavRahfwIFivJsD/npiT9Wyf1q1XXVGbwkujO7ork7bxJeR8XNvFOP70ZKH8jkH8xWraeILCchXka3c/wAMw2/r0/WtI1Iy2ZjKjOO6NeikUhgCpBB6EUtWZBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRTZZEijaSVlRFGWZjgAepoAdVa9v7axUNdTLHu+6OrN9AOTWHfa/JPuj05SidPPkHJ/3VP8z+RrJWMmRpHZpJW+87nLH8f6VjKqlsdEMO5ay0NW71+4lYrYwrEn/PWblj9FHT6k/hWTKj3Lh7uSS4cHIMpyAfUDoPwAqUhUGWIA96jMwJxGhb3PArFylLc6YxhT2HBKdtwMnge9RnzW/i2j/ZFH2cE5bLH35pcoOqhTLGP4gfoM00zD+GNj9cAVKsIpwjFVYh1WVjLKfuoi/Xn/Cm5nPVwv0A/rVzyxR5dFifaMolJT1lc/Q4/lTfIbvJJ/32avlKaUp2FzMoGD1JP1NIbcVfKUhSiwczKHkY6Fh9DR5bj+N/++jV0pTSlKw+ZlT96Okh/IGjzJR12n8MVaKUwpSsUptdSHz8feQj6c0oljY4DDPvxSsgqJ4waTiWqz6k5FJVUKyfcYr7dqeJmH31B91qHFmsaqZPbPLaMWs5XtyTk+WcAn3U8H8RW5Y+JZUwl/AHX/nrDwR9VP8AQ/hWArq/3Tz6Hg0pBqo1JR2CVKFTc72yvra+QvaTLIB1A4K/UHkfjVmvN1ykqyxs0cq/ddDhh+P9K3NP8SSw7U1FDKneaJfmH1UdfqPyreFZPc46mFlHWOp1lFR208VzCs1vIskTDKspyDUlbnKFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFZ+ralHp8QwBJcOP3cWcZ9yewHr/Xik3bVjSbdkSanqEGnwh5iS7cJGv3nPt/jXK3lzcajIHuj8gOUhB+VP8T7n8MUw+bPM01w5kmf7zHgAegHYe38zk05mWMDPLHoB1Nc06jnotjup0lTV3uCqAMscCmmQtxEMD+8f6UgVpCC/TsB0FTomO1SohKp2IVhy25ss3qalWMDtUoWnBaqxi3cjC+1OC1IBS7aYiPbS7ak20YoAZtpMVJigigCIqKQrUuKQigCErSFamIpCKAICtIVqbFIRSGQFaaRU5UU0rQBWZaiZatMKiYUDKrrURFWnFQsKQ7kLAHr2pVkdf9oe/WlYUyk1cuM2tidHV/unnuD1pSKrEA/WnpKw4f5h6gc1m49johVvuWbS5uLGVpLOUxsxyynlH+o/qMH3rrtG1uDUCInHkXYGTEx+97qe4/WuNBBGQcimOoYYOeDkEHBB7EHsfeqhVlD0FVoRq67M9LorltG8Q+WBBqj5XotwR+j4/n09cd+pBBAIOQa7IyUldHmzpypu0goooqiAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqK6njtbeSedgsaDJNAFfVdQj0+28xhukY7Y4x1dvT6ep9K5L95NO80775nPzNj8gPQD0p088l9dNczghiNqIT/AKtfT69z7+wFEjbAFXlz09veuSc+d2Wx6FKmqSu9xZH8vCqMue3p70kcRzublj1JpYYscnljySasKtCRnOdxqrUoWlVaeBVGY0CnBacBSnA60AIBS4p4HFLtoAjxRipMUYpgR4pCKlIpCKQEOKMVIRTSKAGEU0ipMUhFADMUmKkxSYoGREU0ipiKaRQBAy1Ey1ZIqNlpAVHWoWFXHWoHWgZUdaiYVZdahcUgIjQDSkU2kUmPXIOVOPUdjT0cN7HuKizS8H6jofSpcbm0KjiTVqaJrL6aFgnBkss8Y+9EPb1X27dvSsdWPAbr2PrTsmoUnB3R0ShGtGzPSo3WRFeNgyMMhgcgj1p1cLomrtpcgSUk2LH5lxny8/xD29R+P17iN1kRXRgyMMgg5BHrXdCamro8qrSlSdmOoooqzIKKKKACiiigAooooAKKKKACiiigAooooAKKKwPHfimx8FeFL/xBqsVzNZWYQyJbKrSHc6oMBiB1Yd+lAG/RXNxeLrO3tRP4khbwyHYrCur3dqhmwu4lCkrjgdckH2q4nijw++qxaYmuaU2pSqGjtBdxmVwRkEJnJBHI46UAbFFc1J488KC3upYPEWj3LW9vJcvFBfRO/lpncQA3QYIz0zWfoPxR8Hav4bsdabXtN062vNwSO/vIYZFdcFkYbyAwDKSM8Bl9RQB2tFcno/jKLVPH2peHLe2RobSwgvkvUnDrMspOAFA6YGc7jnNUvDfxH0zVfFWu6DfSWWm3mn3/ANhto5rxfMvTtByiEA98YG6gDuaK59/G3hVI5pH8TaGscPErG/iAj+Yr8x3cfMCOe4xSy+NPC0Vpb3UviXREtbgOYZmv4gkoTG/a27B25GcdM0Ab9FYmoeLfDmnWlrdah4g0i0tbtd9vNPexxpMvXKMWww9xWD4I+JGl+JdR1fTrmSy07UrLVrnTIbOS9VprpYcZlVCAcHJ4AOMHk0AdzRWZrmv6PoEUUuu6tp+mRysVje8uUhDkdQCxGTXLxfES0vPieng/TBp87JaLdT3L36q3zAkJFGFbzG24Y5K4U557gHd0UUUAFcnrt4L69EMRJt7diD6PJ0P5dPrn0FbHiC9a0sxHC224nOyM/wB31b8B+uK5yCNYowB8qKMfQVhWl9lHVhqf22KSI0B6k8AepohiPLNyx6miJTI/mHp2HoKtItZxRdSfMxEWpQtOVaeBVGQ0ChlJU7eD2qQLTgKYitDMptjK/AXO72xUVkHnczycLnCj/Pp/P8KozyEPLbKfma4LAf8AfOB+bA/hW7FEscaog+VRgUi2rL1DFLtp4FLimQR4oxUmKMUAREU0ipcU0igCMikIp5pCKQyPFIRT8UYoGMxSYp+KMUARkU0ipcUhFAEJFMZanIphFAFdlqF0zVtlqJlpAUXSoXWrzrUDrQMpFaYwqy61CwpAQmgGnMKYRSKTJAQRg9KUHBw34H1qIGpFIIwelTJXNYTcWP6VseGtVFhJ9muGxaSN8pJ4iY/0P6H61ig4OCfofWnEAggjIPBFRGThK50zjGtGzPTKK53wpqnmp9guGJmjXMbE53p6fUcD6YPrXRV3xkpK6PHnBwlysKKKKokKKKKACiiigAooooAKKKKACiiigArlvif4S/4TnwLqnhz7b9h+2iMfaPK83ZskV/u7lznbjqOtafizUpdG8M6nqNt9j8+2t3kjF5OIISwHAeQ8KM45OPqK8X0740au2kafeXh0soNcstN1O4FpstbaGVGMjpOlzLG+0qBvyAO68igDuvEXwm8P6rceHltLDSrDTdMvGvJ7CLTo/KvCU2YdRgdhyQ3QVmSfB6P+2pJINYWHRX1yPX/saWmJlnRcBFmDgLF6LsyBwCK5O3+NOtXEOivPceHNMgv9V1GxkvbqGRoYo7dFaNsecuSS2D83ORgDvBd/G3xaujeHZxommafcahpj3pl1B1ht5pBMyCNGmniCAoofO52w4wpHzUAdZoHwWi0o+FhJrZmXRV1JHK2gRrgXgYdd527Nx/vZ9qY/wi1pvB+k+Gx40ePTbCKa2aGGzlhS5ikXA8zy7hWZly3VthyAU4O7mvEHj7xt4h0T4gpYx6BYaTpGnnzZQ0sl0PMtd+I2R/LYgkgODgcEBu9PQ/E2o+A9Ps4NJ0i1vZLfwPDq6wWSzQpJI9wqbmhEjRkhTueTbvba3zAHaAD034b/AA0PgvVhenVvt3/EqttL2fZvL/1OfnzvPXPTt6msm++EE174kvryfX4xpd5rcOuSWqWGJhJEMKgmMhAX1OzP0rPl8eXEut+CZP7e0PXI7ue6E8mii4RIAtr5mxokuGEjZ7SKT6Kp5rzzxh8V9R8Y+D/F+i3IsbjT30Mahb3UFuLeTK3UcZV4xcTbeucMVYd1GRQB6rp/wgfSfC11p+h68NN1i51BrufVray8uaaEuW+zuySLJs56rIp44xVPw38ERouoaXctr4nFjc6nceWbRsOLyFY9uWlZvk25ySxbPOOptfHbUdX0nwF4fvdG1NtMSPUrMXU67wFiJwS7K64jzjcDweBkViSfF3xEPH8eixWuhtZJd20BaaeK3a9gkHNzbtJcgkEkFEWOTI435oA3vC/wnvfCkuiXeheIbb+0tP0xtKkkvdOaaKWMytKGVFmUxtlscMQR2p9r8IRb6jb3f9tBjD4on8SY+yYz5gA8jO/tj7/f+7XK6X8WfF2oXmixImgxrq1xqttHmzmPkmzXerH9984YcEfLg857VnT/AB115rC0uF/4R+xeXw2NXWO6hkc3N19oaLyIsSr94LkDDEYPUdAD1Px74Am8Sa7baxp2qx2F7HYXGmuLi0+1RNDMMMQu9Nrj1yR2INQ/D74ZQeC9fa/tdTluYf7Kg0xYZYsMPKJO8vnnOfu4GPWuL1L4weI7bWpLf+yrC1njmsIo9DuI5Df3qzoGkaJt4ACEkfcbod23pTrX4p+KB4e8Q+INVGh2ei2OoS6ZbPBaTTzGZZlUGRGljQIVJG4yKA2DwOCAe60V812PjfUPHGteBbnV4LSK70/xbc2Ba1wI5FSAMrDEkgyQ/wDC7DjgkV7/AOJbs22mOqHE058lPx6n8FBP4Um7K44pydkYF1cnUNRluc5iH7uH/cHf8Tz9MUjjcwjHTq3+FJCFjjzjCqO3YVJbISCzfeY5Nci1d2ehNqEeVEsaYAFTqtIi1KBVo5mAFOApQKeBTENApwFOApwFAHMtGw8XsG+5JsK/gpP8wPyrpwKwNXIt/EemSngSfux9ckf+z10OKSNKm0X5DcUtLRVGY3FFLTWpAIaY1ONNagBpptONJigYmKTFLRSATFJinYoxQA2kxTjSUDG4ppFPpDQBCwqNhSmQG48vPI/wp7Cgdisy1C61aYcVCwpCKjrUEi1dYVBIKBlNhUTVZcVAwpFEVKGxQeDTSakpE4+YYzz2PpSq2Rz17iolbFOJ53fgaiSub0p2diZHeOSOWFtssbbkb0P+ePoa9A0u9TULKK4j43DDKeqsOo/OvPAa2PC94bTU/JY4gueDk9HHQ/j0/KroT5XyvqLF0uePMt0dtRRRXaeWFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAZWqeHtL1TWNJ1S/tfNvtKeR7OXzGXyi67WOAQGyOOQa1aKKACs7W9c0nQbdLjXNUsNNgkfy0kvLhIVZsZwCxAJwDx7Vo1ynxA8Maj4ntbGDTdfuNISCfzLhIhJtukxjy2MckcgHf5XHuDQBek8YeGo/svmeItGX7VGJbfdfRDzkLbQyfN8wLcAjvxWP4S+J/hXxL4dn1qDVLaysreYwzfbriKMxHcQpbDkKG2krk8iuU8D/BCw8O6loFzqd9ba1Fo9hLZxQ3Gnrje9y86yrudtrLv2jAz3yOlMb4KyHw5aaQviMrHp2rNqunyJbSRtGzMxZJSkyl/vDDIY2GDg80Aejv4v8ADSR2sj+IdHVLtPMt2N7EBMu7blDu+YbuMjvxU9j4j0S/+xfYdZ025+3GQWvk3SP9oMf3/Lwfm298Zx3rzrQPgrpun69o2oXzabd2+nRTr9i+wyPG8kjhxLmeaVgwPPU88jFR/C/4c3OgfEjxXrl7bvBppnkTRoHkRwiSkPNIoUnaGYAAHBxngUAevVlDw9pY8UnxGLX/AInJs/sBuPMb/Ub9+zbnb97nOM+9Lrmkf2skK/2jqNl5ZJzZT+WWzj73Bz0rJ/4Q3/qY/En/AIHf/Y0AdVRXK/8ACG/9TH4k/wDA7/7Gk/4Qm3bJl1zxLI3r/asyfopA/SgDq65LxBN9p1oRg/Japt/4G2Cf02/maefBFmB/yGPEn/g5uP8A4uuQt/Dsdwzy/wBr+INrsSv/ABNZ87c/L/F6YrKq9LG+HT5rrodI4yEj9Tk/QVbjXAFcvD4XjeVv+Jv4g2g4H/E1n/8AiqtL4VgJx/bHiHP/AGFp/wD4qs0kXOTbOlUU9RXNf8InbHIOr+IiD1xq9wP1D5p48G6d/wA/3iT/AMKLUP8A49VWRGp0oFPArmR4M03/AJ/vEn/hRah/8fp48F6b/wA/3iT/AMKLUP8A4/RoLU6YClFcz/whemf8/viT/wAKLUP/AI/S/wDCFaZ/z++JP/Ci1D/4/T0DUu+KrCS804SWv/Hzbt5sYHU46j+v1AqfQdWg1exWaIgSDiWPPKN/h6Vl/wDCEaQTmSbXJsdPO1y9kx9N0xxVPUfDB0eFtQ8NzXiXkI3GKa6luFkXuAJGbHHYdceuCJemqNoPnSpy07M7Kg1keGNbh17S0uoQFkB2Sx5+63+HcVqk0J31REouDcZboDTSaCaYWoJFJppNNLUm6gB1IaTOaKACiiigYUUUUgCiiigBuKQinUGgZjo3/E7kU9D0/wC+V/8Ar08Tm6uWSH/VJ1b1rP1iZ4tUcxEBggyfTII49+a17C2FrapGQN/VsetI1krJMcy4qJxVhhULimZFdhUTip3FQuKQytIKgYVZeoHFIorOKjNTuKhakUhAaerVCeKcrVLKROh4x1xxT2BZSAxVuoYdVI5BHuDzUKn5gfXiplrJqzOuD5onoGi339o6bDcEASHKyKOzg4I+mRx7Yq9XJ+DrkR3dxakn96PNX0yMA/pt/Kusr0KcuaKZ5FWHJNxCiiirMwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAKGuzG30a9kQ4cRMF/wB4jA/U1y1mgjhAA+VRx+Fb/i1saMV/vyxr/wCPg/0rCH/HuR64H5nFYVfiOuhpBscZVtbQySttAGSazxdXTTjYCrkZWI44H95z29gP8cXbq2knnh6eSnzEerdvy6/XFPjsIx5ucnzTluevGP5CoBFOCZUlaRRJd3I+UuAML7AngD2HPrk1bTUZACPs7vKvDLGcgf8AAm2g1ZitkRFVFAUDAAGAKmWJR2oAprfXp5W1gx/tTkH9ENXYLtig85VR+4Vtw/PApwjHpQY1I6UxWROkyN0NLLcxQoGlbapOM4J5qk0I5wSKx9VF3bWygP8AaE3jAf5WHB7jg/iB9adxNHQf2laf89f/ABxv8KT+0rT/AJ6/+ON/hXJW17HM2zJSQclG4Yfh/UcVayMVRGpmeHbu30nx3rNkH22t2guYflPXqRjHqzflXZHUrX/nr/463+FeZ+MGew1HTdZiG5YT5cmOpU54/ItXSpMksSyRsGRwGVh0INZwtqjpxF5KNXuvxWn+R0bana/89f8Ax1v8KjbUrX/nqf8Avhv8K50tSdTgfh9ac3yLmOY6H+0rbP8Arf8Ax0/4Ug1G1Iz5p/75b/Cuez9335H5ZH8qeKSd5NBc6Eaja/8APX/x1v8ACnDULX/nr/463+Fc+KcKuwXN/wDtC1/56/8Ajrf4Uf2ha/8APX/x1v8ACsEUUWC5vf2ha/8APX/x1v8ACpoJ4pwTE24A4PBH865utbRP9XL/ALw/lSaGmaVFFFIYGkpaxPE+sJplrsQj7TKCEH90f3jSbsVCDnLliUYcah4jlKndDG+8n/dAA/8AHhn866M1leGLE2emhpVImmw7A9QOw/r9Sa1jQjSq05WWy0I2qJqlao2pmRA9QsKneoXpDK7ioHFWHFQuKRSK7ioWFWHFVL6eK0tJrm4bZDCjSSNgnCgZJwOegpFDWporD0Pxfomu3KW+m3cjTSQ/aI0lt5YTLHnG9N6ruGe4zW4eDSasUnckB4PrVhTkAjoazYLyOS8ntlWcSQhSxaF1Q56bXI2t77Scd8Ul3rVhp15p1leXHl3N/I0Vsmxj5jKMkZAwOPXFRJG9KS6m3a3H2S7t7rtC4Zv93o36E16OORxXlt5OltY3E8wZooo2dwvUgDJxWnafEXTLX4QW/ji6gvX01bZJGjRFMxG8R9CwXOefvVvh3o0cuNjqmd/RTIJBNDHKoIV1DDPXBFPrpOIKKK5/x54rsfBPha81/VYrmaztTGHS2VWkO91QYDEDqw79KAOgooqK8uYrO0nubhtkMKNI7YzhQMk/kKAJaKwvBXiSHxb4fg1m0sb20s7n5rf7WIw0seBiQBHbCnsGweOg4zu0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBieLv+QbEP+m6f1rFXpGvq39Ca2/Fgzp8P/XdP61jYwYz23f0Nc9T4jso/wAMuL0pxFRhqcXAFQCRItOzWZd6nBakCR/mPQAZNQR65Ax+ZZEHqR/hRcdjbBparQXEcyBo3DKe4NT7uKpMhoGrN1rH2ZP9/wDoavs1Z2snNsn+/wD0NAPYxmijkA8xFbByMjOD61IDg03NNdsCrM2VtRt47qF4Jl3RSfeH9a49b/UfCcptruCS70kH91NGPmjHof8AA/h6V2qtlwP72V/Pj/CmrkgZHNc0Y2qSXzN6VbkTjJXi+n6rszK07xFpeoYFveRhz/BIdjfka2FOMMOcc1mX+gaXqGTdWULMerqNrfmMGsg+D2tCW0XUrm1PXYWJU/l/UGtJKTTTVy1DDz2k4+qv+K/yOscYYqP4T/7MB/WngVx41DxHpe7+0LRL6BV5ki4bG4c8e47qPrW1o3iHT9VISCUpcEf6mQYb8Ox/Ams8PLu9dPyJqYacVzLVd1r/AMN8zYpaSlrpOYWiiigYVr6J/qpv94fyrIq7a6haabZTz39xFbxBh8ztjPHQetJjim3ZG3RXCal8SdPEvkaJa3GpXB4G1Si/qNx/KqRs/GfiZsX0i6VYP1jB2kj6A7j9GIFZ866anYsHNK9V8q89/u3Oj8SeLbPSkeG3dLi+6CNTkKf9oj+XWsbR/DF1rUx1LX7rU4GcHbHbX01oz57v5TqcDHAPTnpnnf8ADvhPTdE2yRIZrof8tpeSP90dB/P3roKEne7JnUpxi4U1e+7f9aHM/wDCHaf/AM/3iT/wodQ/+PU0+D9P/wCf/wAR/wDhQ3//AMerpjTDV3ZzWRzJ8IWA/wCX/wAR/wDhQ3//AMepjeErH/n/APEf/hQ3/wD8erpmqJqLsLI5pvClkP8Al/8AEf8A4UF//wDHqibwtZj/AJiHiP8A8KC//wDj1dK1QvS5mVyrsc23hi0H/MQ8R/8AhQX/AP8AHqhbw1a4/wCQj4j/APB/ff8Ax6ujeoGpcz7jUV2Ofbw5bD/mI+Iv/B/ff/HqfqunNceHbzTreWRnltpIEkuZnlbLKQCzsWY9epJNbD1xnjzxdceF5LYrpT3Fm6O899I0iwW4GMBzHFIwJz3UD3pXbKslqczafDi7s/C0SfbILzxDDpwsIftqLLZwruBZVQRgkHB5cMfr0rBh+FmrmxubO5m09bWfU7W9MMcxUKiKwlA8uKMKTuGNqj6g810t98Tltm1ALpiTfZL61styXXyyCdd28HZ0Hp39qgg+J+bqA3ekCOylvbmyWSK68yXfCCSfL2AYIx0bjP517xNoGfrfwxvJpdVi0S6t7KwmWyS3gMjNvSEMGjkLK3yncCMh+nIpbb4YXUcejyC10y4ew1CW5ktby4EsbxSIBtVlt1CgMCQnl4HUHtU1r8U7ibR73VT4au1sYrM3cM+6QRyYfb5bO0QUNjn5S47ZzUM3iDxBrPjXw3BdWM2lWcltNdm2j1Qq0irgq7GNcHA5CEkHJBx3T5i48lya2+HXiD/hMV1iWbRolzeJL9kUQ+aksbKmVWEEkMQWLu/qPf0DT/A+q6t+zxdeBobiyXVI0S2WV3YQ5DpKeQu7HJ/hrkvBPj6+15dNsdO04XN69iL6eXUL0RYUyMgAMcOHPHZFH41qeG/itJosfiKFLdL+9i1a6ghs7i5cTSpCgJ8pbe1clQB/GPlHJc9nScuazFXUOS8SW9+Cus6lFfi4Oi2Ftfa1p99JptlPKIIoYI2SUq4jQ+bJuycKvI+9Uniz4Na3deILZ/Dh0Gw0nTpLNtOcfu7qJIsb0kkMLyyZH3f3yjjlT22vA3jK48W/FrSryCW7t9Kv/B4vhp7zFo0l+2bS237pbAxuxnFVf+Fma5oXiL4o3OuQRXuheHXt/IgglAlj8xfkUARDcGJBYs3ycgbhzXScRXtvg7q8GuJqkN1plvff8JVd6ubuFnEwsplwIg2zls5JUnb7nNV7j4P61L8MdT8MLYeGE1edYwdeE8n2i823KSnzv3O4ZVf778gcY5GzH8YtU8mwFx4Nubaa+1a00y2e5lmgt5vtCOwkR5LdWYKUww2dwQSMZdofxmmv7zR4rrw9HbxajPfWgeO/MhSa1UswwYlyjcYbOeuV45AOn+Hfgyfwl4h8Xzp9ji0nVbyO5srW1JAhATD5TaFUk8/LmvObb4Ka35wW7uNHcouoifUdztc6t9oVvKFypjwAhIP3n6cAHmtG0+PSJpltf6v4dMFvd6RLq1stpe/aHIjfYUkUxpsyQcMCwx+OJtU+Nt1pKXsF74YSTVLc2LLBa6kJIpEuh8v7xo1w4/ukYPUNjmgDv/hf4YPg7wHo+iSx2a3VtAq3DWi4SSXHzPnAJJ9SMmuqrxvxP8Z7rwy0Sar4dtxdRCD+0bKC/kmnsDKcLvZIDD0IIzKC2eBW/wDCTUb2+1n4gJfXlzcpa+IZoIFmlZxFGI0IRAT8q5J4HHNAHotFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBjeKT/oVuvdrhcfkT/SsaUfuj7DNXtdnFzqUcCNlLb5n/wB8jgfgp/8AHhVKcZ2oP4j+neuao7yO6iuWGpITiq127iM7OuOlWJOBVSZutZscTFmjEEgubltyMQr5H3cnAI/EgY/ybbwBowdhXI6Ecin2sX22/bcMw25HHrJ1/QEfifatOeIbelCQN2MBGktZN0LFfUdjWzYaks42t8sg6rms+6jFZ7ho3DKSGHII7U9gtc7ANuHFZ+s5+zJ/v/0NRaXfeemG4deoqfV+bVP9/wDoapMzkrGNVV5N07DsvFWyKz2+W8ceuD+lWZljGRUrZJDHHzc/j3/Xn8RUaVInPyevK/73/wBfp+VZVfdtU7b+n9aiFFPFMU8U8VqINpIZuygA/iykf+zVja54bs9UzIo+zXY5WaMc59x3/nW0M4YD+Jcfj1H6gD8aUcjiualC05xfe/3/APBNIVZU2pQdmcnpGt3emX66V4i4c8Q3RPyuO2T/AF/OuvFZmv6Nb61Ytb3Aw4yY5B1Q+v09qyfB2pziSfRdUP8Ap1p91ic+Yn/1sj8CPet03F2Z0TjGvB1YKzW6/VfqdTRRSMwVSzcADJNWchh+KNeTR4NqbWuWXcAeiD1P49B3rP8ADHgufxC39peJribaeVtgcMQf7x/h/wB0VjaEn/CTeLJrqdc2lsRKVPRm6ID9AM/h7169of8Aqpv94fyrFL2mr2PTqS+pJU6fxtavt5IfpWkafpMPl6daQ2699i8n6nqfxq/RilxWh57k5O7EptONIaQhpphp5NMNAxjVG1SGo2oAiaoHqdu9Qt0pFFdxULVO9QPSKRC1ZGq6DpGqTxz6ppVhezxjCSXFukjIM5wCwJHNa7VE9Ioxbzw9ot3eG7utI06e6+X99JbIz/L935iM8YGPSsvw54N0bw/PcXNnbJLezTyTm6mjQzLvOSocKCF9q6Z+tRMaV2Oy3MZPC+gJJO6aHpSvOpWZhaRgyAnJDccgkA81qQ6dYtdRTmztjPDEYo5DEu5EOMqpxkD2FU9et7i80W+trI232maF40+0x74iSMYde49ev0PSvKYPhVr0mn6vavcaXEt/9kcxRSbIw0TAuQI4UVcjphc+pPUm+7KTcXornpzWPhG61iLw/Lpely3tnbC5itnsVKwxFsZUldo+bsDn2rr/AAz4T8O6heagL/QNJuhujucTWcb/AL1i+6TkfeOBlupwK8mn+FyWfiWW68PwWFrYy6W9kkjuxuLSYliJ0JVizYOMllOO/AqDQfg5rt54S8T6Nb3FlFeXtpZxGRrzEEjRzq+9o0tlIYqjfMWducEnORVJLmVmLEOXI04n0pp+g6Pps8U2naVYWk0MH2WOSC3SNkh3bvLUgcJu52jjPNNm8PaLPqU+ozaRp0moTxGCW5e2QyyRkYKM+MlcDGCcV4f4/wDhSsHi7wvo3gu0vLPRNTglsdaMaySRrarOtwd0zE4d2LqMtk5wOOK+goo0hiSOJFSNAFVFGAoHQAdhXWecYVj4L8LWGz7D4a0S22TJcr5NhEm2VM7JBhfvLubB6jJx1qV/CmgmFUj0fToTG0rxPFaxq0LyjEjocfKzDqR175raooA5PwP8PfDng3Rk07SdOt2PkmCa6mgjM9yhJOJXVRvHOMEdBV+28H+GrWyaztfDujw2jSrOYI7GJUMi/dfaFxuHY9RW7RQBiap4S8OavfG91Xw/pF9eFQpnubKOWQgHIG5lJwK0bLTrKxkuXsrO3tnupTNO0MSoZZCMF3wPmbgcnnirVFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVQ1q/8AsFmWjCtcOdkSnoW9T7DqfpV2V1ijaSQhUQFmJ7Ada46Wd9RvTdSgogG2JG/gX1Puep/AdqzqT5V5m1Gnzy12QtnGIYsuxY5LMzdWJOST7kmpo0PMjjDN29BSxruwxGFH3R/WnSNxWCVjonK7sivKeDWbO/zGrs7da5LxPfanHug03T5JTIpHngghPfGck/lUsInWeHxu05JD1lJkz6gkkfpirs44rgPDHjG4t1Gn3mkTqtoixvLGwO3AGCwOAvGTyfw9OmXxNpM6gi7WPcMjzQUz+eM1a2Id7klylUJU61ba+tJv9VdQP/uyA1GwDcggikykzJlMtvKk8AJeM525wHHcf574reuLhLnTYJYm3I5BB/A1nyw56VJCoitPKHA8zeB9c5/Xn8aI7hJ6C4zWdfrsuI39eDWoo4qnqa/uC3oQa1MWRo3FSdRiqEkzRWzyIu4qM49ansrhLq2jmiOVcZH+FLyDldrl0/OpkHUffHv/AHvx/nQKbGxRwy4yPXoR6GptgZDJCDtH3k6lP8RXMpewfJL4ej7eT/QW43HHv2pwxk46HkD0B/yR+FIvTilH/oJx+B/+uD+daVPdnGfy+/8A4P5gOrk/G9lJC9rrlkMXNmw8zH8Se/5kfRj6V1lMuIlngkikGUkUqw9QRitZLmVjWhVdKal/VupHY3UV7aQ3Nu26KVQymqXie4FvoN42cMyGNfq3H9a5/wAEXb6fqN7oF23zxOzwk9x3A/RvxNVviTqTF7bTLb5pmO4qOpY8KP1P5is3P3LnXTwj+tKmtt7+W5f+GduI9DnuMc3FwxB9VGFH6g16Nof+ql/3h/KuY0GwGl6PaWQOTEmGPqx5P6k10+h/6qX/AHv6VcVaKRz4mp7WtKa6s06CcVR1DUrexA81/mb7qgZZvoByaxptYu5yfKiSBOxkO5v++Rx/49UuSRMacpbHRtIB3qB7lB3rmw13L/rLyUe0aKo/UGhrWdhlL6YN/wBNFVh+gB/Wp5jT2LW50QuFboRT94PQ1yMl5PYzql3gxucJMv3SfQj+E/n9e1bFpehwOaakS4WNUmo2pqyBhTiaoixG3SoXqZ6gekCIXqu9TvUD1JaRE1QyGpmqBzyaRRC9RGpHqJqRSEqe2++fpVcVZtR94/QVEjSmtSyK6fwSuVv5P9tY/wAlz/7NXLiuw8GR7NMmk7Szsw/AKv8A7LV4de+LGO1M3qKKK7jygooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorF17Uni/0Ozb/AEpx8zj/AJZKe/1Pb8/qpSUVdlRi5uyKWv3jXlybGE/6PGR5x/vt1C/Qd/fj1FQrFtC5HyZ+aktLdYY1VRgCppGAU+3Ncjbk+ZnfyqEeVCudtVpG96lnbmqrtmmzJIgmPBqm4bnt71obC1OFoWU5pFXsczodxHbSXcGB/rMkEfe+Uc/mDWq1vp06OrWsGHO5sIASfXIrHnshHqMi9GyefbrWlBbkD79CuhaMlNvZIMJbxAdOEFPjjjCgKgVRwAB0pViA6nNOGBTE2g8tewpkygGLH94/yNTg5qR4CbYSkcbwF9+DmnFakNkAXiql+m63dfUEVePSqd62I2rUzOeN5BAoM0qp9aytM1i0sdTntvOX7HK26N+yMeo9h/hWnAqMgZkUnHUipvsdpOCJraFwf7yA1m0+h0U504pqSbuakbBlDKQQehFSKSrBlJVh0IrlptHudNY3OgSEd2tXOUf6c9f85rU0PWoNUVkCtDdR8SwP95T/AFH+eKTtL3ZIJUfd56buvxXqv6Rtb1b/AFn7tz/GB8p+o7U8wy5I2E5U4K8g45HP1AqEGprJjHcoFOFYkMO31+tceIpTp026b0XR/oYoaDkAg8GlzTB8uV/ukr+RxS5rujLmSYrHB/EWObTL+w1yxOydG8tzjgnBxn6jcKp+ALaTXNdutZ1A+Y0LfL6bz3/Af0roviKok8MSoR8xddv1HP8AIGj4b24t/Clu2MNM7yN/31gfoorHlvU8tz2VX5cBf7V+W/W251FSpfm0s5BFtMzuFQHpnHU+wHNQOcLWfaHz7y4bnCERr+WT/T8q1m7I8yjDmkWY42eRndmeRvvO3U/4D2FTlY4l3SEADuaJZEtrdpJCFVRkk9q54K+qT+dOCY8/u4z0UepHr/L888/megl0RrjWLANgTq2P7vP8qvWl/a3WfImRyOoB5FU9Pso5rZZFBwex6g9xWT4gsvLuLSYblKuUDqcFcjjB+oH5007EuKfU6S8gjmhdJFDo4wynuKwLeWSyvGtpWLD70bn+Jff3HQ/h61b0q/dz9muz++AyrYwJB6/XnkVV18bYDMAC0J8wfT+L9M/pVMjl6M6KyuN6jmtBWyK5jSZ9wHNdBE2VFVFnPONiUmoXqRjULmmTYic1A1SsahakUiJqgc1K5qF6RRE1RNT2qM1JSQCrdv8Ac+pqotW4hhF+lRI2pLUmB5ruPCqFNAtM/wAYaT8GYt/WuDl3eWwTlzwo9zwP1r021hFvbQwr92NAg+gGK3wy1bOfHS0USWiiius84KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorm9b1CS4unsbZmSJOJnXgsSPug9hzyR9PWplJRV2XCDm7IsajrQLNb6biSUZVpsZSM/wDsx9ug7+hz7W2EYYsS7sdzMxyWPqTU1rbLEgCqAAMADtU5GK5m3PVnbGMaatEryHaKpzy8EVbuGABrIu5MA0noVFXJ2n3xg9+9Ni+dqyUvAsuwnrWzYDdg1KdxzhyouQxYHNWVUAUqrxS1ojmbOb8Q2pinW5QZQ8N7e9VIpgRXWyxrKhRwCp4xWJPoWHzbuVH90807E3KiyZ704uBV230Nif3kxx6KK2LTTIIMFUy3qeTRYLmbp+nyTsGmBSP+73P+FaGsoEso1UYAcfyNaPyxrliFUdycVj65ewvCscT+Y4bPy9Oh70OUYbsT1MpzgVlatLtgYDqeKvMznk8e3+f8axtXdozHtVGBJPzqG/nml7ST2j+n/BEkVIhhcVNE2DUUM7OPmSHPtGo/kKV5RFmRLZHbuAzAn6c4qeeS3j/X4DSvoX0aszV9Cg1GVbiKV7W9T7s8XB/H1q5aXdrcrmJnBHUBgSv1GBVtQh6TKD6OpX/EVLqxt7ya+X+RcJTpSvF2Zy8mq6/oo239gNRt1/5eIDhsepAH9BWjonjDStSvbeBHlhuJJFVY5UwScjjIyK2XDxxtIVLIoyTH8/8AKsOHV9CvdVt0cRfbVlXyzLCVcNuGMEjg1E5xnCSjK+h1RcaybdPVdY/qtV+RtzX1pHdTQvdQJKsjZRpAGGTnpn3qxEfNXdF86+q8isfVvDelX+rXVzdWxadnGXEjrn5RjgHFZd/4G0u6A8qa+tmAwPKuXx+Wfeqw8m6UX5IycaTStJ381p+f6Gj41tZZtDYKjkq4PC+xH9ad4GWQ+FNPBjcFVZSCp7MRXnmueGL/AEO2lcs95ZnrKJpA8fPU/NkfqK1Ph9pOn6hb30V4k00kUoZWa4kztYcD73sfzq1Jc52VKM1hNGmk73T+W1j0uSNyv3G/KmaZaP8AvW2MPm9KxD4U0fH/AB7Sf+BEv/xVWdP8IaLJHIXtJGIOBm4l/wDiq0kk0cFKUk9CbxTDO9rDDChzJKAcqSMDJwfyqnZPPbkLPa3Cn/ZiZwfoQP54qrr3hrRbWWzVYHjDyEN/pMgyNp/2vpWnp/hXw9Ko32jnPf7TL/8AFVi1G+51qc1G9je0SCQxzMYpEjeTcgdSDyBnjqOc9ah8Qac9xZSxop34ypx0Ycj9aangfw6wyLFj/wBvEv8A8VUNz4I0AL8tk4/7eJf/AIqqcVYxjUlcxXiklsormON1kjxKoKnII6j8RkfjV+9iaRFJjZlYcjb1Brnrvwxplvd3cTQy4C+ZGftEv3ccj73Yg/mKcfDGlrZQM0Eu8ou4/aJeuP8AeqPdsb3ndOy/r5Fvw6sy28aOj7kGwkqeSOP6V2Fur7B8rflXl+i6Fp1xlpI5mVnYjNzJ03HH8Xpiust/COiMgLWjk/8AXxL/APFVUbGNTmIte8f6LoXjGy8Oam08F1d25uUuGVRAq5cYZs5B+Q9sdOao+GviNpHiWzs7rTobpIbq8eyT7Q8MTb1UMSFaTLDB6KC3qBR4h+HWl+IPFX9qavtubD+y1002DIR92YShxIGBGMYxj8e1Y9t8MEtpbUjVf3cGsXGq7UttuRKu3ywd3GP736CtPdsY+9c1pPHumy+NbTQLGazvFkt5pp7mG7VhbtH1RlGcH6kY9K57X/ivZWT68dMt7bVbbS7aC4E9veqUmMkqxlcqpA27s9T07VWt/hG0dpa2dzrgks7WwudPhEVn5cmyYk5ZvMIJBJ6KM+1Mu/hZcXmn6jb3euwl7uwtdPV4rAoEWB1ZW2mU5JC4PIHf2o90PfPQJdb0pNUGmvqdiuonpamdBKcjP3M5/SsnVfF+k6b4qsfD95OI768jMkbM6Kg5wqnLZ3MeAMHNc+3w1iTxXNq63yywS6gupfZ7hZ2McoOSUKTKmeuCyNgccjitfxD4YfU/E+m6zb3wt5LWGS2kjeEuJI3xu2kMpVsZwee3HrHul+8X18RaJK10I9Y05zaqXuAt0h8lQcEvz8o+tVx4o0Bsbdc0s5cRjF3Hy56L16n0rh7X4Tpa6bPZDU45FNpLZwzvDM0sSOSehn8vGT0CLnrweasan8MBfWuqQjVhGb60s7UN9mz5f2cr833+d23pxj3pWj3GnPsdvFr+jPqA09NW09r4uYvswuUMm8dV25zkdxVqPxDory3USavpzSWis9wguUJhVepcZ+UDuTXnWi+A9SvNf1CfVZltNOj8QNq8ESIGknwPkPmB/lX/AGdueOoqzH8Kf9Dgs31nNrZ2l5aWQW12uouQwZpW3/vMbjgALUNR7m9N1LXSPQNN8VeGRfWMt14i0WG0M2fNkvolQlAHxktjPKcejD1ruLDxjFffEKfwzb26SQppUWqJfJOGWRXkKhQoHTAzu3c56V5dpHwlk1DQrXTtI1v+ybK1tjZ3sdvbPGl+7xBWkfypY2LY2nDMynjIOOe5+H/w2PhHWrPUDq32z7PokOjbPs/l7vLct5md5xnONvb1rroxSjocGKm5T16HVL4p8PtrR0ddd0o6sG2GyF5H54brjy87s+2K57xL8VvB+gWFvdvrVlfRy3UdqRY3UMpjLlgHf5xhBsbJ7bT6GsLVfhTqWq+ObPX7/wAW3Fxb2WrJqVtaSwSN5KD/AJYLiYRhf9ry93qTVW0+B9jZ+BLbRbS/tYtXh1BNQOrLpyhpmSVpESRQ+5lAYr98fh0rU5z0geKvDx1G108a7pRv7pFkgtheR+ZMrDKsi5ywI5BHWoU8Z+F3mWFPEmitK8ohVBfxFjISVCAbvvEqRjrkEdq4Gb4NiXxdNrc2rQ3K3N9BqU9tPDchVuY+rxCO6RV77d6yFc4yRwaOs/B2HTfhX4i0zSrWHVPEd1O95bXcMEdtOZfNEkal2boh9W6ZwO1AHsVjqFnqH2j7Bd2919nma3m8mVX8qVfvI2DwwyMg8irNcx8NPDR8J+CtN0qZhJeqhlvJe8tw53yMT3+Yn8AK6egAooooAKKKKACiiigAooooAKKKKACiiigCvqNyLPT7m5PIijZ8euBXG6KD5QLnc55Zj3J5J/Oul8Vgnw5qGO0RJ+g61yekXA2gE1zVn7yR24Ve7JnTIPlpkoOOKIJAyjmlkYGgfUy7ndWNqLFflOSx7KCT+QrpmQE80z7PGckgVDjc1jKx55cN5L7nSYDrkxNgfpXY+Hpo7qyinhYMjDINLqaxoh+UYrJ8L3AtdQuLIf6pz50Y9M/eH54P/AqiKszSp70bnYAUEU5BkU4rW6OBkdKvWlK0mKBEyEVWvIpX4jllLnoEbaB9TT84p6NUyjzKwFK20hFYyXUrzyHtnC/4mk1pUiso0iRUQPwqjAHBrTBzWXr/APx6p/v/ANDRTpQp/CgMFjmqd/bG4iAXG8HIzVo9aSrEY0VjOmd0Z/Q/ypJIZFBwpB7ZBrcyaNxoC5w2qafqF22YxarIPuy5Kuv4ioYrHxGYxHLqsCJ6gZb89oP613pIP3gD+FJ8o6KPyqXBHTHFSStZfdf8zktJ0VLO4FzPeXFzdD+IuVH1wDz+JNbjNDNPBJewxXPkuro0iguhByCG61pbvagkEEEAg1nUw9Oas0RKtOcuZvU5nxnYazHrp1DQ7gBvKUSW7H5ZMZ554/l9ai0bxZb3M32PU0NhqAO0xycKx9j/AI/rXV3KiSO2lcbvlMbH3Hf9DWNrnh6w1mHZcoRIB8kq/eX8fT2rnwd/ZJLdaP5G8K1OaUKy+a3/AOD+Zq4DqVYBlIwQe4ry/wACalp+l63ffadRt0iKFAu4lhhuMgD0q1eXmt+FY3sbmQ3VnKpS3uc8of8AH2P4Grnwvty51G+IwrMsKfQDJ/mK35lKaVjrVCVHDVJKScXa3nr+B0f/AAlWhf8AQTh/75f/AOJq5p/i3w/HHIG1OLJPaNz2/wB2r9aGmXEEMcizSojMwChmAzxW7tY8uN7nDaz4m0S61SNhqlv5cSnAIYEk+2Pb9amh1rw8q74dUjglPO6JHGfqNuD+Oa1vFFm0F4t6gzERtk9h2P05P5+1aejz7ogp61zu19juTlyaP8P+CZWmeOdIhOy81KDg4Dqj4b8MZB9q0pPG/hxh/wAhRP8Av1J/8TU2sqDZTsDtZELq391l5B/MVpwuTCpPBxmqi1sYzi3rc4PxD4k0K4VHttTg87Oz5kcZVuD/AA9uG/4DVbWfFOi/Z28jU7feFO0MGXnt1HrXWXzifVYk/htl85v94gqv6bvyFcn4hufPu4oBzubzG9gOn64/Kpbj2NYqff8AAztG1rRrZI0OqW2FAHG49PwrrtJ8QaTfTrbWd9HNOwJCBWGcdeoqlpMeAK34zgVUbGc+a+rOJ8afESHw54mt9GeC0R5bb7T9ov7w2sTfNt2I2xgW787QO5FXbzx7oFjb3j6lei2ksY4JLtBG8gh84DYNyqQ2c9VzU3ivwrD4jSaK61LUYbWePy5beIxNG4wRwJEbacEjK7T71zus/CvQ9RF1Gt3qVnbXVvb20sEEibGWDAiOXRmBAAHB5q/d6mPvdDZ/4Tnw++qnThfOLn7YbD5raUR/aB/yz8wrs3egzz2qsvj7w3IZ9mpZWGGW4L+RIEeOPPmNG23EgXBzsJ6Vh6V8Oj/bmo32uXjy27a0+rWtnA48rdjCNJlA24c8Btv15p1p8LNBsYbuC0aaKC4hmg2iC2LosqlW2ymLzeAxxlz6cjik+UacypqHxNs9Q1XQbLwpcR3KahcSQy3L2M8qx7EDkKo2lj8y5OflByeK1rDx5pNxZ2rzzBrq5Mvl29jFPdMQjFSdoiD4yOpUDPQnrVweErBLnwzOJrrf4fhaG1G5cOrRiMl/l5OFHTHNZNh8PdP0yS1n0rUdTs7y3SWIXMbRM7xySGQowaMqQGJI4z71LcSkpl6HxdZtLqazLIy2VwIGFpb3Fw4JXd86rF8vHpuHvniqVn4yTUvFeh2mkSW9zpGo2U1yJ9jByUbbgZxjnIIIzxUWo/DnSr+e5mnu78vcXYvJATE6M4XbgoyFWXvgg89MVb8NeAdL0G40qWynvXbToZoIhK6EFZHLtuwo5ycDGOPWk+W1y0pt2H23jizXxZrOjXkEttDp0CzveOr7CCpZt3yYQADglsN2qyvxB8M/Z5Jm1CRFjMQKvazK583/AFZClNxVuzAY96XUfBOm6lq+pX0812BqVqLS8t1ZfLmQAhTypZSM5BVh0FN8MfB/RbieKxE90LWF4rh2jgtYnHlNlAXSEM2T13E5APfmpjGM2kaznUpRb6f1Y73wb4+8KmLT9Li1CUahc3MloUlsp4sXQ+Z4WZ0AVx02sQcAYq9pXxR8H6pLClpq5AminmikntZ4I5Fhz5pWSRFVtgBJAOQBmqkPwq0OLUlvVutSMq6/J4iAMibftDgAr9z/AFfHA6/7Vc14C+CdvY6JYw+MryTUri0jvoIbWGUfZYUuiwkK/u1csUbBLE4PToK70rKyPIbbd2dY3xY8Fppt3fTaw0NtawxXMhms542MMjhElVGQM6FmA3KCOetOk+KfhFNEg1k3922jzAlb9NNumtxiQxHdII9qfOpHzEdj0IJw7z4JeH7/AE27tNR1PW7t5rGDTEuJJYhJb2sMqypEm2MLjci5LBmPrV74hfCPQvHerPf6xd6kkj2v2Ty4midEXdu3J5kbmNs4+ZCue+cnLEaXgzxVd674x8ZaVOlqLPR7i3jtpIQdzrJCHJYkkHk8YA4qaT4h+G4NSmsLu7u7S8igmujHd6dcwF4ogTI6b4wHAAJ+XOe2ateF/CFh4c1XWb+xmupJtVaFpxMylVMUYjXbhRjgc5zz6VxVh8CvDVlqL3qX+sSTtDdwFpHgLlbhCj7pPK3uQGO0uzY9xxQA6f44+Gp9V8P2/h/z9ZtdTuntZbi3t5825WNXGIxEWkJDDgYI59DjpG+J3hAX01odX/eRCc7/ALNN5T+Qu6YRy7NkjIvJVCT7VDcfDbS5NK8KWdvf6nay+GcCwuoniMuAmw7wyMjZHX5R7YrHt/gl4Xtby/ms2ngivPP3RC2tHMfnIytsmeAzLjcSB5mAfbIoA1dI+LngbWJLZNP16OT7Q0ixM1vKikxxiRwWZAAQjA4JHcDkEV1mgaxY6/o1pqukzNNYXaCSGRo2j3qeh2sAR+Irzr4h/CmPX/h54d8J6TMqQ6XPAgu7qQiZLZVKSbSi4Z2U4x8qnPOMCvTrK1gsbO3tLSNYraCNYoo16IqjAA+gAoAmooooAKKK4fUfiCLHxnB4Zbwzrsuo3CPNA0bWnlyxIcNICZwQPZgG9qAO4orn38beFUjmkfxNoaxw8Ssb+ICP5ivzHdx8wI57jFOk8ZeGI7K3vJPEeipZ3G/yZ2vohHLsGX2tuwdo646d6AN6isG88Z+F7K3tLi88SaLbwXaeZbyS30SLMvTKEthh7irEPiXQpvL8nWtMk8y5Nkm26jO64HJiHPLj+719qANaisKHxh4ZnW+aHxFo0i2I3XZS+iItxnGZPm+XnjnHNMufG3hW1to7i58TaHDbyO0aSyX8SqzL95QS2CR3HagDcuIUuIJIZRujkUow9QRg15dPFNpV9LaTk74jwf769mH1/nkV6AniPQ31gaSms6a2qEbhZi6QzEYznZnd056VPqul2mqwCO8i3beUcHDIfUHt/XvWVWnzrTc3oVvZPXZnBxawycZqtL4zsIZCj3G9h12KWx+VbF94GmZXS2vY5Y2BXbMhU492Xj9BXNXHw+vNMR7mVoZbWIFnVJNzKo6nlRnH1zWHLOPQ7OelPZmvb+MdKkwHuNhP99Sv861U1KCaPfDKrqe6nNcZeaMY4CYLUyHHGGx/Q1Qsop7KVnWwvC7DBwUA/QjP41HO2aqmkdRq18GBVTWJYTlPEFlMp+RCY5D/AL5AA/MD86asGoXjYW2MCnq0hBP4AcfrW9Y6KFs2iIPzA5Y8kk96Sve4VJJRsjs4h8oqTFUdGuDcWSNIMSr8ki+jDrV+uhHnvcYwptKxqMmgQNSA4NITTlFAyRGqlrMbzW6iNSxD5wPoaluJ47eIySttQd6xp9cdifIh+Ud3bFF7Ba5Xazuf+eL0n2O5/wCeLVWk8VRxttkubRW9DJUlr4hlnLeUkUozgFX60uYpwa3Jvsdx/wA8XpPsdx/zxer7Xl2v/LBP+/n/ANaon1G5UZMUaj1L/wD1qOYnlKn2O5/54vUUsMsSkvGQB64qjrXipLNB5moWcRzghSCw/DJ/lWE2uNe4aytL7U5OzbPLjH/Amxj8BSc0axw85K9tPw+83HvADhUdv90ZpLm7ktWK3EEsZAydwHT8657Z4kvpTGstrpijkrEPOkX6k/L+RBqynhFGIm1G9vdQu/788pIH0Hb86nnfRG8cJG15S+7X/gfibNnqkFxbTxASFjh0+Xv+P0FIl8GA3xSr/wABz/Kqdro1pYzrNbh1kXtuzn25qlrVndxXhutPYmNxuZByM9+P8Oa54/uqjf8AN+ZSw9OTsn95D4+njn8K3QUZYMhBYYIO4c4PPTNT/DezuG8JW0kKHa7yNkAcncR/SsbW9WXUNK+zTwASbgTjlWGD+Vdn8NriODw1b2nAVd7p64LnI/M1qpXnfyOmrSdLCezf81/wLRiuo2AeJzk46Vh6zp8sF+txNGTHcHZhh0IHT6EZ/wAmu2jbzrgY6Zql4uKi3s0/iafj/vlq0k7o8+lpNGTp5NtbfKCbYf6yI8gL3Kjtjrgda1LOxjtHJgc+Tj5U4IH0PXFQWK7RyOKsx4igSKPOxBgZPQVkmdUlZ6EV/mdPs46zMIsf7J+9/wCO5P4VoXcywRM7EKoGST2qlpsXnTG8b/VKCsX+1nq39B+PrVPUpPt9yYVP+ixHMx/vN1C/1P5etO1kZ3uyoZylnJO42yXBMhz2HQfoB+Oa5WyY3d1JcnPzn5fZR0/x/GtHxReFtttEfnl4OP4U7n+n4+1LpNvjbxUbs22Rs2CbUFaKniq8KbVqbNaI55aisaic0rGo2NAhjGomNOY1ExpMaGsaYTSk1zer3ks00lttkhaGdCjRyYMmRwD6E5yM5BK4PpU7lbHRE7VLEEgDOB1o065gvbVLi1kEkb9x29j6VycmoXJk/tCGTzJbTbFNCrFQwLcMFPc5IweQQMZ77On6LFI17cTJPaLPMz7ElMZKYGd+09zuPqM1MkbQ01Ny2ljljMkbb1DFOO5BxgfjxXofh3Tf7NsAJAPtMp3ykevZfoOn/wCusTwfoSxiG7miEcMQxbQ4xj/bI/kPx9MdhXXQp8vvM4MXX53yLZBRRRXQcYUUUUAFFFFABRRRQAUUUUAFFFFABXK6h4R+1/EjSvFf27Z9gsZbP7L5Wd+8g7t+7jGOmD9a6qigDybT/hA+k+FrrT9D14abrFzqDXc+rW1l5c00Jct9ndkkWTZz1WRTxxioPDHwWGiXuhzvrguV03U73UTGbRsSfaY1Ty8tKx+XbncSxOefWvYK8J8XXc1t8fdT1G/lsXs9E8Lm9txNpr3TW58wjeiiQfvN+CWGMoNvH36ALGn/AAOu9N0fRbPTfFC2N5p1ubX+1bS0nhu3jNw8xQFbkR7Tuxh0fue+Bun4PWD/ABB1HxFNqdwbG7WaRdNSMKIrmWIRSXAfP3ioPG3gnIPauF0/456/caZ4glj0/TrsWa2clveJFsjiinJDyzxxzzfKhHIEgI6HacgdBrvj6XT/ABBoE41zStXtpNP1OeS/0mO4eBTCilR9njuWSQgnncSfQpyaAIbT4CJb6HfaadbhkMunPpkF49vctPDE0gcKQ10YioI+6saDPIxznZ174PRXP9l/8I1f2XhuaytVtheadZyw3P3gZCrRTomGxyHjfkk5OePLvFHxL1Hxv4J8S2GoR2TwWk2lXNtc20axl0kuEyHRZ5lBBGMb8joQDwPqmgDybTfg5Fp/jE6yNVF5bnVG1cQ3i3DSRzNjcUMdwkWTjq0THHByMCvTNY0/+0rM2/2u7tMsG821k8t+O2cdKu0UAcr/AMIb/wBTH4k/8Dv/ALGq2p+ECmnXTjxF4jJWJzhr3IPB6jbXZ1Q19/L0S+I6mFlH1IwP1NJjW5w9n4VMkCsdf17JA6XY/wDiaU+EeWH9va9x/wBPQ/8Aia6WxG2FR2AxSo25nYdCeKwTZ1ySRy58JEHjXte/8Ch/8TUi+E2xn/hINf8A/Asf/E10uMmpMYWjUh2OQfww9vMrf8JBrwhc4fF2Bg9j938Pyq3/AMIuf+hh8Q/+Bg/+JrekAZSrAFSMEHvSKcAAdBRdktJmCfCzf9DD4h/8DB/8TTP+EXb/AKGHxB/4GD/4muk7UlO7CyOc/wCEWf8A6GHxB/4GD/4mn/8ACKtj/kYfEH/gYP8A4mt55EiwZGC+me9QNePJlbWJm/2iOKiVZR0b1CyOR1Xw9OLhIY9e11l27jvugee38NVD4YlYETa7rDqf4TMuP/Qa624imkkzKw3Dvk/0xVG9aK0j33EsaL0yVzn6dc1i61R7Rf4FJdjmpPDHlRlU1fVgp7CZcf8AoNUdO8Oxpdbjq2pRBZMFxKi4GeTnbW3PrNuQy28Es8o6ItuR+Z4xUNspv45INVsbVVc5Masx46884NL2tT+X8UacjXxaFA6Nquu6mv8AwjnifXotKjJEt7PKrLK3pENoLAc89P69BH4C01iZNTuL/VJioUyXc5PTPQLgd66VbS6hRUiaPYoAVQxAAHYDBphW+HTH4MP/AImh1pfag/w/zG6tmvZ6W+/7zETwjpNujLa6fbxMRwwQFh75NUZVnhk+yAbZT1bHCr6/5/pXTEXue/8A30v+FYmJp76ZpPv7yDyOADgDge1Eat9ORr+vUcW5yvN3JLW1FvEoHJY5JPUn1qZiqE571G6ysMEjgf3jUbxEKGyvbOcmnzPojoUiGVFdyxGPUE0zYmMBgc8jH8JqYRHc/wA4H+6oFRPEFjyXYkfSompzVrAcj4wsYURbqNfLcttdR0bP8Qq14Xutmm25Gf3LkHHpnJ/Q1qzrDcIYp1V1bjDd/wD69VbSwjsAy24LRs27BPI/zis4VeWVp6M6ZVealySOzFxDYWbXU5wgAxjnOegFc/dXz6ldJcyRMkUXyxRZBZmJH4ZPA/rVi5SW90mxGNkcT/MWPUAMo/XH5Vc0WwD3SzEfuouE/wBo4wW/p+da+1jOXLFnFDljq9ye10qeWMNcTtHkfchxgfiRk/p9KmGjQj/WzXEi91aQ4P1xitduBxVeaQKDzW9kjPnlIoau0sVhILMJ5wX5FbgH29q5q6uItO01Ud8LGuXbuzHqfck/zrV1a+WKN2ZgqqMknoBXBXM8mp3QdgRCp+RT/M+/8qznI6KcLasW1R7y7e5lGHkI4znaB0H+e5NdTYwbFFUdLtNoBIraRdopRQTkPUcUE0E4pjNVGQjGonahmqtczJBC8srbY0BZj6CkOw92rP1W+WxtHkOwykHykZseYwBIUe5xTftn2qOSFI3huGQskdwmN4/w7HuM1zuorFeCO08zbMOImlGfKI/5ZyjuDnAb39+T1H6GsdTDQC4kiYmMLI8avkeXz+9Q4+Yc/p09c67Zb8TWvlS3swj3293bMPusTtD+mCPccZ4NWtC0pzCYnEsMcRIVWP7y3fuqt0dCDnmui0rTIrVYrWxgDSsAoCKA0mBjJx/M1LfRGsY2V5FKz0eGG4N5fMt1dnaBIYwCMcAKB3yfrXf6B4dJKXWppgj5ktzzj0Le/t2+vS9oOgR2JS4uiJbwdCPux5/u+/v/ACrdropUbe9Lc4q+J5vdhsFFFFdJxhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVjap4p8P6TqMen6prulWV/KFMdtc3kccjhjgEKxBOSCBWzXlfxW+Feo+P7i8RvFlzZ6ZcQRxpYtDI8cMiOG8xQkyKxOMfvFfHUEcYAOl8W/Ebwt4X03Urq/1iylmsAfNsoLmJrksMZQRlh83zDg46irVt488KzaZpt+/iHSbeDUED23n3sSGTnBUfNgkHKkDOCCK5K5+Dum3a+N3vLmGS98SMxjvPsa+dZKygFVcklgSMkfLn9azNa+Cs2r3Vvd32uW09z/ZiaVdRva3KW88SNlDsiukYHAGQXZSRnaD0APSL7xh4ZsLqe2vvEWjW1xAcTRTX0SPGcZ+YFsjgg81oWmq6de3c1rZ39pcXMKJJLDFMruiuMozKDkBhyCevavPtO+Eej2l14rvdSgtdVl1mERRgWirLbIIPKZI5HZj8w7kjtknrTvgD4Jv/AAb4L/4qDcfEF84e7LusjRoiiOKLcpIIVFHQ9SaAPTKKKKACue8SXXnTR2MRBCsJJiO2OVX8+fwHrVjxPrH9k2ieWAbiYlY89Fx1Y/T09SK5jTLpHbLFmYnczMcliepNY1Jpe6dNCjKXv9DdB8u246t8oqRBtUAVDI6s0Cg8cn+X+NTZqEOe45etOc8VWkn2MVVC5H3sdqfHKsqB1OQaZIrVXnlMS5XBPoeM1MsiMxVXUkdgaGIUjJxmpkm1oBTju7mReLMr9X/+tj9af5d3L9+RY19F6/5/GrXbPam+ZkZVGYevQfrWfs2/ik3+H5ARRWcKHLAyMeSX7/41bbpUMciuCRwQcEHtTVleQny0BQHG4nGf0rSMYw0igEkTLZrPltgJTK4DS4wDj7o9BWgZAG2yAKT0Ocg1Wl82TBSMbW6Ent9MUxrQzphwRWU42XCP68GtW8UwTIJWBDHGcYwaxNRnjbfFG2XPAK9vxqbAd5ZSedZwvnJKDP1pxHJql4bGNEth6Aj/AMeNX261YiFutc/eK0Woz5GAxDKfUYA/mDXQHrWdrMHmW3nKD5kQzx3XuKlmlN2ZS2D5cHr1qOfgsijgikgbeQM07IG8nrUnSiIkYXA56VSvXP3V/Grb/u9p9aw9U+0zyRx2jBMuC8h/hA9u9TKSirs0iruxm+Ira5uBZxWSnzt5ckHGzHvVwR3qaeY2uYReBTtmaPcobsSuRkfiKi1nV49MTav7y4b+HP6mpQ/76MSfNJs3Nn1rks6rvsjaSlKCVtC/4a8TIWi0zWbUadqDyGOBg+ba7Y84hkbGG5/1bfN6b8E128EZiB3kbz1A6Cues7az1PRJ7PUbaG5tJ2IeKVQysOOoPuKzQ+q+Fhi3N1rmhj/lizb7y0X/AGGJzOg/usd47M3C11U6UIvmW550oSi/I7KaUCsi+uwoIBqtBrVnqenpe6bcx3Nq5KiROzDqrA8qw7qQCO4rmfEGosf9GhbEkgyxH8Kf4noPx9KJNrQ6KUE1co6xfHUbnyojm3RuT/fYf0H8/pVrTLLOCRVfTrQFlwMAV0tvEIo8nipSLnK2iHwxBF9AKczelMLFj7elIeaswvcGfFMLU8RMf4T+PFBhPcgfSk2UotkJrP1tGbS5mVS2wrIQO4VgT+gNa2xR2yfemuyqpZyAvck8VPMaKn3KN9HbTWDSTvmJV81XU/dxyGB9aydIso5AY9Ri8rUXDyTc8TI3UH1AyBjsR+ehBpiyTxRWiTzRmQeVA7YjDdRgYycdeeB14xXoukeF4LcJLqLLd3A5xtxGv0Hf6n9KqEHPYmrVjS3Oc0rSbvUtptkCQHrO4+Uf7o6t+HHvXb6RpdtpcJSBSZG+/K33nPuf6dKvgYGBwKK66dKMNjgq15Vd9gooorQwCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOV+IFoZdPt7tels53+ytxn8wv61y9mCvINeosoZSrAFSMEHvXBeJNJt9LkJ0qUiZhuFkRlQPUN/APrn2HFc9and8yO/CV7L2bCEvMyoTwPmNWlBFi0sjEuCdhzyAKytOuryNZjLYSFgBzG6kd/UitGSV2sLfdE8eWQFWxnqPQkVEXZFVY3kb0cSR2+08t3PqfWsYeaNQNtHnZJ82fTHX+n51ckuGCdDVbT7pXv5QxwwUY/En/CquYODRLquLVYpEAGzr9O/6UyCP7YjzyDKdEB9PWjWXBtZN54wc/Sr9ughsIYx0VAP0pkFGzk84i2ySyn5v93/OBWiy84FUdNVV1K5bvsX+bVaeQfaFGQM+/WgDL1GVrOXzF5VxtI/lWrGgSBF9Bis3XdhjXcf4h/Orr3UIQfPn6AmgZV1RC0DMM8CrylXiVl5BGRWfcXii3Zmil2jnO2pNPFw1nGoVEUKME8nHagCt4ggE1lIO+04+tchBFyDiup1tZBbuGkdm6cHGfbjisOKCUzrHsILHAPWkwOy0FNmlQA9xu/M5/rVuSi2UJAigYAAApJTTAhPWmn3p1IaQzmxH5VxJCvAjY/gOo/QinzKojAA5NOuG/wCJndDuWH/oC0n3W5qDsWyK1y2VHpis9sAhVGHbkn0FXrofKvv/ACqkoV/m7sc/h/n+dYVPfkomkVdnC6tAp8QNCMlXlUDJz1xXQTvsuw56H5D/AErGYifxbkfdEp/8dH/1q35IDcO0QGTJx/jTijurysoryNvSbwJYRqTjqfzJNOu9RVEODzWHLDd2o2RYliHAVyQQP97/ABBqpNLeMMLbxIf7zOXx+GB/OpbZiuR6mfrhkt7yTVdLufsWpSDa2E3R3WOizR8BwP73DL2YVDpWpxajf+RdRfYtWmORbO+5Z+P+WD4G8cfcOHHow+arAsJJJS8rM8h6sf5D0FacegWt/aNbX9vHPA/VHGfofYj17VcW9pGNWMd4aGtp1vgD5Tn3GK1lhBHzc+wNc4kmq+HQBcLca1pA/wCWqjfe2w9x/wAt0H/fwf7fSuhsLu21CxhvLC4iubSYZjmibKt6j2I6EHBB4IBq+W2xzqSbs9yVYkA+4Px5p2AOgApc8U1jikzRDJDiq7mpZDUDVDNEQszsSEG0f3m/oKb5S7gzZZx0Ldvp6fhU4WhkZuE++eF+p4FK1yrpHUeC9OURNqMoBd8pF/sqDgn6kj8h7mupqGzgS1tIYI/uRoEH4Cpq9GEeVWPFqTc5OTCiiiqICiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCnq96NP06a5272XARem5iQFH0yRXH28RZnlncyTSHc7nqx/z27V0Hi7d/Z0JBwgmXf9CCB/48Vrm0cjvXNWl71jvwsPdcluXkKRBy2drDBwM8/5NRyTGayKLE5dRjngAjvTYSz425OCDitK3RUusdY51yP94D/D+VTHUKq5WU1ec2Ecr7OQMtj/AOvViLSUidp97GVv4hxUlqg2XNq/IU5X6H/6+an0yXfbGJzl4vlP07fpV2MXJmbb24uNReK4dnQLuVSeOv8A+qrs0JhQqkjqo4A4/rVKWYwazAyAkDO/H93H+OK0790EJbcMYzmgkqaZbI9u8h3GTeQWyc1MLOJssVy3qeTUGhOyxSiUYEjGRM+n+cfnV4MBnNAGRqiRRKrlR8hBye3Na8qjCkAYIrIvx9smFunIP3iOwrQ3yRwiPYZAowCCOlAyvqGPIcHpio9HvVGnRCRgsiKFYHjp3pssU9wSJVCR9xnJNVrm3Q/fAIHqKAK2q3X2qTZEcoCCzjpx2FXdHsWMgllH0HpTrKw3EM64A6L6VsoAi4XigB7EKKgY5NK7ZplIEFNNKelNNIowLhsavcEj+ID/AMdFMZ97E+9LJtlu7mVTlS3X6AD+lNZlSLK43HpUN21Z1x2RVu5Qd5B+6pA9/WqpOwD2Wi5P74L22mqtxJugyO4zXPC/M2+ptTOX0kb9Z8zuS5/PP+Ndzolv8jTuPvfKvuO5rlfDVl5+ohSSBtJYjsK9AijVFVFACqMADsK0RtiZ3lYhe1V+1VZrBfStdVokUYqrHJzWMFbEK3SrkMQQdKtOoFRtxTsF7iVh32hvHey6l4fuRp+pSczKV3W92ewmjyMnsHUhx644razzSimnYlpPRmVpWvRXd6unX9u2m6zgkWkrblmA6tBJwJR3xw47qOtT6xrOmaPGkmr6jZ2EcjbUa6nWIMfQFiM1JqmmWerWjWuo26TwlgwDcFWHIZSOVYdiMEdq434g+G9U1a/8H/2bNdldPvN9xeebG00abNu8+YCHb8D9KNGJOUfM6+yvbXUrOO70+6gurWTOyaCQSI2Dg4YcHkEfhT5GSKN5JWVI0BZmY4CgdSTXl3xI0bxtcTLB4cN/N5Vovl6il/5UkkofO141liiXjI3eW+eBx1F7TdK8TjV9Yk1qDV7q4mZmsLm01IR2sCGPCo0IlX5g3U7GycHtmlyLe5ftHe1j0Kxnt762jubKeK4t5RuSWJw6OPUEcGjw5qdhq+tzWdlP5s9hdpDcrsZfLfhsZIAPHpmvHNY0H4kTeHdLtrO3v01KHTkD3kerMZGuBISVcfaETpn5isucgcdvS/hJoOq6Z4q8Q3esW3lC/v0nhbejbwIcE4UnHzA9cVcaavuZTqtp6HtFFeB6T4W+J1tcaNcx32px3pudUS7a71Tz4EidD9kZojIykBj/AAjcB17Vl2nhT4rp4T16Jr7xB/bM+nJFFGbyMRtcrOhMkc5vHZWKbxgJEhHYHg9Z5x9IUV4d4t8D+P8AT20qDwd4i1y/ivrZ7DUptQ1IF7PfKsn2lOVBZQXUbBuACgZpLzwx8RI/iMZ11TWW0WG9t3s5bWZZYzbKMNFMkl1EDnqzeVI5PIbtQB7lRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBXv7SK+s5bacExyDBwcEehHuDyK5C40W9s2zP+/tx/y1hHOPVk6/ln8K7eionTU9zWlWlS+E5uxWAQq0LKykZDA5zUV8ZEkURLkMdynPAbP+T+dWtYsjZmS+tAfL+9PEOmO7r7jqR3+vWvPKDAHHO1gf1x/Wsrcrsb351zERima4knUBXKhQpPUVJBbGIF1b9833mxwasI2VBpaDMr21sImZ3O6Rup9PakltUlYbmbbnOzPBqxRQAhVSuCOBUTWsLfeVm+rE1NRQAyKKOJdsSKo9hin0UGkA1jngUxbdSwZuSOlPAp2aAHrhaRmpmaaTRcdhxNNzQaQmkOwE5qhq90ba3AjOJZPlX29T+FXc1z2rzhtQZW/5ZKFA+vJ/p+VS2ktTSEbsbAAkWwcL/Sq8rZyx+6vTPenSOZBnO2NR271Ru7jeRFHxx+VZ/H6HSlcikcPuc9M5/KoEVmjMaKWfBwoqRYnlZYYhliMY7AeprWsLRbeOUE7pGUEtjtjGB+INQ3aa8zRtRaM7w9ZeRcJ7Alj6muojX1qhYw7GzjtWpGvFaRRNWV3cUDApj1KRxUUnSqMSu9QNU8lQkUDGUoFAXmnqtAXAClxmnheKdsosCZDszUkaVIEqWNKSQ3ISNK0tKTF/AfQn/wBBNV4460dOTF3Efc/yNawWpz1Je6zbooorpOIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAR1DqysAVIwQe9cRDmK2mtycmBzH+CtgfoBXcVwt0dup6muePtH8wv+NZVejOih1RrQn92KkqOL7g+lSCsxhRRmjNAgopM0maB2HZpM0lFAWDNBNNJxUTtIfuAD3NZzqKO47ExNMeRUHzsqj3OKrPC78ySn3A/zj9Ki8mCPqzH6Hb/ACxWfPUltH73/lcZYN1Fjht3+6Caha+BOEXJ+uT+QzUJltw2EjRmHcLk0155n6KFH+0f8KHGo/tJei/r8hqLew9pJ5Aeqg+vy/8A1/5Vzs5SO9nErbiJM4x1OB2rbKlv9ZIzew4FVptPglkLgMjHrs4zSjTindu78zenDld2Y9xcPJkZ2L79als9Plm+ZsxR+pHzH/PvWxbWkNucxp856seTVkKTV7m3NbYrQW8dum2JQvqe5+pohQsxPbaB+pP/ALMKnlUKuD3/AJd6sW8JCjcPmPJ9qytzVEuxk5akcMWMcVcVMCpY4qlKYFdCRLlcqsvFQSCrjrVd1p2FcpOpzUZWrTrUZWlYLkAWpFSpFSpVSnYLkYSnhKmVKeEosLmIFSp446eqVMiU0hOQRpV2zXFxGfc/yqNEq1briVD71rFGE3oX6KKK1OcKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK4C7ONV1HPUXBJ/T+ld/XE69D5GvXOfuXCrKPy2n/ANBH51jW+G504b4mu6NGHmMEU+q2mTh4grfeHB+tXdtZlNEdLTwuaUJQKxFRiptgpCQtMBgSlIAqKa5VB1FUJb4uT5QyPXtSY0m9i9JIq1TmvFDFVyzeg5qm7lv9Y5b2HAphcAYXAHoKhyRrGi3uTPLK+c4Qe/JqLYp++Wc+54/KopJlQZdgo9SajW4LEbEdh64wP1qeY2VJIug4GAAB7U3kmkXmpUTNFxtWGAc09UqZI6mSKmkQ5EKR1KECqWbgDk1YSLAyeKhCm7l2JkQqclvX/P8A9f0pTly6LdmbmR20JnkMjDCg8D/P+c/StFIgKkjjVFCqAFAwB6VIFq6dPkWu5HMMC0jCpcUhFaWFcqutQOtXWWomWlYdyi6UzZzVxkpuyiwXK6pUqR1KqVKqU7CuRqlOCVMEp4SnYVyEJUyJTwlSKtNIlyBFqeMYIPvSKtSgVaRk2T0UDpRVmYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVi+KbFrqzWeFC89uSwVerKfvD+uPatqilJcysyoycWmjz21n+7JEwIIB4/iFbNteoy4J5HWn6x4ffzZLnTAuWO54CcAnuVPYn06E+nNc88vlyiK5RoZ+ySja34ev1HFcbUqejPQXJW1i9TpxOnqKRrlF7iucMjdncfjTSc/eZ2+rf4UvaIPq8jbn1KJONwz6DrVKa8lk4QbR6t/h/+qqSkL90AfSmyTKhUO4Bb7ozyfoO9J1G9i1QS3JiRnLku3qf8Ka0lT22m6hd8w2jIh/juD5Y/Ijd+la9t4WQtuv7l5R/zziGxfxPU/pTVOchSrUqelzkrrUYIHEbSL5p6IOW/Kq32meZuP3K/gW/wH616jFp1lFbmCO0gEJ4KbBg/X1rj/EugJpo+2WKkWhOJI+vlZ7j/AGfbt9OjqUZRV0KlioSlytWMq2hXO4Al+7Nyfzq9HFVe0OcCtOJM4rFI65OwkcdW4oc9qdFHVyJBitoxOWciJIalCBRk9KmC07b61pY52yjJE9w237sQ6+/+f8+lXI41jQKgwB0FSYpcUowSd+ohuKdilFKBViG4pMVJijFOwrkRWmFasFaaVosFyqUpuyrRWm7KLCuQBKlVKeFqQLTsK4xVp4WnqtPC07CuRhaeq08LTgKdiWwVaeBQBTqoljl6UUgpaZIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFRzwRXERjnjSWM9VdQwP4GpKKAMd/Dels2Vtmi9opXRR/wABBx+lMPhuy7POB6bgf6Vt0VPJF9DRVZrqzGHhvTcgukzkeszj9AQK0LOwtLIH7Jaww56lEAJ+p71ZopqKWyJc5S3YUUUUyQpk8STwvFKoaN1Ksp6EHqKfRQB5t9nayvZrV23NC5TPqOqn8iDWrbnIFTeLrfy9UtbhRxMhjY/7S8j9C35VDbDgVwyjyyaPVhPngmy/FVuMVVhFXIxxVxMpkgFLigCnYrQxuIBS4pQKXFOwriYpcUoFOAp2JuNApcU4ClxTsK43FJtqTFGKLCuRFaTbU2KMU7BciC04LT8U4CiwrjQKcBTgKUCnYVxAKUClxS4piClooFMQUtFFAgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDF8Vxh7CFz1jnUj8cr/AOzVl26VseJTmzhT+/Mo/IFv6VnQL0rnqL3jsoO0CxElW414qOJeKsKKEhSkAFKBSgU4CrsZ3GgU4ClApcU7CuJilApQKcBTFcbinAUUuKBXEpcUoFLimK43FGKdilxRYVxuKUClxSgUwuJilxS0UCCijFLTAMUUUUCCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDG8QfNJaJ2yz/kAP/ZqggXpVrWlzcWx9FcfqtRwr0rGS946YO0CxGvFTAU2McVIBTSJbEApcU4ClxVE3G4pwFLRigVxKXFKBS4piEpcUuKWmITFLijFLQITFLRRQAUUAUuKYCAUtFFAgooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigClqse6KN/7j8/Q8fzxUES1ozIJImQ9xiqUQ4GRg96iS1uaweliVBUgFNUVIBQhNiYoxTsUuKdhDaXFLilxTEJiloxS0CExS0UUAFFFGKYBilxRRQIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqvIm2UkdG5qxTZBlfcc0mNOxGop4FIBTqBhijFLRQIKKKKACiiimAUUYpcUAAooooEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFADdtLiiigBcUYoooAMUmKKKAFxRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41762=[""].join("\n");
var outline_f40_50_41762=null;
var title_f40_50_41763="Drug packet radiograph";
var content_f40_50_41763=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59243%7EPULM%2F78845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59243%7EPULM%2F78845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Plain abdominal radiography demonstrating drug packets",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 281px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In both radiographs, drug packets are clearly visible in the descending colon; on the left, they are also visible in the rectum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen Traub, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Drug packet ingestion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 217px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Abdominal radiograph showing radiopaque drug packets ingested by a \"body packer.\"",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael J Burns, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41763=[""].join("\n");
var outline_f40_50_41763=null;
var title_f40_50_41764="AbobotulinumtoxinA (botulinum toxin type A, Dysport): Patient drug information";
var content_f40_50_41764=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   AbobotulinumtoxinA (botulinum toxin type A, Dysport): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/16/12549?source=see_link\">",
"     see \"AbobotulinumtoxinA (botulinum toxin type A, Dysport): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7999220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dysport&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10023704\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700505",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad side effects have happened when this drug has spread from where it is being used.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10023706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692182",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower the number of  lines and wrinkles of the face.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692091",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat spasms of the head. It may take 2 weeks to get better.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10023705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705253",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to abobotulinumtoxinA or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701034",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to milk, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703160",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an infection where the shot will be given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703746",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had a botulinum toxin product in the last 3 or 4 months.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10023710\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697314",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have nerve disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble swallowing, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10023711\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698253",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle weakness or changes in eyesight may happen. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Less blinking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Seeing double.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry eyes. Using artificial tears may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eyelid droop.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding in the eye may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10023713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698643",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing or speaking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to control bladder.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10023708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the muscle(s) causing the spasms.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696414",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the muscles of the face.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10023709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10023714\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10023715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11342 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-655E7897C0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41764=[""].join("\n");
var outline_f40_50_41764=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7999220\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023704\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023706\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023705\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023710\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023711\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023713\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023708\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023709\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023714\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10023715\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?12/16/12549?source=related_link\">",
"      AbobotulinumtoxinA (botulinum toxin type A, Dysport): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_50_41765="Mechanisms of nutrient absorption and malabsorption";
var content_f40_50_41765=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mechanisms of nutrient absorption and malabsorption",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41765/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41765/contributors\">",
"     Joel B Mason, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41765/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41765/contributors\">",
"     Timothy O Lipman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41765/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41765/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/50/41765/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malabsorption refers to impaired absorption of nutrients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41765/abstract/1\">",
"     1",
"    </a>",
"    ]. It can result from congenital defects in the membrane transport systems of the small intestinal epithelium (primary malabsorption) or from acquired defects in the epithelial absorptive surface (secondary malabsorption). Another factor that can interfere with nutrient absorption is maldigestion, which is due to impaired digestion of nutrients within the intestinal lumen or at the terminal digestive site of the brush border membrane of mucosal epithelial cells.",
"   </p>",
"   <p>",
"    Although malabsorption and maldigestion are pathophysiologically different, the processes underlying digestion and absorption are interdependent, so that in clinical practice, the term malabsorption has come to denote derangements in either process.",
"   </p>",
"   <p>",
"    Three steps are required for normal nutrient absorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41765/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Luminal processing",
"     </li>",
"     <li>",
"      Absorption into the intestinal mucosa",
"     </li>",
"     <li>",
"      Transport into the circulation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Malabsorption can result from defects in any of these three phases (",
"    <a class=\"graphic graphic_table graphicRef54743 \" href=\"mobipreview.htm?5/6/5229\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41765/abstract/3\">",
"     3",
"    </a>",
"    ]. Furthermore, one or more mechanisms may exist concurrently. Thus, while the clinical sequelae may be the same, the underlying pathophysiology and treatment may be different.",
"   </p>",
"   <p>",
"    Malabsorption may either be global or partial (isolated). Global malabsorption results from diseases associated with either diffuse mucosal involvement or a reduced absorptive surface. An example is celiac sprue in which diffuse mucosal disease can lead to impaired absorption of almost all nutrients. Partial or isolated malabsorption results from diseases that interfere with the absorption of specific nutrients. An example is pernicious anemia, a disease that leads to defective cobalamin (vitamin B12) absorption.",
"   </p>",
"   <p>",
"    This topic will review the mechanisms leading to the absorption of fats, carbohydrates, proteins, vitamins, minerals, and trace elements. It will illustrate the many interdependent steps that are required for normal absorption, and some of the various perturbations that can exist leading to malabsorption of these nutrients. The clinical features, diagnosis, and treatment of malabsorption are discussed separately (",
"    <a class=\"graphic graphic_table graphicRef76166 \" href=\"mobipreview.htm?22/44/23244\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/21/38232?source=see_link\">",
"     \"Clinical features and diagnosis of malabsorption\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22279?source=see_link\">",
"     \"Overview of the treatment of malabsorption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FAT ABSORPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most dietary lipids are absorbed in the proximal two-thirds of the jejunum. Absorption is influenced by several factors, including the types of dietary lipids consumed and the presence of other ingested nutrients. Normally, more than 94 percent of dietary fat is absorbed. As a result, on a diet containing 100 grams of fat per day, the presence of &gt;6 grams of fecal fat in a 24-hour collection indicates fat malabsorption.",
"   </p>",
"   <p>",
"    Central to the mechanism of fat absorption is the problem of solubilizing lipids in an aqueous environment. The process begins by the generation of a suspension of fat in water, known as an emulsion. Dietary lipids, consisting mostly of triglycerides, must be emulsified to expose a large surface area to lipolytic enzymes. Emulsification begins in the upper gastrointestinal tract through mastication and gastric mixing. Fat droplets released by these mechanical means are coated with phospholipids to form a stable emulsion. Ingested phospholipids (mostly phosphatidylcholine) exist in a ratio to triglycerides of approximately 1:30, which is adequate for coating. Additional phospholipid from bile is added once the emulsion reaches the duodenum.",
"   </p>",
"   <p>",
"    Fat hydrolysis begins in the stomach by the actions of lingual lipase, which is secreted from von Ebner's glands near the circumvallate papillae, and gastric lipase. In adults, lingual lipase is much less important than in newborns in whom it contributes to as much as 50 percent of lipid hydrolysis. Free fatty acids released by gastric lipolysis contribute to stimulating the secretion of pancreatic lipase and colipase, which are responsible for the majority of lipid hydrolysis. Two other factors optimize the effect of these pancreatic enzymes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The entry of gastric hydrogen ions into the duodenum stimulates the release of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/49/28435?source=see_link\">",
"       secretin",
"      </a>",
"      , which enhances pancreatic bicarbonate secretion. This raises the intraluminal pH to approximately 6.5, which is optimal for fat digestion. Diseases that substantially decrease duodenal pH, such as Zollinger-Ellison syndrome, can selectively inhibit fat absorption.",
"     </li>",
"     <li>",
"      Bile salts further enhance fat solubilization, producing an emulsion of microscopic micelles consisting predominantly of triglycerides, cholesterol esters, and some diglycerides coated by phospholipid.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lipid emulsion in the duodenum is then exposed to pancreatic lipase, which enzymatically degrades each triglyceride molecule into a 2-monoglyceride and two fatty acids. Optimizing the activity of pancreatic lipase depends upon the presence of another enzyme, colipase, which appears to anchor lipase to triglyceride droplets and prevent bile salts from deactivating lipase. Dietary and biliary phospholipids and cholesterol are further hydrolyzed by the action of phospholipase A2 and pancreatic cholesterol esterase.",
"   </p>",
"   <p>",
"    The resulting mixture is a complex soup of lipolytic products. These products, along with other lipids and fat soluble vitamins, are mixed with bile salts forming small aggregates known as micelles or larger aggregates known as liposomes. In this form, 2-monoglycerides and fatty acids readily enter the unstirred water layer that lies adjacent to the enterocyte and are then absorbed across the apical membrane of the cell. The bile salts themselves remain in the intestinal lumen, eventually reaching the terminal ileum where they are actively resorbed, enter the portal circulation, and are then re-secreted into bile. This cycle is known as the enterohepatic circulation.",
"   </p>",
"   <p>",
"    Disease, or resection, of greater than 100 cm of terminal ileum commonly results in severe impairment of the enterohepatic circulation of bile salts such that the liver's ability to upregulate de novo bile acid synthesis is inadequate to meet normal physiological needs for bile production, resulting in fat malabsorption. Similarly, deconjugation of bile acids by florid small bowel bacterial overgrowth defunctionalizes the bile acids, and can also result in fat malabsorption.",
"   </p>",
"   <p>",
"    A much milder form of bacterial overgrowth often accompanies atrophic gastritis or the use of proton pump inhibitory drugs, but this condition does not typically result in fat malabsorption. However, it does appear to interfere with the absorption of vitamin B12.",
"   </p>",
"   <p>",
"    Loss of shorter segments of the terminal ileum may still result in chronic diarrhea even though it may not result in fat malabsorption since the bile acids not absorbed in the small intestine may stimulate water secretion in the colon (which is called 'cholerheic diarrhea').",
"   </p>",
"   <p>",
"    Although the absorption of fatty acids was once believed to occur by passive diffusion, more recent evidence has indicated that active transport processes may be involved. A protein involved in long-chain fatty acid absorption (FATP4) has been identified, although its precise role is not fully defined since it does not appear to be indispensible to the absorptive process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41765/abstract/3\">",
"     3",
"    </a>",
"    ]; it is a member of a larger family of fatty acid transport proteins that are located on the apical side of mature enterocytes in the small intestine. Characterization of this protein may produce novel drugs for the treatment of obesity.",
"   </p>",
"   <p>",
"    Once within villus absorptive cells, fatty acids are transported intracellularly to the smooth endoplasmic reticulum where triglycerides are resynthesized. Triglycerides, cholesterol esters, phospholipid, and apoproteins form an aggregate known as a chylomicron, which binds to the basolateral membrane and is transported to the intestinal lymphatics to enter the general circulation.",
"   </p>",
"   <p>",
"    Disturbances in any of the above mentioned steps in fat assimilation can lead to fat malabsorption and steatorrhea. These include impaired production or activity of pancreatic lipase or colipase, disorders of bile acid metabolism, a decrease in the absorptive surface area, or abnormalities in lymphatic flow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CARBOHYDRATE ABSORPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Starch, sucrose, and lactose are the most abundant digestible carbohydrates in the human diet. Dietary starch and disaccharides must be broken down into their constituent monosaccharides prior to absorption (",
"    <a class=\"graphic graphic_figure graphicRef70035 \" href=\"mobipreview.htm?15/7/15486\">",
"     figure 1",
"    </a>",
"    ). Some plant polysaccharides, such as cellulose, cannot be digested in the small intestinal lumen, although they are fermented to a degree in the colon.",
"   </p>",
"   <p>",
"    Dietary starch consists of the two principal polysaccharides: amylose and amylopectin. Both salivary and pancreatic amylase contribute to their digestion. The products of digestion by amylase are oligo- and disaccharides that are then further degraded at the level of the microvillus membrane. At this site, brush border enzymes (primarily disaccharidases) hydrolyze both digested and ingested oligo- and disaccharides into monosaccharides, which can be absorbed by either active or passive transport processes.",
"   </p>",
"   <p>",
"    Impaired absorption of carbohydrates may result from a deficiency in pancreatic amylase, reduced disaccharidase activity in the small intestinal epithelium, or decreased absorptive intestinal surface area. In primary carbohydrate malabsorption, single functional elements of carbohydrate digestion or absorption are missing, such as in congenital",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    deficiency and sucrase-isomaltase deficiency. Secondary carbohydrate malabsorption can occur from diseases leading to a reduced intestinal absorptive area, such as celiac disease.",
"   </p>",
"   <p>",
"    Carbohydrates that are not digested and absorbed in the small intestine undergo bacterial degradation in the colon. The terminal phase of bacterial carbohydrate degradation is fermentation, which results in the formation of short-chain fatty acids (butyrate, propionate, acetate, lactate), as well as carbon dioxide, hydrogen (H2), and methane. Excessive bacterial fermentation is the reason for acidic stools, abdominal distension, and flatulence in patients with carbohydrate malabsorption.",
"   </p>",
"   <p>",
"    Short-chain fatty acids are available as an additional energy source as they are efficiently absorbed from the colon, and are a preferred energy source for colonic epithelial cells. This allows the body to recover a portion of the potential energy contained within indigestible food fiber and other undigested carbohydrates.",
"   </p>",
"   <p>",
"    The production of hydrogen and methane, resulting from the fermentation of unabsorbed carbohydrates, and their subsequent excretion through the lungs constitutes the basis of a number of noninvasive breath tests designed to look for malabsorption of particular carbohydrates. The most common of these tests is the lactose breath test, which accurately defines those who are deficient in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41765/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/32/5641?source=see_link&amp;anchor=H14#H14\">",
"     \"Lactose intolerance\", section on 'Lactose breath hydrogen test'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With the rising use of fructose as a sweetener in commercially prepared foods, often as high-fructose corn syrup, concern about fructose intolerance has emerged, although the clinical syndrome remains a matter of controversy. Some individuals seem to develop symptoms of carbohydrate malabsorption when sufficiently large quantities of fructose are consumed, particularly if the fructose is in a form other than as one of the monosaccharide components of sucrose. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22279?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of the treatment of malabsorption\", section on 'Fructose intolerance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PROTEIN ABSORPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Protein digestion begins in the stomach by the action of gastric pepsins, which are released as proenzymes (pepsinogen 1 and 2), and undergo autoactivation at low pH. The amount of proteolysis achieved by gastric pepsins depends upon the composition of other dietary constituents, gastric motility, and pH. The observation that patients who are achlorhydric or have lost control of gastric emptying can still digest proteins suggests that proteolysis within the stomach is not essential for protein digestion. However, amino acids released from gastric digestion play a role in releasing cholecystokinin (CCK) from duodenal and jejunal endocrine epithelial cells. CCK is critical for stimulating the release of pancreatic enzymes responsible for nutrient absorption.",
"   </p>",
"   <p>",
"    In the duodenum, several proteases act together to digest proteins into amino acids, or dipeptides and tripeptides. Like gastric pepsinogens, pancreatic enzymes are secreted as inactive proenzymes, which are activated by hydrolysis of a peptide bond. Central to this process is enterokinase, which is released from the microvillus membrane of duodenal absorptive cells by the action of bile salts. Enterokinase converts trypsinogen to trypsin, which then catalyzes the conversion of all other pancreatic proteases to their active forms, as well as auto-catalyzing the activation of additional trypsinogen.",
"   </p>",
"   <p>",
"    Following pancreatic enzyme digestion, amino acids, dipeptides, and tripeptides can be absorbed through highly efficient sodium-dependent amino acid co-transporters at the brush border membrane; this step is passive but is called secondary active transport since the energy is indirectly provided by the sodium-potassium ATPase pump. By maintaining a low intracellular sodium concentration and a cell interior negative potential, the pump provides a strong inward gradient for sodium entry which can drive the absorption of amino acids.",
"   </p>",
"   <p>",
"    Different classes of amino acid transporters exist on the brush border, as evidenced by selectivity expressed for neutral, basic, and acidic amino acids. Transporters for dipeptides and tripeptides are also distinct from those responsible for free amino acid transport. Additional peptidases are located within the brush border membrane and the cytoplasm of absorptive cells.",
"   </p>",
"   <p>",
"    Impaired digestion and absorption of dietary protein occurs when pancreatic protease secretion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    activity is impaired, as in chronic pancreatitis or cystic fibrosis. Protein malabsorption can also occur in diseases associated with a generalized reduction of the intestinal absorptive surface. Possible clinical consequences include hypoalbuminemia and protein malnutrition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     VITAMIN, MINERAL, AND TRACE ELEMENT ABSORPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamins and minerals represent a wide array of compounds, possessing an equally wide array of biochemical properties. It is therefore not surprising that the intestine has many types of transport mechanisms to facilitate assimilation of these nutrients across the intestinal barrier. Some nutrients, such as the carotenoids, appear to be absorbed solely by passive diffusion, while many others are absorbed by carrier-mediated, non-energy requiring processes or active transport systems (ie, energy-requiring transporters that can work against a chemical gradient), such as folate and calcium. The type of transport varies in different portions of the small intestine for many micronutrients.",
"   </p>",
"   <p>",
"    A more detailed discussion of the transport mechanisms for each nutrient is beyond the scope of this discussion but a few general remarks can be made that have implications in regard to the clinical management of malabsorption:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fat-soluble vitamins (A, D, E, and K) require solubilization in a mixed micellar phase in order to be absorbed. As a result, factors that adversely impact on fat absorption will usually affect absorption of these vitamins in a parallel manner.",
"     </li>",
"     <li>",
"      The proximal half of the small intestine is the predominant site for the absorption of most vitamins and minerals. A notable exception is vitamin B12, which is absorbed by a specific ileal receptor that recognizes the B12-intrinsic factor complex. Thus, extensive ileal disease or resection decreases B12 absorption and often leads to a deficiency state. As a general rule, ileal disease or resection exceeding 100 cm is associated with a high risk of B12 deficiency. As mentioned above, this degree of ileal impairment is also associated with fat malabsorption and may thereby interfere with assimilation of fat-soluble vitamins. Another exception is magnesium. Although an understanding of the intestinal absorption of magnesium remains somewhat unclear, it appears to occur just as avidly in the distal intestine (including the colon) as more proximal sites.",
"     </li>",
"     <li>",
"      The excess fatty acids present in the intestinal lumen of patients with untreated fat malabsorption bind divalent cations, such as calcium and magnesium, creating soaps and causing undue losses of these minerals. Clinically significant deficiencies of these minerals are common in untreated fat malabsorption and create a substantial risk for metabolic bone disease. The problem of calcium depletion in this setting will be further magnified if vitamin D deficiency is also present. Magnesium is needed for both the secretion and peripheral action of parathyroid hormone. As a result, refractory hypocalcemia in the setting of fat malabsorption occasionally responds to magnesium replacement. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44632?source=see_link\">",
"       \"Treatment of hypocalcemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The avidity with which some nutrients are absorbed in the intestine is regulated by the nutritional status of the individual in regard to the specific nutrient. Examples include calcium, for which the upregulation of transport appears to be primarily a vitamin D-mediated process, and inorganic (ie, non-heme) iron absorption, for which systemic iron deficiency causes a remarkable increase in the efficiency of iron absorption.",
"     </li>",
"     <li>",
"      The number of surgeries done to correct obesity continues to rise, underscoring the need to appreciate nutrient deficiencies that commonly accompany the resulting weight loss. Roux-en-Y gastric bypass is presently the most common procedure of this type performed in the United States. In addition to discouraging the intake of food, this surgical procedure produces mild malabsorption of a multifactorial nature. Vitamin B12, iron, calcium, and vitamin D deficiencies are the most commonly observed; more rarely ascorbic acid (vitamin C) and copper deficiencies have been described. Routine",
"      <span class=\"nowrap\">",
"       multivitamin/mineral",
"      </span>",
"      supplementation is indicated, although it is not sufficient to prevent micronutrient deficiencies in some instances, so ongoing monitoring is indicated. There have been many reports of thiamin deficiency, with classical symptoms of beriberi, arising in the setting of persistent vomiting and poor food intake after this type of surgery. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link\">",
"       \"Complications of bariatric surgery\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H77722886\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malabsorption can result from defects in any of the three phases of nutrient absorption (",
"      <a class=\"graphic graphic_table graphicRef54743 \" href=\"mobipreview.htm?5/6/5229\">",
"       table 1",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Luminal processing",
"     </li>",
"     <li>",
"      Absorption into the intestinal mucosa",
"     </li>",
"     <li>",
"      Transport into the circulation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Disturbances in the steps in fat assimilation can lead to fat malabsorption and steatorrhea. These include impaired production or activity of pancreatic lipase or colipase, a large increase in gastric acid secretion which inactivates pancreatic enzymes (eg, gastrinoma), disorders of bile acid metabolism or bile secretion, a decrease in the absorptive surface area, or abnormalities in lymphatic flow. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Fat absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Impaired absorption of carbohydrates may result from a deficiency in pancreatic amylase, reduced disaccharidase activity in the small intestinal epithelium, or decreased absorptive intestinal surface area. In primary carbohydrate malabsorption, single functional elements of carbohydrate digestion or absorption are missing, such as in congenital",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/62/14306?source=see_link\">",
"       lactase",
"      </a>",
"      deficiency and sucrase-isomaltase deficiency. Secondary carbohydrate malabsorption can occur from diseases leading to a reduced intestinal absorptive area, such as celiac disease. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Carbohydrate absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Impaired digestion and absorption of dietary protein occurs when pancreatic protease secretion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      activity is impaired, as in chronic pancreatitis or cystic fibrosis. Protein malabsorption can also occur in diseases associated with a generalized reduction of the intestinal absorptive surface. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Protein absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The fat-soluble vitamins (A, D, E, and K) require solubilization in a mixed micellar phase in order to be absorbed. As a result, factors that adversely impact on fat absorption will usually affect absorption of these vitamins in a parallel manner. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Vitamin, mineral, and trace element absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The proximal half of the small intestine is the predominant site for the absorption of most vitamins and minerals. A notable exception is vitamin B12, which is absorbed by a specific ileal receptor that recognizes the B12-intrinsic factor complex. Thus, extensive ileal disease or resection decreases B12 absorption and often leads to a deficiency state. As a general rule, ileal disease or resection exceeding 100 cm is associated with a high risk of B12 deficiency. This degree of ileal impairment is also associated with fat malabsorption and may thereby interfere with assimilation of fat-soluble vitamins. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Vitamin, mineral, and trace element absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Excess fatty acids present in the intestinal lumen of patients with untreated fat malabsorption bind divalent cations, such as calcium and magnesium, creating soaps and causing undue losses of these minerals. Clinically significant deficiencies of these minerals are common in untreated fat malabsorption and create a substantial risk for metabolic bone disease. The problem of calcium depletion in this setting will be further magnified if vitamin D deficiency is also present. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Vitamin, mineral, and trace element absorption'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Hogenauer C, Hammer H. Maldigestion and Malabsorption. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 9th ed, Feldman M, Friedman L, Brandt L (Eds), Saunders, Philadelphia, PA 2010. p.1735.",
"    </li>",
"    <li>",
"     Farrell JJ. Digestion and absorption of nutrients and vitamins. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 9th ed, Feldman M, Friedman L, Brandt L (Eds), Saunders, Philadelphia, PA 2010. p.1695.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41765/abstract/3\">",
"      Shim J, Moulson CL, Newberry EP, et al. Fatty acid transport protein 4 is dispensable for intestinal lipid absorption in mice. J Lipid Res 2009; 50:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41765/abstract/4\">",
"      Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002; 97:1113.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4781 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-287B6DBA01-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41765=[""].join("\n");
var outline_f40_50_41765=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H77722886\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FAT ABSORPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CARBOHYDRATE ABSORPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PROTEIN ABSORPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      VITAMIN, MINERAL, AND TRACE ELEMENT ABSORPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H77722886\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4781\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4781|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?15/7/15486\" title=\"figure 1\">",
"      Structure of starches",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4781|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/6/5229\" title=\"table 1\">",
"      Mechanisms of malabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/44/23244\" title=\"table 2\">",
"      Clinical features malabsorption",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/21/38232?source=related_link\">",
"      Clinical features and diagnosis of malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=related_link\">",
"      Complications of bariatric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/32/5641?source=related_link\">",
"      Lactose intolerance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/48/22279?source=related_link\">",
"      Overview of the treatment of malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44632?source=related_link\">",
"      Treatment of hypocalcemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_50_41766="Large local reactions to mosquito bites (Skeeter Syndrome)";
var content_f40_50_41766=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Large local reactions to mosquito bites (Skeeter Syndrome)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41766/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41766/contributors\">",
"     F Estelle R Simons, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41766/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41766/contributors\">",
"     David B Golden, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41766/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41766/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/50/41766/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H406746\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reactions to mosquito bites are caused by an immunologic response to proteins in mosquito saliva. Many people who are bitten by mosquitoes develop an immune response to these proteins; however, only a small proportion of them develop clinically relevant allergic reactions, most commonly large local reactions.",
"   </p>",
"   <p>",
"    This topic briefly reviews the types of reactions that may result from mosquito bites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/1\">",
"     1",
"    </a>",
"    ]. It then focuses on large local reactions to mosquito bites and their clinical features, pathogenesis, natural history, diagnosis, differential diagnosis, treatment, and prevention. Other issues related to insect bites are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/35/28216?source=see_link\">",
"     \"Insect bites\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43031?source=see_link\">",
"     \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5318273\">",
"    <span class=\"h1\">",
"     TYPES OF REACTIONS TO MOSQUITO BITES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406753\">",
"    <span class=\"h2\">",
"     Typical (normal) reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typical local cutaneous reactions to mosquito bites consist of immediate wheals (swelling) with surrounding flares (redness) peaking at 20 minutes, and delayed itchy, indurated (firm) papules peaking at 24 to 36 hours, which diminish over 7 to 10 days.",
"   </p>",
"   <p>",
"    The typical clinical course of sensitization and natural desensitization to the salivary proteins injected when mosquitoes bite was described initially in the 1940s. It evolves over months or years (",
"    <a class=\"graphic graphic_table graphicRef63430 \" href=\"mobipreview.htm?7/53/8027\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/2\">",
"     2",
"    </a>",
"    ]. People who have never been exposed to a particular species of mosquito do not develop reactions to the initial bites from such mosquitoes. Subsequent bites result in the appearance of delayed local skin reactions. After repeated bites, immediate wheals develop. With further exposure, the delayed local reactions wane and eventually disappear, although the immediate reactions persist. People who are repeatedly exposed to bites from the same species of mosquito eventually also lose their immediate reactions. The duration of each of these five different stages differs, depending on the intensity and timing of mosquito exposure (",
"    <a class=\"graphic graphic_table graphicRef63430 \" href=\"mobipreview.htm?7/53/8027\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/2\">",
"     2",
"    </a>",
"    ]. These typical reactions are annoying, but should not cause undue alarm. The immunological basis of sensitization and natural desensitization to mosquito bites was described in the 1990s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406760\">",
"    <span class=\"h2\">",
"     Large local reactions to mosquito bites (Skeeter Syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large local reactions are by far the most common type of allergic reactions to mosquito bites:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Large local reactions (termed Skeeter Syndrome) typically consist of an itchy or even painful area of redness, warmth, swelling",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      induration that ranges from a few cm to more than 10 cm in diameter. Large local reactions develop within hours of the bite, progress over 8 to 12 hours or more, and resolve within 3 to 10 days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Large local reactions can involve the entire periorbital region and much of the face, or an entire extremity, especially in an infant or child. They can interfere with seeing, eating, drinking, or normal use of extremities. Severe large local reactions can be accompanied by low grade fever and malaise [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      By inspection and palpation, it can be difficult to differentiate between allergic inflammation caused by mosquito bites and inflammation caused by secondary bacterial infection after scratching the bites. It is important to obtain a meticulous history of the time of onset of the red, warm swollen area at the site of a witnessed or likely mosquito bite in relationship to the time of the bite. Large local reactions typically begin within hours. Secondary bacterial infections typically begin within days.",
"     </li>",
"     <li>",
"      Sometimes, large local reactions develop an ecchymotic appearance or are associated with blisters, vesicles or bullae.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406767\">",
"    <span class=\"h2\">",
"     Systemic allergic reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic allergic reactions to mosquito bites include papular or acute generalized urticaria, and rarely, asthma symptoms, anaphylaxis, serum sickness, or lymphadenopathy, hepatosplenomegaly, fever, and necrotic skin reactions at mosquito bite sites (",
"    <a class=\"graphic graphic_table graphicRef56254 \" href=\"mobipreview.htm?12/32/12811\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. These allergic reactions are not discussed further in this review.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3868921\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;People at increased risk of allergic reactions to mosquito bites include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those with a high level of exposure (eg, civilian or military outdoor workers)",
"     </li>",
"     <li>",
"      Infants and young children with low or absent natural immunity",
"     </li>",
"     <li>",
"      Immigrants or visitors to a geographic area where there are indigenous mosquitoes that they had not previously encountered and to which they have no natural immunity",
"     </li>",
"     <li>",
"      Patients with primary or secondary immunodeficiency diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406774\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES AND PATHOGENESIS OF LARGE LOCAL REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of Skeeter Syndrome was investigated in a study of five otherwise healthy young children age two to four years who developed large local reactions within hours of witnessed mosquito bites, and five age-matched control children who developed smaller typical reactions within hours of mosquito bites. All the children with the large local reactions had been diagnosed initially with bacterial cellulitis by primary care clinicians. All received systemic antibiotic treatment which was discontinued after a few days when the swelling was subsiding and the blood cultures performed at the time of initial presentation were reported as negative. In two of the children, radiographs were obtained to rule out osteomyelitis underlying the extensive soft tissue swelling at the site of a witnessed bite on an extremity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An indirect enzyme-linked immunosorbent assay (ELISA) was used to measure IgE and IgG4 subclasses recognizing salivary gland allergens of the predominant indigenous mosquito Aedes vexans. The salivary allergens used in the ELISA were obtained by dissecting the salivary glands from the heads and thoraces of 370 laboratory-reared female A. vexans mosquitoes and dispersing them in 1 mL of diluent. In the children with Skeeter Syndrome, serum levels of IgE, IgG1, IgG3, and IgG4 to A. vexans salivary gland allergens were significantly elevated as compared with the levels in control children. In Western blotting, sera from children with Skeeter Syndrome (but not from control children) reacted with 8 to 10 A. vexans salivary gland allergens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/5,8\">",
"     5,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IgE and IgG, especially IgG4 and IgG1, are involved in the development of Skeeter Syndrome. Serum mosquito salivary gland&ndash;specific IgG levels correlated significantly with the size of the immediate skin reaction to mosquito bites and with salivary gland&ndash;specific IgE levels. Specific IgE and IgG concentrations were significantly higher at the end of summer, as compared with levels at the end of the following winter after no exposure to mosquitoes had occurred for six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406781\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY OF LARGE LOCAL REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of immune deficiency, the prognosis of Skeeter Syndrome appears to be favorable. As an example, children often continue to develop recurrent large local reactions to mosquito bites for several more summers, after which the reactions cease to occur. The time to resolution varies, however [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] and in some patients in northern latitudes (eg, Alaska, Canada, and the Nordic countries) this natural desensitization may take longer to develop because it depends on the frequency and intensity of the patient's exposure to mosquitoes, which is intermittent and limited in most cases by the short summer season. Additionally, it is reduced by efforts to avoid mosquitoes and prevent mosquito bites.",
"   </p>",
"   <p>",
"    In a subsequent study of sera from 402 children living in the same region of Canada where Skeeter Syndrome was originally described, levels of mosquito saliva-specific IgE and IgG correlated inversely with age, peaked at one to six months of age, and decreased after age five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/11\">",
"     11",
"    </a>",
"    ]. In this geographic region, only 18 percent of 1059 adult blood donors had demonstrable antibodies to mosquito salivary allergens, suggesting that in most adults, sensitization had been lost and natural desensitization had occurred.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406788\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeeter Syndrome develops within hours of mosquito bites. Diagnosis is based on the time of onset of the reaction in relationship to a witnessed or likely mosquito bite, and on the physical finding of an itchy, red, warm swollen area at the site of the bite.",
"   </p>",
"   <p>",
"    Testing for the presence of antibodies to mosquito saliva is not practical because the only commercially available mosquito reagents are unstandardized whole body extracts that contain minimal mosquito salivary allergens but may contain irritant proteins. Obtaining pure mosquito salivary allergen for use in skin tests and",
"    <em>",
"     in vitro",
"    </em>",
"    tests by dissection of mosquito salivary glands, or by direct collection from living female mosquitoes, is labor-intensive and time-consuming. Such allergens are not commercially available. Mosquito bite challenge tests are contraindicated because of the risk of disease transmission through a \"wild\" mosquito bite, and the risk of causing another severe large local reaction in a susceptible patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/1,12,13\">",
"     1,12,13",
"    </a>",
"    ]. Recombinant salivary allergens have been developed as a research tool, but are not commercially available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406795\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of a large local reaction to a mosquito bite includes bacterial cellulitis and large local reactions to other insect bites and stings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406802\">",
"    <span class=\"h2\">",
"     Bacterial cellulitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The key information needed to facilitate the diagnosis of Skeeter Syndrome is the time elapsed (hours) between a witnessed mosquito bite, or exposure to mosquitoes and a likely mosquito bite, and the appearance of an itchy, red, warm, swollen, area at the bite site. A typical presentation of Skeeter Syndrome might involve a two-year-old child who presents with a history of playing in a park and being exposed to mosquitoes the previous evening, and then wakes up the next morning with an itchy, red, warm swelling of the entire periorbital region at the site of a mosquito bite. In contrast, bacterial cellulitis does not typically develop within hours of a mosquito bite. Instead, it appears several days later, after scratching and excoriation of the itchy area at the bite site and development of a secondary infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12825?source=see_link\">",
"     \"Cellulitis and erysipelas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406809\">",
"    <span class=\"h2\">",
"     Large local reactions to other insect bites and stings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mosquito bites are painless, in contrast to painful bites from flies and other insects that cause large local reactions, and painful stings from bees, wasps, yellow jackets, yellow hornets, white-faced hornets, or fire ants that cause large local reactions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/35/28216?source=see_link\">",
"     \"Insect bites\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/1/12313?source=see_link\">",
"     \"Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/51/7994?source=see_link\">",
"     \"Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/16/24839?source=see_link\">",
"     \"Approach to the patient with a suspected spider bite: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406816\">",
"    <span class=\"h1\">",
"     PREVENTION AND TREATMENT OF LARGE LOCAL REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention of large local reactions consists of mosquito avoidance and prophylaxis with an oral non-impairing, non-sedating H1-antihistamine. Treatment of large local reactions involves antihistamines and, for severe reactions, glucocorticoids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H877634\">",
"    <span class=\"h2\">",
"     Mosquito avoidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Written information about insect repellents and environmental control measures to reduce mosquito populations near the home should be provided for patients who have experienced large local reactions, and for parents and caregivers of children who have experienced such reactions. Key points are reviewed briefly here and discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43031?source=see_link\">",
"     \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Activities should be modified to avoid mosquito bites. Measures might include staying indoors at dawn and dusk, and avoidance of wetlands, bush, and tall grass.",
"     </li>",
"     <li>",
"      Standing water should be eliminated around the home or other immediate environment in order to reduce breeding areas for mosquitoes. Screens on windows and doors should be well-maintained.",
"     </li>",
"     <li>",
"      The insecticide",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/20/23875?source=see_link\">",
"       permethrin",
"      </a>",
"      is suitable for application to fabrics, for example, camp tents, sleeping bags, and clothing, but not for direct application to human skin. Permethrin-impregnated clothes, eg, shirts, are available commercially.",
"     </li>",
"     <li>",
"      Different insect repellents are available in a variety of formulations and concentrations. The most effective repellents are DEET and picaridin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/14,15\">",
"       14,15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Humans attract mosquitoes by their body odor, skin temperature, and exhaled carbon dioxide. DEET-containing products provide excellent protection against bites. The higher the DEET concentration, the longer-lasting the protection. DEET in a concentration of 10 percent can be applied safely to the skin of infants over age six months and to young children. DEET is potentially neurotoxic if applied in high concentrations to abraded or sunburned skin or if unintentionally ingested or inhaled. DEET is also a plasticizer and as such, it can dissolve mosquito nets, spandex, rayon and leather, as well as plastic eyeglass frames and watches. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43031?source=see_link&amp;anchor=H6#H6\">",
"       \"Prevention of arthropod and insect bites: Repellents and other measures\", section on 'DEET'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Picaridin blocks insects' ability to locate human skin by forming a barrier on the skin. It is odorless, leaves no residue, and has long-lasting efficacy (between 8 to 10 hours). Overall, in comparison to DEET, it is more effective against mosquitoes and less potentially toxic to humans; however, it is not recommended for use on the skin of children under two years of age. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43031?source=see_link&amp;anchor=H7#H7\">",
"       \"Prevention of arthropod and insect bites: Repellents and other measures\", section on 'Picaridin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other agents such as citronella and lemon eucalyptus oil are less effective and relatively short-acting; for example, citronella may be effective for only 20 minutes, and eucalyptus oil may be effective for only two hours.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5317951\">",
"    <span class=\"h2\">",
"     Antihistamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;In randomized double-blind placebo-controlled trials of patients bitten by mosquitoes in laboratory and field settings, prophylactic administration of a non-impairing, non-sedating H1-antihistamine, (eg,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/7/18549?source=see_link\">",
"     cetirizine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/13/23765?source=see_link\">",
"     desloratadine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?3/37/3670?source=see_link\">",
"     fexofenadine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/63/9205?source=see_link\">",
"     levocetirizine",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/5/8278?source=see_link\">",
"     loratadine",
"    </a>",
"    ) relieved itching in the early-phase allergic reaction and reduced the late-phase reactions (redness, swelling, and induration). H1-antihistamines are the only class of pharmacologic agents that has been studied prospectively in prevention or treatment of large local reactions to insect stings or bites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. We suggest to patients that a non-impairing, non-sedating antihistamine be taken on a regular daily basis when mosquito exposure is inevitable and that such antihistamines should also be used to treat itching, redness, and swelling that occur at mosquito bite sites.",
"   </p>",
"   <p>",
"    The short-term and long-term safety of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/7/18549?source=see_link\">",
"     cetirizine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?23/13/23765?source=see_link\">",
"     desloratadine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?3/37/3670?source=see_link\">",
"     fexofenadine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/63/9205?source=see_link\">",
"     levocetirizine",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/5/8278?source=see_link\">",
"     loratadine",
"    </a>",
"    has been confirmed in randomized controlled trials, even in young children. In contrast, the safety of impairing, sedating H1-antihistamines such as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/29/34256?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?24/52/25413?source=see_link\">",
"     chlorpheniramine",
"    </a>",
"    has not been optimally studied in randomized controlled trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5317958\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids are used to treat the allergic inflammation associated with large local reactions to stinging insects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41766/abstract/19\">",
"     19",
"    </a>",
"    ]. This approach has been extrapolated to the treatment of large local reactions to mosquito bites.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To reduce itching, redness, warmth and swelling, a moderately potent topical glucocorticoid cream with a good benefit-to-risk ratio, for example,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/57/36752?source=see_link\">",
"       mometasone",
"      </a>",
"      cream 0.1 percent, may be applied twice daily for 5 to 10 days.",
"     </li>",
"     <li>",
"      For severe large local reactions that are distressing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      interfere with normal vision, ingestion of liquid or food, or ambulation, an oral glucocorticoid such as",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/23/29047?source=see_link\">",
"       prednisone",
"      </a>",
"      1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      to a maximum of 50 mg may be given for 5 to 7 days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A variety of topical lotions and creams containing local anesthetics",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    H1-antihistamines such as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/29/34256?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/25/34192?source=see_link\">",
"     doxepin",
"    </a>",
"    are available for application to affected mosquito bite sites; however, these interventions are",
"    <strong>",
"     not",
"    </strong>",
"    recommended because topical application of these medications can lead to systemic absorption and contact hypersensitivity.",
"   </p>",
"   <p>",
"    Antibiotic treatment is",
"    <strong>",
"     not",
"    </strong>",
"    indicated for large local reactions that develop within hours of mosquito bites, because it is unlikely that bacterial infection would develop within this brief time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H406837\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Many people who are bitten by mosquitoes become sensitized to mosquito salivary allergens, but few develop mosquito allergy, most commonly large local reactions to mosquito bites. Systemic reactions, including anaphylaxis, are rare. (See",
"      <a class=\"local\" href=\"#H5318273\">",
"       'Types of reactions to mosquito bites'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Large local reactions to mosquito bites (Skeeter Syndrome) are caused by an allergic reaction to mosquito saliva. These itchy, red, warm swellings typically develop within hours of bites on the face or extremities, and resolve with or without treatment over 3 to 10 days. Skeeter Syndrome is most common in young children who have not yet developed natural immunity to mosquitoes. It is sometimes accompanied by low-grade fever and malaise. (See",
"      <a class=\"local\" href=\"#H406760\">",
"       'Large local reactions to mosquito bites (Skeeter Syndrome)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of large local reactions (Skeeter Syndrome) is made clinically. The key information needed is the time elapsed, measured in hours (not days) between a witnessed mosquito bite or exposure to mosquitoes and a likely mosquito bite, and the appearance of an itchy, red, warm, swollen area at the bite site. Prompt recognition and appropriate treatment helps avoid unnecessary diagnostic procedures and unnecessary antibiotic treatment. (See",
"      <a class=\"local\" href=\"#H406788\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Large local reactions to mosquito bites (Skeeter Syndrome) are frequently misdiagnosed as bacterial cellulitis; however, Skeeter Syndrome typically develops within hours of a bite, and bacterial cellulitis typically develops a few days later, after bite sites have been scratched and excoriated. (See",
"      <a class=\"local\" href=\"#H406788\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H406795\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical diagnosis of allergic reactions to mosquito bites is difficult to confirm because of lack of availability of high-quality standardized allergens (mosquito salivary gland or saliva extracts) for use in skin tests or in measurement of serum mosquito saliva-specific IgE levels.",
"     </li>",
"     <li>",
"      In otherwise healthy children, large local reactions (Skeeter Syndrome) typically cease to occur within a few years. (See",
"      <a class=\"local\" href=\"#H406781\">",
"       'Natural history of large local reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Environmental measures to limit mosquito breeding habitats and repellents to prevent bites are the primary means of preventing large local reactions in patients with a history of past reactions. If mosquito exposure is predictable or inevitable, we recommend a non-impairing, non-sedating H1-antihistamine, taken before spending time outdoors (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Treatment of large local reactions to mosquito bites is symptomatic (see",
"      <a class=\"local\" href=\"#H406816\">",
"       'Prevention and treatment of large local reactions'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with bothersome itching, we recommend an oral non-impairing, non-sedating H1-antihistamine (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/7/18549?source=see_link\">",
"       Cetirizine",
"      </a>",
"      , at age appropriate doses, is an example.",
"     </li>",
"     <li>",
"      For patients with swelling and induration several centimeters in diameter, we suggest a topical glucocorticoid cream (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We typically use",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/57/36752?source=see_link\">",
"       mometasone",
"      </a>",
"      0.1 percent, applied twice daily for 5 to 10 days.",
"     </li>",
"     <li>",
"      For patients with extensive periorbital swelling that interferes with vision, lip swelling that interferes with liquid or food ingestion, or swelling of a limb that interferes with ambulation, we suggest a short course of an oral glucocorticoid such as",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/23/29047?source=see_link\">",
"       prednisone",
"      </a>",
"      (1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      to a maximum of 50 mg) once daily for 5 to 7 days (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/1\">",
"      Peng Z, Simons FE. Advances in mosquito allergy. Curr Opin Allergy Clin Immunol 2007; 7:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/2\">",
"      Mellanby K. Man's reaction to mosquito bites. Nature 1946; 158:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/3\">",
"      Reunala T, Brummer-Korvenkontio H, R&auml;s&auml;nen L, et al. Passive transfer of cutaneous mosquito-bite hypersensitivity by IgE anti-saliva antibodies. J Allergy Clin Immunol 1994; 94:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/4\">",
"      Peng Z, Yang M, Simons FE. Immunologic mechanisms in mosquito allergy: correlation of skin reactions with specific IgE and IgG antibodies and lymphocyte proliferation response to mosquito antigens. Ann Allergy Asthma Immunol 1996; 77:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/5\">",
"      Simons FE, Peng Z. Skeeter syndrome. J Allergy Clin Immunol 1999; 104:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/6\">",
"      Engler RJ. Mosquito bite pathogenesis in necrotic skin reactors. Curr Opin Allergy Clin Immunol 2001; 1:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/7\">",
"      McCormack DR, Salata KF, Hershey JN, et al. Mosquito bite anaphylaxis: immunotherapy with whole body extracts. Ann Allergy Asthma Immunol 1995; 74:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/8\">",
"      Peng Z, Beckett AN, Engler RJ, et al. Immune responses to mosquito saliva in 14 individuals with acute systemic allergic reactions to mosquito bites. J Allergy Clin Immunol 2004; 114:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/9\">",
"      Peng Z, Simons FE. A prospective study of naturally acquired sensitization and subsequent desensitization to mosquito bites and concurrent antibody responses. J Allergy Clin Immunol 1998; 101:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/10\">",
"      Palosuo K, Brummer-Korvenkontio H, Mikkola J, et al. Seasonal increase in human IgE and IgG4 antisaliva antibodies to Aedes mosquito bites. Int Arch Allergy Immunol 1997; 114:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/11\">",
"      Peng Z, Rasic N, Liu Y, Simons FE. Mosquito saliva-specific IgE and IgG antibodies in 1059 blood donors. J Allergy Clin Immunol 2002; 110:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/12\">",
"      Peng Z, Simons FE. Comparison of proteins, IgE, and IgG binding antigens, and skin reactivity in commercial and laboratory-made mosquito extracts. Ann Allergy Asthma Immunol 1996; 77:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/13\">",
"      Wang Q, Beckett A, Simons FE, Peng Z. Comparision of the mosquito saliva-capture enzyme-linked immunosorbent assay and the unicap test in the diagnosis of mosquito allergy. Ann Allergy Asthma Immunol 2007; 99:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/14\">",
"      Katz TM, Miller JH, Hebert AA. Insect repellents: historical perspectives and new developments. J Am Acad Dermatol 2008; 58:865.",
"     </a>",
"    </li>",
"    <li>",
"     Cohen B, Hebert AA. Assault of the arthropods. Which product should you recommend to prevent insect bites? AAP News 2011; (April):15. www.aapnews.org (Accessed on June 09, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/16\">",
"      Karppinen A, Kautiainen H, Petman L, et al. Comparison of cetirizine, ebastine and loratadine in the treatment of immediate mosquito-bite allergy. Allergy 2002; 57:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/17\">",
"      Karppinen A, Brummer-Korvenkontio H, Petman L, et al. Levocetirizine for treatment of immediate and delayed mosquito bite reactions. Acta Derm Venereol 2006; 86:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/18\">",
"      Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol 2011; 128:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41766/abstract/19\">",
"      Golden DB, Moffitt J, Nicklas RA, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011; 127:852.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16198 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-3384FBAA07-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41766=[""].join("\n");
var outline_f40_50_41766=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H406837\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H406746\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5318273\">",
"      TYPES OF REACTIONS TO MOSQUITO BITES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H406753\">",
"      Typical (normal) reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H406760\">",
"      Large local reactions to mosquito bites (Skeeter Syndrome)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H406767\">",
"      Systemic allergic reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3868921\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H406774\">",
"      CLINICAL FEATURES AND PATHOGENESIS OF LARGE LOCAL REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H406781\">",
"      NATURAL HISTORY OF LARGE LOCAL REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H406788\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H406795\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H406802\">",
"      Bacterial cellulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H406809\">",
"      Large local reactions to other insect bites and stings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H406816\">",
"      PREVENTION AND TREATMENT OF LARGE LOCAL REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H877634\">",
"      Mosquito avoidance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5317951\">",
"      Antihistamines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5317958\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H406837\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/16198\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/16198|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/53/8027\" title=\"table 1\">",
"      Typical local reactions to mosquito bites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/32/12811\" title=\"table 2\">",
"      Types of systemic reactions to mosquito bites",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/16/24839?source=related_link\">",
"      Approach to the patient with a suspected spider bite: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/1/12313?source=related_link\">",
"      Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/35/28216?source=related_link\">",
"      Insect bites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/1/43031?source=related_link\">",
"      Prevention of arthropod and insect bites: Repellents and other measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/51/7994?source=related_link\">",
"      Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_50_41767="Treatment and prognosis of cutaneous mastocytosis";
var content_f40_50_41767=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and prognosis of cutaneous mastocytosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41767/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41767/contributors\">",
"     Mariana C Castells, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41767/contributors\">",
"     Cem Akin, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41767/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41767/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41767/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41767/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41767/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/50/41767/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous mastocytosis describes a group of disorders characterized by the presence of excessive numbers of mast cells in the skin. Patients with cutaneous mastocytosis do not fulfill diagnostic criteria for systemic mastocytosis and show no evidence of organ involvement other than the skin.",
"   </p>",
"   <p>",
"    Forms of cutaneous mastocytosis include three variants recognized by the World Health Organization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maculopapular cutaneous mastocytosis (MPCM) or urticaria pigmentosa (UP)",
"     </li>",
"     <li>",
"      Diffuse cutaneous mastocytosis",
"     </li>",
"     <li>",
"      Solitary cutaneous mastocytoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are also two forms about which there is some controversy surrounding classification:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Telangiectasia macularis eruptive perstans (TMEP)",
"     </li>",
"     <li>",
"      Nodular mastocytosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no therapies that change the natural course of these disorders, although the prognosis in children is generally good.",
"   </p>",
"   <p>",
"    The treatment and prognosis of the different forms of cutaneous mastocytosis will be presented here. The clinical manifestations, classification, and diagnosis of cutaneous mastocytosis are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/1/6170?source=see_link\">",
"     \"Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18650?source=see_link\">",
"     \"Evaluation and diagnosis of mastocytosis (cutaneous and systemic)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The specific mediators released from mast cells and the symptoms caused by these mediators are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/28/20936?source=see_link\">",
"     \"Mast cells: Surface receptors and signal transduction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/21/18778?source=see_link\">",
"     \"Pathophysiology of anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL MEASURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of cutaneous mastocytosis begins with practical measures, such as the use of lukewarm water for bathing, air conditioning during hot weather, and avoidance of triggers for mast cell degranulation. All",
"    <span class=\"nowrap\">",
"     patients/caretakers",
"    </span>",
"    should be periodically trained in how to recognize and treat anaphylaxis and should carry an epinephrine autoinjector at all times.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Preparation for treating possible anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with extensive skin involvement or elevated serum baseline tryptase may be at increased risk for anaphylaxis from a variety of triggers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/2\">",
"     2",
"    </a>",
"    ]. One series found that children with tryptase levels &gt;6",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    are more likely to require daily treatment to manage symptoms and prevent severe episodes, and those with levels &gt;15.5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    were at risk for hospitalization due to severe symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Epinephrine is the primary treatment for anaphylaxis. Mastocytosis patients or their caretakers should have at least two doses of epinephrine in a self-injectable form available at all times for treatment of possible anaphylaxis, since a single dose may be inadequate to counteract a massive release of mediators. Clinicians should also make patients and caregivers aware of the importance of lying down with the legs elevated during anaphylaxis involving hypotension. Hypotension during anaphylaxis is more common than asthma or laryngeal edema in patients with mastocytosis, and ensuring that patients are placed in this position as soon as possible is an important therapeutic intervention. The treatment of anaphylaxis in adults and children is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mastocytosis patients should consider wearing a medical identification bracelet, and should carry an Anaphylaxis Emergency Action Plan or wallet card that identifies the condition and describes the proper treatment of anaphylaxis (",
"    <a class=\"graphic graphic_form graphicRef60439 \" href=\"mobipreview.htm?2/42/2722\">",
"     form 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_form graphicRef54466 \" href=\"mobipreview.htm?22/62/23524\">",
"     form 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Trigger avoidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should avoid exposures that trigger or aggravate their symptoms to the extent possible. These exposures may include heat, humidity, cold, emotional stress, exercise, alcohol, and lack of sleep. In infants and young children, irritability (fussing, whining, anger), fever, teething, and skin rubbing can induce symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/2\">",
"     2",
"    </a>",
"    ]. Spicy foods, such as those containing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/44/14022?source=see_link\">",
"     capsaicin",
"    </a>",
"    , may cause flushing, nasal congestion, and gastrointestinal symptoms in some patients. Patients should avoid only those triggers that bother them; empiric avoidance of these factors by all patients is not necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Problematic medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are various medications that may cause mast cell activation in patients with either cutaneous or systemic mastocytosis. As a precaution, these medications should be avoided when possible, unless the patient's tolerance for a specific agent is already known.",
"   </p>",
"   <p>",
"    Potentially problematic medications include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Opioid analgesics, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"       codeine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      and other nonsteroidal antiinflammatory agents (NSAIDs) including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/62/35808?source=see_link\">",
"       ketorolac",
"      </a>",
"     </li>",
"     <li>",
"      Radiocontrast agents",
"     </li>",
"     <li>",
"      Certain muscle relaxants and general anesthetics (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33510?source=see_link\">",
"       succinylcholine",
"      </a>",
"      , D-tubocurarine, metocurine, doxacurium",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?6/14/6374?source=see_link\">",
"       atracurium",
"      </a>",
"      , mivacurium, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/26/19879?source=see_link\">",
"       rocuronium",
"      </a>",
"      are more likely to cause a reaction than non-depolarizing muscle relaxants)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the potential for problems with the medications listed above, the majority of patients do tolerate these drugs. A study reviewed anesthetic management of 22 children with mastocytosis (14 with cutaneous and 8 with systemic disease) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/4\">",
"     4",
"    </a>",
"    ]. Most of these patients were receiving medications to counteract mast cell mediators, which were continued before and after the procedures, although other medications were administered at the discretion of the anesthesiologist. The study found that the perioperative courses were uncomplicated and without serious adverse events. Another retrospective series found that among 45 children with mastocytosis, most of whom had cutaneous disease, general anesthesia was usually well tolerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Medications that are usually tolerated",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients tolerate",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , local anesthetics, and benzodiazepines.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     Fentanyl",
"    </a>",
"    appears to be a less potent mast cell degranulator than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    in equimolar concentrations in vitro, although fentanyl has not been specifically studied in patients with mastocytosis.",
"   </p>",
"   <p>",
"    If anesthesia is required in a patient with no previous history of exposure to anesthetics, certain agents, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/34/15908?source=see_link\">",
"     etomidate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    , cis-",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/14/6374?source=see_link\">",
"     atracurium",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/33/19990?source=see_link\">",
"     pancuronium",
"    </a>",
"    are recommended over others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/6\">",
"     6",
"    </a>",
"    ]. A volatile anesthetic, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/47/23286?source=see_link\">",
"     sevoflurane",
"    </a>",
"    , can be used to maintain anesthesia. However, allergic reactions to any medication can develop without precedent and the clinician must be prepared to handle any such reaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1370673\">",
"    <span class=\"h2\">",
"     Premedication before anticipated trigger exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients can be premedicated in advance of an anticipated exposure to a possible or known trigger. The approach for patients with cutaneous mastocytosis is similar to that for those with systemic mastocytosis and is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39817?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment and prognosis of systemic mastocytosis\", section on 'Preparation for medical and surgical procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with diffuse cutaneous mastocytosis can be sensitive to anesthetics, analgesics and vaccinations and exposure can trigger exacerbations and bullous eruptions. Premedication is recommended for any procedures involving these medications and before the administration of vaccines, and we suggest the combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (1 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    up to approximately 40 mg), as well as both H1 and H2 antihistamines.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Treatment of coexistent allergic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with mastocytosis may have concomitant allergic diseases, including allergic rhinitis, asthma, food, and drug allergies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. However, the incidence of allergic disease in patients with mastocytosis does not appear to be increased compared with the general population. In most cases, these conditions should be managed as they would be in patients without mastocytosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/1/6170?source=see_link\">",
"     \"Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=see_link\">",
"     \"Pharmacotherapy of allergic rhinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/37/8794?source=see_link\">",
"     \"An overview of asthma management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The administration of subcutaneous immunotherapy for respiratory allergies warrants careful consideration in patients with mastocytosis because they are at greater risk for systemic reactions and anaphylaxis as a consequence of the therapy itself.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Hymenoptera venom hypersensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with all forms of mastocytosis (ie, cutaneous and systemic) are at increased risk for anaphylaxis in response to Hymenoptera stings, compared with patients who are sensitive to these venoms, but do not have mastocytosis. Patients with elevated tryptase levels are at greater risk for anaphylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/2,11\">",
"     2,11",
"    </a>",
"    ]. Less is known about the risk of sting-induced anaphylaxis in children with cutaneous mastocytosis. Patients with IgE-mediated systemic reactions to Hymenoptera stings should be offered venom immunotherapy to reduce the risk of anaphylaxis upon subsequent stings. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Treatment of coexistent allergic disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Despite the risk of systemic allergic reactions to immunotherapy, venom immunotherapy has been shown to be beneficial for patients with cutaneous (or systemic) mastocytosis who have evidence of venom-specific IgE (ie, positive skin or IgE tests to hymenoptera venoms) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/10\">",
"     10",
"    </a>",
"    ]. Therefore, venom immunotherapy is recommended for adults with cutaneous or systemic mastocytosis, a history of systemic symptoms following a known or suspected sting, and evidence of venom specific IgE. The evaluation and management of Hymenoptera venom reactions in patients with mastocytosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39817?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment and prognosis of systemic mastocytosis\", section on 'Venom immunotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimal approach in children with cutaneous mastocytosis and hymenoptera reactions is not known and management should be guided by recommendations for children with Hymenoptera allergy, but without mastocytosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16936?source=see_link&amp;anchor=H7#H7\">",
"     \"Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action\", section on 'Indications and patient selection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pharmacologic treatment of cutaneous mastocytosis is comprised of medications to prevent mast cells mediator release, and when mediator release does occur, to reduce the resulting symptoms. There are no randomized controlled trials evaluating different therapies in cutaneous mastocytosis, and recommendations are based upon extrapolation from allergic diseases, small series, and expert opinion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diffuse cutaneous disease and urticaria pigmentosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;For both children with cutaneous disease and adults with UP, oral antihistamines are administered to control itching and flushing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/12\">",
"     12",
"    </a>",
"    ]. Oral sodium cromolyn is helpful for patients with gastrointestinal symptoms (which are reported by over one-third of patients with cutaneous mastocytosis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Antihistamines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both H1 and H2 antihistamines are useful in the treatment of cutaneous mastocytosis. H1 antihistamines are administered to prevent flushing and itching. H2 antihistamines are helpful in controlling abdominal pain, heartburn, cramping,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diarrhea, and may enhance the antipruritic effects of H1 antihistamines.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Commonly used H1 antihistamines (adult dosing) include oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36390?source=see_link\">",
"       cetirizine",
"      </a>",
"      (10 mg daily),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/33/35350?source=see_link\">",
"       fexofenadine",
"      </a>",
"      (180 mg daily), or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/24/391?source=see_link\">",
"       hydroxyzine",
"      </a>",
"      (25 mg every six hours) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/13\">",
"       13",
"      </a>",
"      ]. Each of these agents may be used in children, at",
"      <span class=\"nowrap\">",
"       age/weight-appropriate",
"      </span>",
"      doses. In some patients, a combination of two or more H1 antihistamines may provide better symptom control than the use of a single agent. Adult patients may benefit from twice daily dosing of non-sedating antihistamines.",
"     </li>",
"     <li>",
"      H2 antihistamines (adult dosing) include oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/56/42888?source=see_link\">",
"       ranitidine",
"      </a>",
"      (150 mg every 12 hours),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/45/728?source=see_link\">",
"       famotidine",
"      </a>",
"      (10 mg every 12 hours), and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/54/2921?source=see_link\">",
"       cimetidine",
"      </a>",
"      (400 mg twice daily) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/13\">",
"       13",
"      </a>",
"      ]. Ranitidine and famotidine may be used in children at",
"      <span class=\"nowrap\">",
"       age/weight",
"      </span>",
"      appropriate doses.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/16/33024?source=see_link\">",
"       Ketotifen",
"      </a>",
"      , which has both mast cell stabilizing and H1 antihistamine properties, is used to control mast cell activation and pruritus and is the first-line agent where available, although it can be quite sedating for some patients. This drug is not available in oral form in the United States. The adult dose is 2 to 4 mg orally every 12 hours [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/14\">",
"       14",
"      </a>",
"      ]. Ketotifen may be used in children at",
"      <span class=\"nowrap\">",
"       age/weight",
"      </span>",
"      appropriate doses.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Cromoglycates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anecdotal evidence suggests that topical cromoglycate ointments may be symptomatically effective for the diffuse skin disease seen in some children with mastocytosis, as well as in adults with UP, although formal studies have not yet been performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/2,15\">",
"     2,15",
"    </a>",
"    ]. Cromoglycates have been shown to have mast cell stabilizing properties in vitro and topical preparations have been studied in the treatment of atopic dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cromoglycate ointments at strengths ranging from 0.21 to 4 percent have been used in children with mastocytosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/15\">",
"     15",
"    </a>",
"    ]. One of the authors (MC) has",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/53/37712?source=see_link\">",
"     cromolyn sodium",
"    </a>",
"    (powder) compounded into hydrated petrolatum to generate a 4 percent ointment. This is applied twice daily to the affected areas to alleviate pruritus and reduce flares. Similar products are available commercially in Europe. Cromoglycates have an excellent safety record in the treatment of pediatric asthma and other diseases, as they are not believed to be systemically absorbed to a significant degree. However, these agents do not cause permanent regression of the skin lesions or alter the natural history of the disease.",
"   </p>",
"   <p>",
"    In infants with diffuse skin involvement, resolution of pruritus and bullae formation with topical cromoglycates can be seen within three months, although this may vary depending upon severity. Use of the ointment is then tapered to once daily for another month and then discontinued if no new lesions or symptoms appear. This regimen can be repeated as needed. Adverse effects have not been reported with this therapy.",
"   </p>",
"   <p>",
"    Cromolyn can also be administered orally (Gastrocrom, 200 mg up to four times daily in patients 13 years or older, or 100 mg up to four times daily in patients aged 2 to12 years) to treat gastrointestinal symptoms caused by mast cell mediator release, which are present in 20 to 30 percent of patients with cutaneous disease. This medication is generally mixed into a glass of water and taken one hour before meals and then before bed. We typically begin with one or two doses daily and increase gradually to four times daily. Some patients do not tolerate this medication because of bloating, cramping, and diarrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Leukotriene modifying agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antileukotriene drugs (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/49/37654?source=see_link\">",
"     montelukast",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/54/20325?source=see_link\">",
"     zafirlukast",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/33/17940?source=see_link\">",
"     zileuton",
"    </a>",
"    ) may be added in patients with symptoms, such as flushing, itching, abdominal cramping, and recurrent anaphylaxis that are suboptimally controlled by H1 and H2 antihistamines and cromoglycates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Treatment of refractory symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;In selected patients with symptoms refractory to cromoglycates, antihistamines, and leukotriene modifying agents,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and limited use of topical glucocorticoids may be helpful.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      (in adults only) (up to 325 mg four times daily) may be administered to control flushing, provided the patient is known to tolerate NSAIDs. This should be administered with caution because NSAIDs can trigger mediator release in some patients, and may precipitate peptic ulcer disease. Techniques for safely administering aspirin to patients with mastocytosis are reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39817?source=see_link\">",
"       \"Treatment and prognosis of systemic mastocytosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Topical glucocorticoids &mdash; Short-term use of topical glucocorticoids may be useful for temporarily decreasing the number of skin mast cells and reducing refractory symptoms of mediator release. However, the benefit is short-lived and this should not be considered a form of long-term management because of the side effects associated with chronic glucocorticoid use including adrenal suppression if they are applied to large areas. Glucocorticoids creams or ointments may be applied to the skin of children older than two years. For areas &lt;10 percent of body surface area (BSA) or for solitary mastocytomas, the preparation can be applied under an occlusive dressing. For &gt;10 percent BSA, some authors recommend the topical glucocorticoid be diluted one part to three parts and applied for three to six weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Psoralen-ultraviolet A therapy (PUVA) decreases the number of mast cells and controls pruritus that cannot be managed with antihistamines alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/19-21\">",
"       19-21",
"      </a>",
"      ]. However, long-term use is associated with an increased risk of skin cancer, and the skin lesions usually recur after therapy is stopped. Phototherapy may be considered for temporary symptomatic relief in patients with diffuse cutaneous mastocytosis with extensive skin involvement refractory to medical management.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Therapies that are not recommended",
"    </span>",
"    &nbsp;&mdash;&nbsp;With adult forms of UP or other variants, several forms of therapy have been used to decrease the number of mast cells in the skin. These therapies provide only temporary relief, do not affect the development of systemic disease, and are associated with side effects. Thus, they are not recommended, although they are included here because their use is a common source of inquiries:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Systemic glucocorticoids are",
"      <strong>",
"       not",
"      </strong>",
"      recommended for routine management of skin lesions in patients with cutaneous mastocytosis, although brief courses may be considered to control severe symptoms during acute flares, especially in bullous outbreaks of diffuse cutaneous mastocytosis.",
"     </li>",
"     <li>",
"      Mast cell cytoreductive therapies, including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/1/17434?source=see_link\">",
"       imatinib",
"      </a>",
"      , are NOT indicated in patients with disease limited to skin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Cutaneous mastocytomas",
"    </span>",
"   </p>",
"   <p>",
"    Physical irritation of the mastocytoma lesion should be avoided as it may lead to generalized symptoms of mediator release, such as flushing, urticaria, and wheezing.",
"   </p>",
"   <p>",
"    Surgical removal of mastocytomas is potentially curative if the lesion is resectable, although this is usually not necessary unless patients suffer from uncontrollable symptoms due to mediator release. Mastocytomas rarely recur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral antihistamines are helpful for symptoms caused by mediator release, as with other forms of cutaneous mastocytosis. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Antihistamines'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Localized application of topical glucocorticoids may be beneficial in patients with cutaneous mastocytomas who experience local or generalized symptoms. We suggest a medium to high potency preparation initially, applied under an occlusive dressing for 7 to 10 days. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=see_link\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Yearly monitoring is appropriate for children with cutaneous mastocytosis and stable symptoms. A complete blood count (CBC) with differential, chemistry panel including alkaline phosphatase, and serum tryptase level are generally sufficient. If the serum tryptase level is found to be consistently &gt;20",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    or if there is an unexplained persistent abnormality in the CBC with differential, or hepatomegaly or splenomegaly, or unexplained lymphadenopathy, an evaluation for systemic mastocytosis should be considered.",
"   </p>",
"   <p>",
"    In all patients who experience onset of skin lesions in adulthood, an evaluation for systemic workup with a bone marrow biopsy and aspiration should be considered. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18650?source=see_link\">",
"     \"Evaluation and diagnosis of mastocytosis (cutaneous and systemic)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis of cutaneous forms of mastocytosis is related to the age at presentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Infants and young children",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis is excellent for children with cutaneous forms of mastocytosis who have onset of skin lesions within the first two years of life, because spontaneous resolution is common after several years (usually before the onset of puberty) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mastocytomas in children usually involute spontaneously after several years.",
"     </li>",
"     <li>",
"      The lesions of UP in children resolve during adolescence in over 50 percent of patients, with fading or improvement of the lesions in most of the remaining patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Overall, more than 80 percent of children with cutaneous mastocytosis experience spontaneous resolution. The remaining children may have persistent cutaneous disease or may progress to systemic forms of the disease.",
"   </p>",
"   <p>",
"    As an example, a series of 15 patients with onset of mastocytosis in childhood reported that complete regression of cutaneous findings and symptoms occurred in 10 (67 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/23\">",
"     23",
"    </a>",
"    ]. Of the remaining five patients, three had major and two had partial regression. Three of those with persistent disease underwent bone marrow examinations and one (7 percent of the group) was found to have systemic mastocytosis.",
"   </p>",
"   <p>",
"    Risk factors for the development of systemic disease include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Late onset of skin lesions (beyond two years of age)",
"     </li>",
"     <li>",
"      Persistence of skin lesions beyond adolescence",
"     </li>",
"     <li>",
"      Presence of unexplained hepatomegaly, splenomegaly, or lymphadenopathy",
"     </li>",
"     <li>",
"      Abnormal blood counts (to detect anemia, leukocytosis, leukopenia, presence of blast forms, or abnormal numbers of platelets)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several studies have found a surprisingly high rate (up to 80 percent) of c-kit mutations in lesional skin samples obtained from children with cutaneous mastocytosis. While approximately 40 percent of these mutations involved exon 17 (as seen in adult onset disease), 40 percent had mutations in other exons. The prognostic significance of these findings is not clear. One study suggested that c-kit mutations at codon 816 (in exon 17) may be associated with persistent disease in adulthood and systemic mastocytosis, while other mutations in exons 8 and 9 were associated with remission of cutaneous disease at puberty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/24\">",
"     24",
"    </a>",
"    ]. However, another study did not find associations between specific mutations and prognosis and further work is needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Older children and adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous mastocytosis that develops after the age of two years or in adulthood tends to persist. Approximately 90 percent of adult patients with skin lesions have evidence of systemic disease at the time of diagnosis, with the majority belonging to the category of indolent systemic mastocytosis. Rare cases of progression of pediatric-onset cutaneous disease to aggressive forms of mast cell disease such as mast cell sarcoma and mast cell leukemia have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41767/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/1/6170?source=see_link\">",
"     \"Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are no therapies that alter the natural course of cutaneous mastocytosis or urticaria pigmentosa (UP), and management consists of avoiding triggers of mast cell degranulation and pharmacotherapy for symptomatic relief. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with itching or flushing due to diffuse cutaneous involvement or urticaria pigmentosa, we suggest H1 antihistamines",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      topical cromoglycate ointments as initial therapies (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Antihistamines may be administered on a scheduled or as needed basis, depending upon symptom frequency. We typically begin treatment with non-sedating antihistamines, and reserve sedating agents for refractory symptoms. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Antihistamines'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Cromoglycates'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with gastrointestinal symptoms, such as abdominal pain, heartburn, cramping,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      diarrhea, we suggest H2 antihistamines",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      oral cromolyn as initial therapies (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Antihistamines'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Cromoglycates'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with flushing, itching, or abdominal symptoms despite the above measures, we suggest the addition of an antileukotriene agent (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Leukotriene modifying agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of isolated cutaneous mastocytomas involves avoiding physical contact or rubbing of the lesion(s), as this causes mediator release and systemic symptoms. Systemic symptoms are managed primarily with antihistamines. Surgical removal is rarely necessary unless the patient experiences uncontrollable systemic symptoms. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Cutaneous mastocytomas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prognosis for young children with cutaneous mastocytosis is excellent, because the majority will experience spontaneous resolution before puberty. In contrast, cutaneous disease that first develops after two years of age tends to be persistent, and many patients will develop systemic forms of mastocytosis. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Horny HP, Metcalfe DD, Bennet JM, et al. Mastocytosis. In: WHO Classification of the Tumors of Haematopoietic and Lymphoid Tissues, Swerdlow SH, Campo E, Harris NL, et al.  (Eds), IARC, Lyon 2008. p.54.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/2\">",
"      Alvarez-Twose I, Va&ntilde;&oacute;-Galv&aacute;n S, S&aacute;nchez-Mu&ntilde;oz L, et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy 2012; 67:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/3\">",
"      Deverri&egrave;re G, Carr&eacute; D, Nae I, et al. [Bullous mastocytosis in infancy: a rare presentation]. Arch Pediatr 2012; 19:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/4\">",
"      Carter MC, Uzzaman A, Scott LM, et al. Pediatric mastocytosis: routine anesthetic management for a complex disease. Anesth Analg 2008; 107:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/5\">",
"      Ahmad N, Evans P, Lloyd-Thomas AR. Anesthesia in children with mastocytosis--a case based review. Paediatr Anaesth 2009; 19:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/6\">",
"      Konrad FM, Unertl KE, Schroeder TH. [Mastocytosis. A challenge in anaesthesiology]. Anaesthesist 2009; 58:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/7\">",
"      Brockow K, Akin C, Huber M, Metcalfe DD. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. J Am Acad Dermatol 2003; 48:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/8\">",
"      M&uuml;ller U, Helbling A, Hunziker T, et al. Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa. Allergy 1990; 45:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/9\">",
"      Greenhawt M, Akin C. Mastocytosis and allergy. Curr Opin Allergy Clin Immunol 2007; 7:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/10\">",
"      Gonz&aacute;lez de Olano D, Alvarez-Twose I, Esteban-L&oacute;pez MI, et al. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol 2008; 121:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/11\">",
"      Ru&euml;ff F, Przybilla B, Bil&oacute; MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/12\">",
"      Hartmann K, Metcalfe DD. Pediatric mastocytosis. Hematol Oncol Clin North Am 2000; 14:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/13\">",
"      Worobec AS. Treatment of systemic mast cell disorders. Hematol Oncol Clin North Am 2000; 14:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/14\">",
"      P&oacute;voa P, Ducla-Soares J, Fernandes A, Palma-Carlos AG. A case of systemic mastocytosis; therapeutic efficacy of ketotifen. J Intern Med 1991; 229:475.",
"     </a>",
"    </li>",
"    <li>",
"     Escribano L. Section Chief, Hematology Services, Director, Mast Cell Unit, Hospital Ramon y Cajal, Madrid, personal communication.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/16\">",
"      Moore C, Ehlayel MS, Junprasert J, Sorensen RU. Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis. Ann Allergy Asthma Immunol 1998; 81:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/17\">",
"      Stainer R, Matthews S, Arshad SH, et al. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Br J Dermatol 2005; 152:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/18\">",
"      Heide R, Beishuizen A, De Groot H, et al. Mastocytosis in children: a protocol for management. Pediatr Dermatol 2008; 25:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/19\">",
"      Godt O, Proksch E, Streit V, Christophers E. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology 1997; 195:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/20\">",
"      Sotiriou E, Apalla Z, Ioannides D. Telangiectasia macularis eruptive perstans successfully treated with PUVA therapy. Photodermatol Photoimmunol Photomed 2010; 26:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/21\">",
"      Rishpon A, Matz H, Gat A, Brenner S. Telangiectasia macularis eruptiva perstans: unusual presentation and treatment. Skinmed 2006; 5:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/22\">",
"      JOHNSON WC, HELWIG EB. Solitary mastocytosis (urticaria pigmentosa). Arch Dermatol 1961; 84:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/23\">",
"      Uzzaman A, Maric I, Noel P, et al. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer 2009; 53:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/24\">",
"      Bodemer C, Hermine O, Palm&eacute;rini F, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2010; 130:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/25\">",
"      Sotlar K, Escribano L, Landt O, et al. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 2003; 162:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/26\">",
"      Auquit-Auckbur I, Lazar C, Deneuve S, et al. Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma. Am J Surg Pathol 2012; 36:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41767/abstract/27\">",
"      Chantorn R, Shwayder T. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia. Pediatr Dermatol 2012; 29:605.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4785 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-6C4A8C19E1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41767=[""].join("\n");
var outline_f40_50_41767=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL MEASURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Preparation for treating possible anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Trigger avoidance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Problematic medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Medications that are usually tolerated",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1370673\">",
"      Premedication before anticipated trigger exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Treatment of coexistent allergic disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Hymenoptera venom hypersensitivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PHARMACOLOGIC THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diffuse cutaneous disease and urticaria pigmentosa",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Antihistamines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Cromoglycates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Leukotriene modifying agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Treatment of refractory symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Therapies that are not recommended",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Cutaneous mastocytomas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Infants and young children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Older children and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/4785\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/4785|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"mobipreview.htm?2/42/2722\" title=\"form 1\">",
"      Anaphylaxis action plan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"mobipreview.htm?22/62/23524\" title=\"form 2\">",
"      Anaphylaxis wallet card",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/37/8794?source=related_link\">",
"      An overview of asthma management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/1/6170?source=related_link\">",
"      Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18650?source=related_link\">",
"      Evaluation and diagnosis of mastocytosis (cutaneous and systemic)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16936?source=related_link\">",
"      Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/28/20936?source=related_link\">",
"      Mast cells: Surface receptors and signal transduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/21/18778?source=related_link\">",
"      Pathophysiology of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=related_link\">",
"      Pharmacotherapy of allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39817?source=related_link\">",
"      Treatment and prognosis of systemic mastocytosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_50_41768="Epidemiology and etiology of cerebral palsy";
var content_f40_50_41768=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology and etiology of cerebral palsy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41768/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41768/contributors\">",
"     Geoffrey Miller, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41768/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41768/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41768/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41768/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41768/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/50/41768/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral palsy (CP) consists of a heterogeneous group of nonprogressive clinical syndromes that are characterized by motor and postural dysfunction. These conditions, which range in severity, are due to abnormalities of the developing brain resulting from a variety of causes. Although the disorder itself is not progressive, the appearance of neuropathologic lesions and their clinical expression may change over time as the brain matures.",
"   </p>",
"   <p>",
"    The epidemiology and etiology of CP are reviewed here. The clinical manifestations, diagnosis, management, and prognosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29209?source=see_link\">",
"     \"Clinical features of cerebral palsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/0/4104?source=see_link\">",
"     \"Diagnosis and classification of cerebral palsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/37/15962?source=see_link\">",
"     \"Management and prognosis of cerebral palsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The precise prevalence of cerebral palsy (CP) in the United States is uncertain because consistent information is lacking on follow-up of an entire population, especially for term and late preterm infants, which comprise the majority of births. A population-based surveillance study using data from three regions in the United States estimated a prevalence of 3.6 cases per 1000 children at eight years of age, but the study did not distinguish between children with and without a history of prematurity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/1\">",
"     1",
"    </a>",
"    ]. No data are available on CP prevalence in North America for term infants born since the mid-1980s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/2\">",
"     2",
"    </a>",
"    ]. In one report that used standard definitions and included 6000 children with CP from 13 geographically defined populations in Europe born from 1980 to 1990, the overall rate was",
"    <span class=\"nowrap\">",
"     2.08/1000",
"    </span>",
"    live births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of CP is much higher in preterm than term infants, and increases with decreasing birth weight and gestational age. This is illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study from Europe, the rate was more than 70 times higher in infants with birth weight &lt;1500 g than in those with birth weight &gt;2500 g [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a population-based study from Sweden of 216 children with CP born between 1987 and 1990, the prevalence was 1.4, 14, 68, and 57 for birth weights &ge;2500 g, 1500 to 2499 g, 1000 to 1499 g, and &lt;1000 g, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Severe neuromotor disability was present in 10 percent of surviving infants born at &le;25 weeks gestation in 1995 in the United Kingdom and Ireland and evaluated at 30 months of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a review of 42 studies published after 1970, CP occurred in 12 percent of surviving infants born with gestational age &le;26 weeks and 8 percent of those with birth weight &le;800 g [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even among infants born at term, small variations in gestational age are associated with risks for CP. In a population study of infants without congenital anomalies in Norway, the risk for CP was lowest among infants born at 40 weeks as compared with those born at 38 or 42 weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/7\">",
"     7",
"    </a>",
"    ]. The explanation for this association has not been established; it is possible that the presence of CP disrupts the timing of delivery or that the timing of the delivery causes the increased risk for CP.",
"   </p>",
"   <p>",
"    The risk of CP increases at the extremes of birth weight across gestational ages. In the largest epidemiologic study on CP and birth weight, 4503 singleton children with CP born at 32 to 42 weeks gestation were compared to two reference standards for intrauterine growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/8\">",
"     8",
"    </a>",
"    ]. The risk of CP was four to six times greater in infants with birth weight &lt;10th percentile than those with birth weight between the 25th and 75th percentile. In those with birth weight &gt;97th percentile, the risk was increased 1.6 to 3.1 times. The risk of CP was lowest in children with birth weight approximately one standard deviation above average. It is not known whether CP causes or results from abnormal growth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of CP and the extent of disability increased in preterm infants born in the 1960s through 1980s as survival improved for the most immature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/10\">",
"     10",
"    </a>",
"    ]. During the 1980s and 1990s, the rate of CP remained stable for term and late preterm babies, most of whom survive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/2\">",
"     2",
"    </a>",
"    ]. Although the risk is small for an individual, approximately one-half the cases of CP occur in infants born at or late preterm.",
"   </p>",
"   <p>",
"    More recent data suggest a reversal of the trend in some areas. In Western Europe, there was a significant decrease in rates of CP among infants born at gestational age 28 to 31 weeks between 1981 and 1995, most likely because of improvements in perinatal care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/11\">",
"     11",
"    </a>",
"    ]. The study showed similar findings when the data were analyzed by birthweight: the birth prevalence of CP fell from 60.6 per 1000 liveborn very low birthweight infants in 1980 to 39.5 per 1000 in 1996. This improvement occurred despite overall increases in survival and multiple births, and decreases in mean birthweight among this group. Similarly, in Northern Alberta, the prevalence of CP among infants born between 20 and 27 weeks gestation began to decrease in the mid 1990s, in the setting of stable or decreasing mortality, reversing previous trends [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/12\">",
"     12",
"    </a>",
"    ]. In that study, CP prevalence per 1000 live births decreased from 155 in 1992-1994 to 16 in the years 2001-2003.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of cerebral palsy (CP) is multifactorial. Known causes account for only a small proportion of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/13\">",
"     13",
"    </a>",
"    ]. Most cases are thought to be due to prenatal factors, although perinatal asphyxia plays a role in some; prematurity is a common association.",
"   </p>",
"   <p>",
"    The multifactorial etiology was illustrated in a series of 213 children diagnosed with CP in Australia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/14\">",
"     14",
"    </a>",
"    ]. Major CP-associated pathologies other than acute intrapartum hypoxia were identified in 98 percent of cases; some children had more than one associated pathology:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prematurity (78 percent)",
"     </li>",
"     <li>",
"      Intrauterine growth restriction (34 percent)",
"     </li>",
"     <li>",
"      Intrauterine infection (28 percent)",
"     </li>",
"     <li>",
"      Antepartum hemorrhage (27 percent)",
"     </li>",
"     <li>",
"      Severe placental pathology (21 percent)",
"     </li>",
"     <li>",
"      Multiple pregnancy (20 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A few studies have suggested that heavy maternal alcohol consumption is a risk factor for CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/15\">",
"     15",
"    </a>",
"    ]. Epidemiologic studies suggest that heavy maternal alcohol consumption increases the risk for CP more than threefold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/16\">",
"     16",
"    </a>",
"    ]. In addition, between 2 and 10 percent of children with fetal alcohol syndrome also have CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Perinatal asphyxia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although it is often suspected as a cause, perinatal hypoxia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ischemia likely accounts for only a small minority of cases of CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/24/2442?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/14/30953?source=see_link\">",
"     \"Etiology and pathogenesis of neonatal encephalopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many studies that linked the development of CP to perinatal asphyxia used a low Apgar score at five minutes as a marker for asphyxia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/18\">",
"     18",
"    </a>",
"    ]. However, the use of Apgar scores alone is an inappropriate criterion, as they can be low due to maternal analgesia or prematurity when umbilical cord pH is normal, or normal in the presence of acute asphyxia or maternal metabolic acidosis. In the National Collaborative Perinatal Project that was performed in the 1960s and included approximately 49,000 subjects, the risk of CP at age seven years in infants with an Apgar score of 0 to 3 at five minutes was 4.7 percent, approximately 25 times the risk for those with scores of 7 to 10 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/22\">",
"     22",
"    </a>",
"    ]. In another study of children with birth weight &gt;2500 g born in Norway in 1983 to 1987, the risk of CP with an Apgar score of 0 to 3 at five minutes was 6.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/22\">",
"     22",
"    </a>",
"    ]. In both studies, however, 93 to 95 percent of infants with Apgar scores of 0 to 3 at five minutes did",
"    <strong>",
"     not",
"    </strong>",
"    have CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intrapartum abnormalities that may lead to asphyxia occur in children with and without CP but do not support a strong causative association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/24\">",
"     24",
"    </a>",
"    ]. In one study, tight nuchal cord was associated with spastic quadriparesis but not hemiplegia or diplegia, while placental abruption, placental previa, and prolapsed cord were rare and were not associated with development of CP. Intrauterine infection and coagulation disorders were more strongly associated with the development of spastic CP than was birth asphyxia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2003, the American College of Obstetricians and Gynecologists, in collaboration with the American Academy of Pediatrics, convened a Task Force on Neonatal Encephalopathy and Cerebral Palsy that published a report illustrating the best scientific data and opinion on these issues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/27\">",
"     27",
"    </a>",
"    ]. According to the task force, four essential criteria are required to define an intrapartum asphyxial event sufficient to cause CP, as listed in the Table (",
"    <a class=\"graphic graphic_table graphicRef66304 \" href=\"mobipreview.htm?6/27/6587\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/28\">",
"     28",
"    </a>",
"    ]. In addition, the definition requires that at least three out of five other criteria be present to indicate that the timing of the insult is likely to have occurred during the peripartum period (within 48 hours of labor and delivery) (",
"    <a class=\"graphic graphic_table graphicRef67282 \" href=\"mobipreview.htm?10/10/10411\">",
"     table 2",
"    </a>",
"    ). The latter criteria may be related to development of CP but are not considered to be specific for asphyxia.",
"   </p>",
"   <p>",
"    In a retrospective study using these criteria, only 4 percent of children with CP who were born at full term had evidence of an acute hypoxic event during labor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/14\">",
"     14",
"    </a>",
"    ]. The criteria have not been prospectively validated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Neonatal encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the term infant, severe perinatal asphyxia can cause parasagittal cortical injury and infarction in the brainstem and basal ganglia and lead to the development of spastic quadriparesis. Perinatal hypoxia-ischemia also can cause necrosis in the spinal cord gray matter, contributing to flaccidity, hypokinesia, and absent reflexes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infants with severe intrapartum hypoxia-ischemia have encephalopathy (eg, seizures, coma, hypotonia), dysfunction of another organ system, a persistently low Apgar score, and evidence of profound metabolic acidosis. The outcome depends upon the severity of the hypoxic-ischemic encephalopathy (HIE).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants with mild HIE in the neonatal period have a very high probability (97 to 100 percent) of being completely normal at follow-up.",
"     </li>",
"     <li>",
"      Infants with moderate encephalopathy have a 20 to 35 percent risk of later sequelae from the insult, although those whose neurologic examinations are completely normal within one week have a good likelihood of normal outcome.",
"     </li>",
"     <li>",
"      Infants with severe encephalopathy have a 75 percent risk of dying in the neonatal period; among survivors, a universal risk of sequelae exists. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/24/2442?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of neonatal encephalopathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Congenital abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of CP in term infants often is of prenatal origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. This is supported by the observation that congenital abnormalities are more common in children with than without CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. In a population-based case-control study in California, congenital abnormalities occurred in 19.2 percent of children with CP and 4.3 percent of controls (OR 5.2, 95% CI 2.8-9.7) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/32\">",
"     32",
"    </a>",
"    ]. This was attributable to a greater proportion of structural central nervous system (CNS) abnormalities in children with CP (14.5 versus 1 percent). The proportion of abnormalities outside the CNS was similar in the two groups. In another report, minor congenital anomalies were more frequent in children with ataxic CP than in related or unrelated controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intrapartum events may be influenced by a preexisting abnormality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. In one report, birth defects (mostly non-CNS anomalies) occurred more often in term infants with neonatal encephalopathy, a risk factor for CP, than in controls (27.5 versus 4.3 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/37\">",
"     37",
"    </a>",
"    ]. The birth defect was considered the cause of the encephalopathy in approximately one-third of affected infants.",
"   </p>",
"   <p>",
"    In a series of 150 affected patients, the etiology was attributed to congenital disorders in 53 and 35 percent of those with quadriplegic and non-quadriplegic CP, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/38\">",
"     38",
"    </a>",
"    ]. Furthermore, many infants with anomalies have a breech presentation at birth, which also is a risk factor for CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/30,39\">",
"     30,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Brain malformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some children, CP results from brain malformations. The biologic basis of most of these is unknown. Some result from abnormalities that occur during brain development and affect cell proliferation, migration, differentiation, survival, or synaptogenesis. Disorders of development occasionally result from exposure to radiation, toxins, or infectious agents during a critical period of gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/40-43\">",
"     40-43",
"    </a>",
"    ]. Some disorders (eg, schizencephaly) are genetic and follow mendelian inheritance patterns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/44-48\">",
"     44-48",
"    </a>",
"    ]. Chromosomal abnormalities are associated with some cerebral malformations, such as trisomies 13 and 18 and holoprosencephaly. Some neurocutaneous syndromes are associated with brain malformations (eg, hemimegalencephaly and hypomelanosis of Ito or the linear sebaceous nevus syndrome) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Genetic susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;The aggregation of CP in groups with high consanguinity, and observations of increased familial risk for CP suggests a genetic contribution to CP risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. Several genetic polymorphisms have been associated with susceptibility for CP, including apolipoprotein E [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/52\">",
"     52",
"    </a>",
"    ], genes associated with thrombophilias (such as prothrombin) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/53,54\">",
"     53,54",
"    </a>",
"    ], and with inflammation (certain cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/55,56\">",
"     55,56",
"    </a>",
"    ], inducible nitric oxide synthetase (iNOS), and lymphotoxin alpha (LTA, also known as TGF-beta) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/56\">",
"     56",
"    </a>",
"    ]). However, only the association with a prothrombin gene mutation was confirmed by a subsequent large study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Multiple births",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of CP is increased among multiple births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/58-63\">",
"     58-63",
"    </a>",
"    ]. Causes that may contribute to this risk include low birth weight, congenital anomalies, cord entanglement, and abnormal vascular connections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/64\">",
"     64",
"    </a>",
"    ]. In a study of births in Western Australia in 1980 to 1989, the prevalence of CP was 1.6, 7.3, and 28 per 1000 survivors to one year of age in singletons, twins, and triplets, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/58\">",
"     58",
"    </a>",
"    ]. In this report, the increased rates of CP in multiples were limited to infants of normal birth weight, although multiples were more likely to have low birth weight.",
"   </p>",
"   <p>",
"    Death of a co-twin greatly increases the risk of CP. In the report from Western Australia, the risk of CP among twins was greater when one twin died in utero (96 versus 12 per 1000 twin pairs) compared to both surviving [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/58\">",
"     58",
"    </a>",
"    ]. The mechanism may include release of thromboplastin and emboli from the dead twin causing injury to the survivor. It is possible that some cases of CP in apparent singletons may be due to an unrecognized fetal death of a co-twin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postnatal death also increases the risk of CP in the surviving co-twin and monozygosity appears to influence this risk. In a report from England and Wales in 1993 to 1995, birth and death certificate data were analyzed for different sex (dizygotic) and same sex (dizygotic and monozygotic) twins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/66\">",
"     66",
"    </a>",
"    ]. Disability in the surviving twin after neonatal death of the co-twin was ascertained by a questionnaire sent to physicians. The risk of CP was significantly greater in same sex compared to different sex twin survivors (167 versus 21 per 1000) for infants of birth weight 1000 to 1999 g, although only marginally greater (224 versus 220 per 1000) for birth weight &lt;1000 g.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stroke in the perinatal period contributes to CP, especially spastic hemiparesis. Thromboembolism and prothrombotic disorders contribute to the etiology of this disorder. Lesions typically are identified by cranial imaging studies following a neonatal seizure. However, some newborns with stroke are asymptomatic until hemiparesis or other abnormalities develop later in infancy or childhood. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27690?source=see_link\">",
"     \"Stroke in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Intracranial hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial hemorrhage (ICH) in term infants is unusual but frequently results in neuromotor abnormalities. Most are recognized because of the sudden and dramatic onset of symptoms, including seizures, abnormal movements, apnea, lethargy, irritability, vomiting, and bulging fontanelle. Diagnosis is made by cranial imaging.",
"   </p>",
"   <p>",
"    The incidence depends in part upon the method of ascertainment. In one series of 33 term infants with symptomatic ICH, the regional incidence was estimated to be 0.27 per 1000 live births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/67\">",
"     67",
"    </a>",
"    ]. Approximately one-third of cases were related to coagulopathies. In another report from Germany, ICH was diagnosed by ultrasound scan in 54 of 2019 term infants (2.7 percent) treated in a newborn intensive care unit from 1989 to 1999 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/68\">",
"     68",
"    </a>",
"    ]. Neurologic impairment developed in 28 percent.",
"   </p>",
"   <p>",
"    Thalamic hemorrhage with residual germinal matrix hemorrhage is a common source of ICH in this population. When no source is apparent, the ICH is thought to originate from the choroid plexus. In one report, thalamic hemorrhage was identified in 12 of 19 term infants younger than one month of age with ICH diagnosed by computed tomography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/69\">",
"     69",
"    </a>",
"    ]. Thalamic hemorrhage typically occurred in infants with uneventful birth histories and presentation after one week of age. Many had predisposing factors for cerebral vein thrombosis (eg, sepsis, congenital heart disease, coagulopathy, electrolyte disturbance). At 18 months of age, the majority had CP, predominantly hemiplegia, and other neurologic abnormalities such as hydrocephalus and seizures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Intrauterine infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrauterine infection is associated with an increased risk of CP. Congenital infections with organisms such as cytomegalovirus, syphilis, varicella virus, and toxoplasmosis play a role. Bacterial infections leading to chorioamnionitis are also associated with CP.",
"   </p>",
"   <p>",
"    Chorioamnionitis is associated with an increased risk of CP in term infants, although few studies are available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/25,70,71\">",
"     25,70,71",
"    </a>",
"    ]. In one report, a population-based case-control study in California in 1983 to 1985 evaluated maternal infection in children with disabling spastic CP with birth weight &gt;2500 g and no identified prenatal brain lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/25\">",
"     25",
"    </a>",
"    ]. The risk of CP was increased by maternal temperature &gt;38 degrees in labor (OR 9.3) or a clinical diagnosis of chorioamnionitis. Indicators of maternal infection were more likely to occur in children with CP and spastic quadriplegic CP compared to controls (22 and 37 versus 2.9 percent). In addition, maternal infection was associated with birth depression and need for resuscitation and neonatal seizures.",
"   </p>",
"   <p>",
"    In another case-control study in California of term singleton infants born at &ge;36 weeks gestation between 1991 and 1998, chorioamnionitis occurred more often in children with CP than controls (14 versus 4 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/71\">",
"     71",
"    </a>",
"    ]. Cerebral palsy could be attributed to chorioamnionitis in 11 percent of cases, and the odds ratio for developing cerebral palsy after a diagnosis of chorioamnionitis was 4.1 (95% CI, 1.6-10.1) in multivariable analysis. Other independent risk factors for CP included intrauterine growth restriction, maternal black ethnicity, maternal age &gt;25 years, and nulliparity.",
"   </p>",
"   <p>",
"    The role of intrauterine infection is supported by the presence of increased concentrations of inflammatory mediators (interleukins 1, 8, 9, tumor necrosis factor-alpha, and RANTES [regulated on activation normally T-cell expressed and secreted]) in neonatal blood samples of children with CP compared to controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/72\">",
"     72",
"    </a>",
"    ]. In the same study, concentrations of antibodies to antithrombin, a translational product of factor V Leiden mutation, and proteins C and S also were higher in children with CP.",
"   </p>",
"   <p>",
"    In preterm infants, perinatal infection appears to play a key role in the pathogenesis of periventricular leukomalacia (PVL) and subsequent CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/73\">",
"     73",
"    </a>",
"    ]. PVL refers to necrosis of cerebral white matter in a specific distribution, dorsolateral to the external angles of the lateral ventricles and involving the region adjacent to the trigones and to the frontal horn and body of the lateral ventricles. In a meta-analysis of observational studies of the association of chorioamnionitis and CP and cystic PVL, clinical chorioamnionitis was significantly associated with CP (relative risk 1.9) and cystic PVL (RR 3.0) in preterm infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/74\">",
"     74",
"    </a>",
"    ]. Histologic chorioamnionitis was also associated with these outcomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/7/33913?source=see_link\">",
"     \"Periventricular leukomalacia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The development of PVL may be mediated by a fetal inflammatory response, as evidenced by increased concentration of cytokines in the amniotic fluid or umbilical cord blood. In one series of 94 preterm pregnancies in which amniocentesis was performed, 23 newborns had subsequent sonographic evidence of PVL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/75\">",
"     75",
"    </a>",
"    ]. Median amniotic fluid concentrations of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 were higher in newborns with PVL than in those without. All eight infants who later developed cerebral palsy had PVL and elevated amniotic fluid cytokine levels. In another report, concentrations of interleukin-6, but not interleukin 1(beta), interleukin-1 receptor antagonist, and tumor necrosis factor-alpha, were higher in umbilical cord plasma in preterm infants with than without PVL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Prematurity",
"    </span>",
"    &nbsp;&mdash;&nbsp;CP develops in approximately 5 to 15 percent of surviving very low birth weight infants. In this population, it is associated with the presence of PVL. In addition to perinatal inflammation and other etiologies discussed above, cerebral ischemia in a specific distribution contributes to PVL and leads to CP in preterm infants. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/7/33913?source=see_link&amp;anchor=H5#H5\">",
"     \"Periventricular leukomalacia\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other conditions that primarily affect preterm infants and may lead to CP include severe intraventricular hemorrhage (IVH) and periventricular hemorrhagic infarction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/46/31465?source=see_link\">",
"     \"Management and complications of intraventricular hemorrhage in the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27690?source=see_link\">",
"     \"Stroke in the newborn\"",
"    </a>",
"    .) Posthemorrhagic hydrocephalus, a complication of IVH, frequently leads to CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of motor impairment is greater in preterm infants affected by bronchopulmonary dysplasia (BPD). The mechanism is not known but may involve the use of corticosteroids to improve lung disease. A more detailed discussion of this issue is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/14/27880?source=see_link\">",
"     \"Prevention of bronchopulmonary dysplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An extrapyramidal movement disorder has been described in a series of 10 preterm infants with severe BPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/78\">",
"     78",
"    </a>",
"    ]. This disorder became apparent at approximately three months of age. It persisted in three of the surviving seven infants and partially or completely resolved in the rest. A similar choreic disorder may occur in infants following cardiopulmonary bypass and profound hypothermia for repair of congenital heart defects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/79\">",
"     79",
"    </a>",
"    ]. Neuropathologic findings consisted of neuronal loss, reactive astrocytosis, and degeneration of myelinated fibers, primarily in the outer segment of the globus pallidus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Acquired postnatal causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 to 18 percent of cases of CP are acquired after the neonatal period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41768/abstract/81\">",
"     81",
"    </a>",
"    ]. Most of these patients have spastic CP. Causes include stroke, trauma, and severe hypoxic events such as near-drowning. Bacterial, viral, and fungal infections also may lead to CP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Kernicterus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with severe hyperbilirubinemia are at risk for kernicterus, permanent neurologic sequelae of bilirubin-induced neurotoxicity (BIND) that manifests itself as a type of CP characterized by choreoathetosis, with gaze abnormalities and sensorineural hearing loss. The disorder results when unconjugated bilirubin enters the brain and causes focal necrosis of neurons and glia. The regions most often affected include the basal ganglia and the brainstem nuclei for oculomotor and auditory function, accounting for the clinical features of this condition. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/63/25593?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants\", section on 'Kernicterus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MAGNESIUM SULFATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/29/34262?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    is neuroprotective in animals exposed to hypoxic-ischemic injury, it was hypothesized that cerebral palsy (CP) might be reduced in offspring of mothers treated with magnesium sulfate for preeclampsia or preterm labor. There is increasing evidence from clinical trials that antenatal administration of magnesium sulfate to women with preterm labor decreases the incidence and severity of cerebral palsy in their offspring, without affecting mortality. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/49/43799?source=see_link\">",
"     \"Neuroprotective effects of in utero exposure to magnesium sulfate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The prevalence of cerebral palsy (CP) is approximately 2 to 4 cases per 1000 children. The risk is markedly increased among infants with low birthweight, so the prevalence of CP in a given population also depends on rates of premature birth and survival of such infants. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiology of CP is multifactorial. Most cases are thought to be due to prenatal factors. The most commonly identified prenatal risk factors for CP are prematurity, intrauterine growth restriction, intrauterine infection, antepartum hemorrhage, severe placental pathology, and multiple pregnancy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Perinatal hypoxia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ischemia likely accounts for only a small minority of cases of CP. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Perinatal asphyxia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stroke in the perinatal period may cause CP, and is typically manifested as spastic hemiparesis. Thromboembolism and prothrombotic disorders contribute to the etiology of this disorder. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Stroke'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27690?source=see_link\">",
"       \"Stroke in the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CP develops in approximately 5 to 15 percent of surviving very low birth weight infants. In this population, it is associated with the presence of periventricular leukomalacia, intraventricular hemorrhage and periventricular hemorrhagic infarction. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Prematurity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is increasing evidence that antenatal administration of",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/29/34262?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      to women with preterm labor decreases the incidence and severity of cerebral palsy in their offspring, without affecting mortality. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Magnesium sulfate'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/49/43799?source=see_link\">",
"       \"Neuroprotective effects of in utero exposure to magnesium sulfate\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/1\">",
"      Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS, et al. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics 2008; 121:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/2\">",
"      Nelson KB. The epidemiology of cerebral palsy in term infants. Ment Retard Dev Disabil Res Rev 2002; 8:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/3\">",
"      Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol 2002; 44:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/4\">",
"      Hagberg B, Hagberg G, Olow I, von Wendt L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr 1996; 85:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/5\">",
"      Wood NS, Marlow N, Costeloe K, et al. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000; 343:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/6\">",
"      Lorenz JM, Wooliever DE, Jetton JR, Paneth N. A quantitative review of mortality and developmental disability in extremely premature newborns. Arch Pediatr Adolesc Med 1998; 152:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/7\">",
"      Moster D, Wilcox AJ, Vollset SE, et al. Cerebral palsy among term and postterm births. JAMA 2010; 304:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/8\">",
"      Jarvis S, Glinianaia SV, Torrioli MG, et al. Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet 2003; 362:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/9\">",
"      Petersen MC, Palmer FB. Birthweight and risk for cerebral palsy. Lancet 2003; 362:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/10\">",
"      Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 1996; 75:F169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/11\">",
"      Platt MJ, Cans C, Johnson A, et al. Trends in cerebral palsy among infants of very low birthweight (&lt;1500 g) or born prematurely (&lt;32 weeks) in 16 European centres: a database study. Lancet 2007; 369:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/12\">",
"      Robertson CM, Watt MJ, Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 2007; 297:2733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/13\">",
"      Nelson KB. Can we prevent cerebral palsy? N Engl J Med 2003; 349:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/14\">",
"      Strijbis EM, Oudman I, van Essen P, MacLennan AH. Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstet Gynecol 2006; 107:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/15\">",
"      Oleg&aring;rd R, Sabel KG, Aronsson M, et al. Effects on the child of alcohol abuse during pregnancy. Retrospective and prospective studies. Acta Paediatr Scand Suppl 1979; 275:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/16\">",
"      O'Leary CM, Watson L, D'Antoine H, et al. Heavy maternal alcohol consumption and cerebral palsy in the offspring. Dev Med Child Neurol 2012; 54:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/17\">",
"      Abel EL. Cerebral palsy and alcohol consumption during pregnancy: is there a connection? Alcohol Alcohol 2010; 45:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/18\">",
"      Perlman JM. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: medicolegal issues. Pediatrics 1997; 99:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/19\">",
"      Nelson KB. What proportion of cerebral palsy is related to birth asphyxia? J Pediatr 1988; 112:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/20\">",
"      Hankins GD, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003; 102:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/21\">",
"      Ellenberg JH, Nelson KB. The association of cerebral palsy with birth asphyxia: a definitional quagmire. Dev Med Child Neurol 2013; 55:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/22\">",
"      Nelson KB, Ellenberg JH. Apgar scores as predictors of chronic neurologic disability. Pediatrics 1981; 68:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/23\">",
"      Paneth N. Cerebral palsy in term infants--birth or before birth? J Pediatr 2001; 138:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/24\">",
"      Nelson KB, Grether JK. Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight. Am J Obstet Gynecol 1998; 179:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/25\">",
"      Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/26\">",
"      Nelson KB, Grether JK. Selection of neonates for neuroprotective therapies: one set of criteria applied to a population. Arch Pediatr Adolesc Med 1999; 153:393.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists and American Academy of Pediatrics. Neonatal encephalopathy and cerebral palsy: defining the pathogenesis and pathophysiology, ACOG, Washington, DC 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/28\">",
"      American Collge of Obstetricians and Gynecologists (ACOG). Neonatal encephalopathy and cerebral palsy: executive summary. Obstet Gynecol 2004; 103:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/29\">",
"      Clancy RR, Sladky JT, Rorke LB. Hypoxic-ischemic spinal cord injury following perinatal asphyxia. Ann Neurol 1989; 25:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/30\">",
"      Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 1986; 315:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/31\">",
"      Gaffney G, Sellers S, Flavell V, et al. Case-control study of intrapartum care, cerebral palsy, and perinatal death. BMJ 1994; 308:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/32\">",
"      Croen LA, Grether JK, Curry CJ, Nelson KB. Congenital abnormalities among children with cerebral palsy: More evidence for prenatal antecedents. J Pediatr 2001; 138:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/33\">",
"      Miller G. Minor congenital anomalies and ataxic cerebral palsy. Arch Dis Child 1989; 64:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/34\">",
"      Pharoah PO. Prevalence and pathogenesis of congenital anomalies in cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2007; 92:F489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/35\">",
"      Freeman JM, Nelson KB. Intrapartum asphyxia and cerebral palsy. Pediatrics 1988; 82:240.",
"     </a>",
"    </li>",
"    <li>",
"     Brann AW. Factors during neonatal life that influence brain disorder. In: Prenatal and Perinatal Factors Associated with Brain Disorders (NIH Pub. No. 85-1149), Freeman JM (Ed), US Government Printing Office, Washington, DC 1998. p.263.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/37\">",
"      Felix JF, Badawi N, Kurinczuk JJ, et al. Birth defects in children with newborn encephalopathy. Dev Med Child Neurol 2000; 42:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/38\">",
"      Naeye RL, Peters EC, Bartholomew M, Landis JR. Origins of cerebral palsy. Am J Dis Child 1989; 143:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/39\">",
"      Andersen GL, Irgens LM, Skranes J, et al. Is breech presentation a risk factor for cerebral palsy? A Norwegian birth cohort study. Dev Med Child Neurol 2009; 51:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/40\">",
"      Wood JW, Johnson KG, Omori Y. In utero exposure to the Hiroshima atomic bomb. An evaluation of head size and mental retardation: twenty years later. Pediatrics 1967; 39:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/41\">",
"      Dekaban AS. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. I. J Nucl Med 1968; 9:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/42\">",
"      Brent RL, Beckman DA. Environmental teratogens. Bull N Y Acad Med 1990; 66:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/43\">",
"      Rorke LB. A perspective: the role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders. J Neuropathol Exp Neurol 1994; 53:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/44\">",
"      Hilburger AC, Willis JK, Bouldin E, Henderson-Tilton A. Familial schizencephaly. Brain Dev 1993; 15:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/45\">",
"      Haverkamp F, Zerres K, Ostertun B, et al. Familial schizencephaly: further delineation of a rare disorder. J Med Genet 1995; 32:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/46\">",
"      Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996; 14:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/47\">",
"      Dobyns WB, Andermann E, Andermann F, et al. X-linked malformations of neuronal migration. Neurology 1996; 47:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/48\">",
"      Barkovich AJ, Kuzniecky RI, Dobyns WB, et al. A classification scheme for malformations of cortical development. Neuropediatrics 1996; 27:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/49\">",
"      Dodge NN, Dobyns WB. Agenesis of the corpus callosum and Dandy-Walker malformation associated with hemimegalencephaly in the sebaceous nevus syndrome. Am J Med Genet 1995; 56:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/50\">",
"      Bundey S, Griffiths MI. Recurrence risks in families of children with symmetrical spasticity. Dev Med Child Neurol 1977; 19:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/51\">",
"      Hemminki K, Sundquist K, Li X. Familial risks for main neurological diseases in siblings based on hospitalizations in Sweden. Twin Res Hum Genet 2006; 9:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/52\">",
"      Kuroda MM, Weck ME, Sarwark JF, et al. Association of apolipoprotein E genotype and cerebral palsy in children. Pediatrics 2007; 119:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/53\">",
"      Gibson CS, MacLennan AH, Hague WM, et al. Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am J Obstet Gynecol 2005; 193:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/54\">",
"      O'Callaghan ME, Maclennan AH, Gibson CS, et al. Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study. Pediatrics 2012; 129:e414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/55\">",
"      Gibson CS, MacLennan AH, Goldwater PN, et al. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006; 194:674.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/56\">",
"      Gibson CS, Maclennan AH, Dekker GA, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008; 122:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/57\">",
"      Wells J, Rosenberg M, Hoffman G, et al. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis. Pediatrics 2012; 129:e339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/58\">",
"      Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ 1993; 307:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/59\">",
"      Pharoah PO, Cooke T. Cerebral palsy and multiple births. Arch Dis Child Fetal Neonatal Ed 1996; 75:F174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/60\">",
"      Larroche JC, Droull&eacute; P, Delezoide AL, et al. Brain damage in monozygous twins. Biol Neonate 1990; 57:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/61\">",
"      Scheller JM, Nelson KB. Twinning and neurologic morbidity. Am J Dis Child 1992; 146:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/62\">",
"      Weig SG, Marshall PC, Abroms IF, Gauthier NS. Patterns of cerebral injury and clinical presentation in the vascular disruptive syndrome of monozygotic twins. Pediatr Neurol 1995; 13:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/63\">",
"      Bonellie SR, Currie D, Chalmers J. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Child Neurol 2005; 47:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/64\">",
"      Bejar R, Vigliocco G, Gramajo H, et al. Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol 1990; 162:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/65\">",
"      Pharoah PO. Twins and cerebral palsy. Acta Paediatr Suppl 2001; 90:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/66\">",
"      Pharoah PO. Cerebral palsy in the surviving twin associated with infant death of the co-twin. Arch Dis Child Fetal Neonatal Ed 2001; 84:F111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/67\">",
"      Hanigan WC, Powell FC, Miller TC, Wright RM. Symptomatic intracranial hemorrhage in full-term infants. Childs Nerv Syst 1995; 11:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/68\">",
"      Gradnitzer E, Urlesberger B, Maurer U, et al. [Cerebral hemorrhage in term newborn infants--an analysis of 10 years (1989-1999)]. Wien Med Wochenschr 2002; 152:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/69\">",
"      Roland EH, Flodmark O, Hill A. Thalamic hemorrhage with intraventricular hemorrhage in the full-term newborn. Pediatrics 1990; 85:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/70\">",
"      Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. I. Univariate analysis of risks. Am J Dis Child 1985; 139:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/71\">",
"      Wu YW, Escobar GJ, Grether JK, et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003; 290:2677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/72\">",
"      Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/73\">",
"      O'Shea TM. Cerebral palsy in very preterm infants: new epidemiological insights. Ment Retard Dev Disabil Res Rev 2002; 8:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/74\">",
"      Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000; 284:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/75\">",
"      Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/76\">",
"      Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996; 174:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/77\">",
"      Dykes FD, Dunbar B, Lazarra A, Ahmann PA. Posthemorrhagic hydrocephalus in high-risk preterm infants: natural history, management, and long-term outcome. J Pediatr 1989; 114:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/78\">",
"      Perlman JM, Volpe JJ. Movement disorder of premature infants with severe bronchopulmonary dysplasia: a new syndrome. Pediatrics 1989; 84:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/79\">",
"      Wical BS, Tomasi LG. A distinctive neurologic syndrome after induced profound hypothermia. Pediatr Neurol 1990; 6:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/80\">",
"      Kupsky WJ, Drozd MA, Barlow CF. Selective injury of the globus pallidus in children with post-cardiac surgery choreic syndrome. Dev Med Child Neurol 1995; 37:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41768/abstract/81\">",
"      Pharoah PO, Cooke T, Rosenbloom L. Acquired cerebral palsy. Arch Dis Child 1989; 64:1013.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6173 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-C070ECA3F8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41768=[""].join("\n");
var outline_f40_50_41768=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Perinatal asphyxia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Neonatal encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Congenital abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Brain malformations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Genetic susceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Multiple births",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Intracranial hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Intrauterine infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Prematurity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Acquired postnatal causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Kernicterus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MAGNESIUM SULFATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6173\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6173|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/27/6587\" title=\"table 1\">",
"      Criteria for asphyxial CP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/10/10411\" title=\"table 2\">",
"      Nonasphyxial events and CP",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29209?source=related_link\">",
"      Clinical features of cerebral palsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/24/2442?source=related_link\">",
"      Clinical features, diagnosis, and treatment of neonatal encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/63/25593?source=related_link\">",
"      Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/0/4104?source=related_link\">",
"      Diagnosis and classification of cerebral palsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/14/30953?source=related_link\">",
"      Etiology and pathogenesis of neonatal encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/46/31465?source=related_link\">",
"      Management and complications of intraventricular hemorrhage in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/37/15962?source=related_link\">",
"      Management and prognosis of cerebral palsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/49/43799?source=related_link\">",
"      Neuroprotective effects of in utero exposure to magnesium sulfate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/7/33913?source=related_link\">",
"      Periventricular leukomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/14/27880?source=related_link\">",
"      Prevention of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27690?source=related_link\">",
"      Stroke in the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_50_41769="Prognosis after myocardial infarction";
var content_f40_50_41769=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prognosis after myocardial infarction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Peter WF Wilson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Pamela S Douglas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Patricia A Pellikka, MD, FACC, FAHA, FASE",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Juan Carlos Kaski, MD, DM, DSc, FRCP, FESC, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41769/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/50/41769/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Survivors of a myocardial infarction (MI) face a substantial excess risk of further cardiovascular events, including an increase in mortality. The prognosis for an individual varies markedly according to the presence or absence of adverse risk factors. Factors affecting patient prognosis will be presented here, while methods of risk stratification are discussed separately. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Predictors of mortality'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/52/35658?source=see_link\">",
"     \"Risk stratification for cardiac events after acute ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=see_link\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25754?source=see_link\">",
"     \"Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SHORT-TERM MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of causes of death in the early (initial 30 days) post-MI period in patients who have recently had a MI, including cardiogenic shock, sudden cardiac death, progressive heart failure, mechanical cardiac complications, and repeat MI. In-hospital death rates following MI have fallen substantially in the past few decades with the increasing use of reperfusion techniques, which often limit the amount of permanent myocardial damage, necrosis, and scar tissue formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/1-9\">",
"     1-9",
"    </a>",
"    ]. In a report that evaluated the interval 1987 to 2002, the 28-day case fatality fell from 5.3 to 3.8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/10\">",
"     10",
"    </a>",
"    ]. A similar trend was noted in an analysis of data on 2.5 million patients from the National Registry of Myocardial Infarction (NRMI) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/7\">",
"     7",
"    </a>",
"    ]. In-hospital mortality after an acute MI declined from 10.4 percent in 1994 to 6.3 percent in 2006.",
"   </p>",
"   <p>",
"    The following section will provide general data on mortality within the first 30 days after MI. The specific issue of sudden cardiac death related to MI is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/24/20874?source=see_link\">",
"     \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H21\">",
"     'Sudden cardiac death'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     ST elevation MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following discussion will review mortality following STEMI in specific groups of patients. However, the prognosis for an individual varies markedly according to the presence or absence of adverse clinical and epidemiologic factors. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Predictors of mortality'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/52/35658?source=see_link\">",
"     \"Risk stratification for cardiac events after acute ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The bulk of the improvement in 30-day mortality after STEMI has come from increased use of fibrinolytic therapy and primary percutaneous coronary intervention (PCI), as well as increased use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , ACE inhibitors, statins, and beta blockers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/4\">",
"     4",
"    </a>",
"    ]. The adoption of these proven therapies has been hastened by several national quality improvement programs, including pay for performance and public reporting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The in-hospital or 30-day mortality rates have been lowest in clinical trials (performed in the 1990s) in which patients were carefully selected and therapy carefully monitored. Among patients with an STEMI, approximate in-hospital or 30-day mortality rates were 13 percent with medical therapy alone, 6 to 7 percent with optimal fibrinolytic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/12,13\">",
"     12,13",
"    </a>",
"    ], and as low as 3 to 5 percent with primary PCI when performed within two hours of hospital arrival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/27/14778?source=see_link\">",
"     \"Characteristics of fibrinolytic (thrombolytic) agents and clinical trials in acute ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/46/16106?source=see_link&amp;anchor=H4#H4\">",
"     \"Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Determinants of outcome\", section on 'Time from hospital arrival (door-to-balloon time) on outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Somewhat higher in-hospital and 30-day mortality rates after STEMI have been described in patients not enrolled in clinical trials and cared for during a similar time period. The reported in-hospital mortality was between 7 and 9.3 percent and the 30-day mortality was 11.1 percent for patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. A number of factors could contribute to this difference including patient selection, less frequent use of appropriate therapies, and data collection before trials supporting the value of primary PCI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More contemporary reports of patients not enrolled in trials have documented a continued decline in mortality in STEMI patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. For example, outcomes were presented in a 2012 report of 6707 STEMI patients in four French nationwide registries conducted five years apart (1995, 2000, 2005, and 2010) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/22\">",
"     22",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There were significant decreases in crude 30-day mortality (from 13.7 to 4.4 percent) and mortality standardized to 2010 population characteristics (from 11.3 to 4.4 percent). These declines were seen irrespective of the type of reperfusion (fibrinolysis or PCI) and were seen in patients who were not reperfused.",
"     </li>",
"     <li>",
"      Time from symptom onset to hospital admission decreased, with a shorter time from onset to first call, and broader use of mobile intensive care units.",
"     </li>",
"     <li>",
"      During this time, the average age fell and the prevalence of most risk factors increased.",
"     </li>",
"     <li>",
"      The use of reperfusion therapy increased from 50 to 75 percent, driven mostly by an increase of the use of PCI, as did the use of recommended preventative medical therapies.",
"     </li>",
"     <li>",
"      Within the STEMI population assessed in these registries, the relative proportion of older patients decreased, and the proportion of younger men and women increased. These registry data suggest that future strategies aimed at further reducing AMI incidence and mortality will need to specifically target prevention in younger men and women.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Non-ST elevation MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following discussion will review the short-term mortality following an NSTEMI or unstable angina. However, the prognosis for an individual varies markedly according to the presence or absence of adverse clinical and epidemiologic factors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=see_link\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25754?source=see_link\">",
"     \"Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H7\">",
"     'Predictors of mortality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Among patients with a non-ST elevation acute coronary syndrome (ACS), in-hospital or 30-day mortality has been about 2 percent in major clinical trials, lower than that seen in STEMI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. An early invasive strategy is now performed in most patients because of reductions in recurrent MI or rehospitalization for an ACS. However, mortality rates in FRISC II and TACTICS-TIMI 18 were not significantly reduced in-hospital or at six months in patients treated with an early invasive strategy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/36/29257?source=see_link\">",
"     \"Trials of conservative versus early invasive therapy in unstable angina and non-ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following are examples of the short-term mortality rates in patients with NSTEMI not enrolled in clinical trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The in-hospital mortality was 5 percent with NSTEMI (and 3 percent with unstable angina) in the GRACE registry of over 10,000 patients from 14 countries worldwide seen in 1999 and 2000 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The in-hospital mortality and 30-day mortality rates were 5.8 and 7.4 percent for patients with a final diagnosis of NSTEMI (and 1.0 and 1.7 percent with unstable angina) in the Euro Heart Survey review of over 10,000 patients from 25 countries in Europe seen from late 2000 through May 2001 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A number of factors could contribute to this difference including patient selection, less frequent use of appropriate therapies, and more high-risk features (eg, older age, more diabetes, smoking, and renal insufficiency, and a greater likelihood of a history of heart failure) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The short-term mortality is lower in patients with an NSTEMI (2 percent) compared with 3 to 5 percent in patients with STEMI treated with primary PCI within two hours of hospital arrival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/14,15,17,23,24\">",
"     14,15,17,23,24",
"    </a>",
"    ]. Better short-term outcomes for patients with NSTEMI have also been noted in other studies (eg, in-hospital mortality 5 to 7 percent compared with 7.0 to 9.3 percent with STEMI in the GRACE and Euro Heart registries) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/16,17,23\">",
"     16,17,23",
"    </a>",
"    ]. Coronary arteriography performed in the acute period of NSTEMI has shown that the infarct-related artery is not occluded in 60 to 85 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/26-29\">",
"     26-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The similar or worse long-term prognosis in NSTEMI is in part related to more than a 50 percent prevalence of multivessel disease in affected patients and to a greater likelihood of residual ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/26,30,31\">",
"     26,30,31",
"    </a>",
"    ]. Thus, a significant amount of myocardium often remains at risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     STEMI versus NSTEMI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older studies suggest somewhat higher in-hospital mortality for patients with STEMI, particularly for those enrolled in clinical trials of reperfusion therapy, compared with NSTEMI. However, at one and two years the cumulative mortality for NSTEMI exceeds that of STEMI patients, an observation reported from the first direct comparison of patients with STEMI and NSTEMI not enrolled in a clinical trial (OPERA registry) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/32\">",
"     32",
"    </a>",
"    ]. Cardiovascular outcomes were evaluated in 2151 consecutive patients (71 percent STEMI) with confirmed MI during 2002 and 2003. The STEMI patients were treated with primary PCI (71 percent) or fibrinolytic therapy (29 percent), while PCI was performed in 52 percent of NSTEMI patients. In-hospital mortality was not different for both groups (4.6 versus 4.3 percent), while the one-year post-discharge mortality was higher with NSTEMI (8.2 versus 5.0 percent).",
"   </p>",
"   <p>",
"    At this point it is difficult to reach a consensus concerning prognosis for STEMI vs NSTEMI patients, largely because the burden of underlying cardiovascular disease and risk factors may differ between the patient groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Predictors of mortality",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Severity of the event",
"    </span>",
"    &nbsp;&mdash;&nbsp;The short-term prognosis after MI is determined in part by the severity of the event. In the ARIC study, the severity of MI declined from 1987 to 2002 as evidenced by significant decreases in electrocardiographic abnormalities such as the percent of cases with ST segment elevation (1.9 percent per year) or subsequent Q-waves (4.5 percent per year) on the electrocardiogram, maximum creatinine kinase-MB (7.6 percent per year), and the percent with shock (5.7 percent per year) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/1,10\">",
"     1,10",
"    </a>",
"    ]. The presence of each of these markers was strongly and positively associated with the adjusted 28-day case fatality. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Short-term mortality'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Risk scores",
"    </span>",
"    &nbsp;&mdash;&nbsp;As expected, the outcome after acute MI is worse in patients with larger infarct size and more comorbidity. Several risk scores have been developed to assess short- and long-term outcomes after MI. The most widely used are the TIMI risk scores for STEMI (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?27/53/28497?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) and NSTEMI (",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?5/34/5665?source=see_link\">",
"     calculator 2",
"    </a>",
"    ) to predict 14- to 30-day mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/52/35658?source=see_link&amp;anchor=H2#H2\">",
"     \"Risk stratification for cardiac events after acute ST elevation myocardial infarction\", section on 'Risk scores'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=see_link&amp;anchor=H7#H7\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\", section on 'TIMI risk score'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The GRACE risk score is an alternative model that can be used to estimate in-hospital and six-month mortality following ACS which may have a slightly higher predictive value than the TIMI risk score. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=see_link&amp;anchor=H10#H10\">",
"     \"Risk stratification after unstable angina or non-ST elevation myocardial infarction\", section on 'GRACE risk models'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimal approach to accurate assessment of risk in women with a non-ST elevation ACS may differ from that in men. This was suggested by an analysis from TACTICS-TIMI 18 which found that women were more likely to have elevations of CRP and BNP, and less likely to have elevations of troponins and CK-MB, than men, despite similar levels of risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/35\">",
"     35",
"    </a>",
"    ]. When a multimarker approach incorporating CRP, BNP and troponins was used, women with any positive marker benefited from an invasive strategy, while those with no positive markers benefited from a conservative strategy and in fact were harmed by a more aggressive strategy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/36/29257?source=see_link&amp;anchor=H15#H15\">",
"     \"Trials of conservative versus early invasive therapy in unstable angina and non-ST elevation myocardial infarction\", section on 'Effect in women'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Ischemic MR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemic mitral regurgitation (MR) is a relatively common complication of myocardial infarction. The MR is usually due to infarction with annulus dilatation or papillary muscle displacement from ischemic left ventricular remodeling long-term follow-up studies have shown that ischemic MR is associated with increased mortality and that this effect is more pronounced with moderate to severe compared to mild MR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/55/18297?source=see_link\">",
"     \"Ischemic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Recurrent MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with an acute MI, those with a past history of MI have an increased risk for complications and mortality when compared with those with a first MI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. The mortality risk is greatest in patients with a current infarct in a territory remote from the previous event or with a second anterior infarct [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     MI with normal coronary arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with a non-ST elevation ACS, coronary angiography in major trials revealed either normal vessels or no vessel with &ge;50 percent stenosis in 12 to 14 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. A somewhat lower rate (7.5 percent) has been noted in patients with STEMI. Possible mechanisms for the absence of significant coronary disease include rapid clot lysis, vasospasm, and coronary microvascular disease as occurs in cardiac syndrome X. These patients have a lower mortality than those with an identifiable culprit lesion. The data supporting these conclusions are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28505?source=see_link&amp;anchor=H10#H10\">",
"     \"Classification of unstable angina and non-ST elevation myocardial infarction\", section on 'Absence of significant coronary disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/42/5802?source=see_link&amp;anchor=H4#H4\">",
"     \"Cardiac syndrome X: Angina pectoris with normal coronary arteries\", section on 'Acute coronary syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     MI without chest pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although chest pain is considered a cardinal symptom among patients presenting with an ACS, up to 33 percent of patients have atypical symptoms such as dyspnea alone, nausea",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vomiting, palpitations, syncope, or cardiac arrest. In one series of 2096 patients with a first confirmed MI, the 20 percent who presented without chest pain had higher mortality at 30 days (49 versus 18 percent with chest pain) and one year (61 versus 26 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/40\">",
"     40",
"    </a>",
"    ]. These patients were less likely to receive treatment strategies of proven benefit, which may partly account for worse outcomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/41/44697?source=see_link\">",
"     \"Overview of the acute management of ST elevation myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326129\">",
"    <span class=\"h3\">",
"     Bundle branch block",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of left or right bundle branch block after an acute MI is associated with a significant increase in mortality. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/11/4282?source=see_link&amp;anchor=H18#H18\">",
"     \"Conduction abnormalities after myocardial infarction\", section on 'Bundle branch block'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Clinician experience",
"    </span>",
"    &nbsp;&mdash;&nbsp;The experience of the clinician caring for patients with an acute MI affects patient survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. In a review of almost 100,000 Canadian patients with an acute MI treated by over 5300 clinicians, the risk-adjusted mortality was significantly higher when the admitting clinician cared for &le;5 cases per year (lowest quartile) compared with those who cared for &gt;24 cases per year (highest quartile) at both 30 days (15.3 versus 11.8 percent) and one year (24.2 versus 19.6 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/41\">",
"     41",
"    </a>",
"    ]. In this study, clinician subspecialty was not an independent predictor after adjusting for clinician volume. However, other studies have suggested that patients cared for by a cardiologist have a lower mortality than those cared for by a nonspecialist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/42-45\">",
"     42-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Hospital experience",
"    </span>",
"    &nbsp;&mdash;&nbsp;The experience of the hospital may be another determinant of outcome. The magnitude of this effect was examined in an analysis of 98,898 Medicare patients admitted with an acute MI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/44\">",
"     44",
"    </a>",
"    ]. The patients in the quartile admitted to hospitals with the lowest acute MI volume were more likely to die within 30 days than patients in the quartile admitted to hospitals with the highest acute MI volume (hazard ratio 1.17; 95% CI 1.09-1.26).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Off-hour presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The adverse impact of off-hour presentation in patients who might be treated with primary PCI for ST elevation MI is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/46/16106?source=see_link&amp;anchor=H4#H4\">",
"     \"Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Determinants of outcome\", section on 'Time from hospital arrival (door-to-balloon time) on outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1144483338\">",
"    <span class=\"h1\">",
"     EARLY REHOSPITALIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of rehospitalization within 30 days after acute MI is reported to range between 17 and 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. In a single-community (Olmsted County, Minnesota, United States) study of 3010 patients who were hospitalized for a first-ever MI (31 percent STEMI) between 1987 and 2010, rehospitalization within 30 days occurred in about 19 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/48\">",
"     48",
"    </a>",
"    ]. Of these, 30 percent were and 43 percent were not related to the incident event. Diabetes, chronic obstructive pulmonary disease, anemia, higher Killip class (",
"    <a class=\"graphic graphic_table graphicRef65592 \" href=\"mobipreview.htm?3/59/4027\">",
"     table 1",
"    </a>",
"    ), longer length of stay during the index hospitalization, and a complication of angiography or reperfusion or revascularization were associated with increase rehospitalization risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     LONG-TERM OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term (more than 30 days) complications and morbidity following MI can result from some of the same mechanisms as the short-term complications, while other complications can arise via different mechanisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     After ST elevation MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to short-term outcomes, long-term mortality rates after STEMI have also declined. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Short-term mortality'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    An analysis of 23 published studies in which follow-up was completed prior to 1980 illustrated the mortality after MI in the era prior to modern therapy with primary PCI or fibrinolytic agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/33\">",
"     33",
"    </a>",
"    ]. Of 14,211 patients followed prospectively after an MI (primarily STEMI), 6817 had died at seven years. After a first MI, the death rates during hospital admission, in the first year, and for each year thereafter were 16, 10, and 5 percent, respectively. For a subsequent MI, the comparable rates were 30, 19, and 10 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     After non-ST elevation ACS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are very little published data on the long-term outcomes after NSTEMI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     STEMI versus NSTEMI",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to the in-hospital findings, long-term outcomes have been similar or worse with NSTEMI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/2,23,30,49-52\">",
"     2,23,30,49-52",
"    </a>",
"    ]. The largest experience comes from the GUSTO-IIb trial performed in the early 1990s of 12,142 patients with an STEMI, NSTEMI (using only CK-MB, not troponins, for diagnosis), or unstable angina [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/30\">",
"     30",
"    </a>",
"    ]. Among the patients with STEMI, primary PCI was performed in only 11 percent; among the patients with NSTEMI or unstable angina, angiography and revascularization were performed in 57 and 34 percent, respectively.",
"   </p>",
"   <p>",
"    The mortality rate at 30 days was similar in NSTEMI and STEMI (5.7 versus 6.1 percent) and lower in those with unstable angina (2.4 percent). In contrast, the mortality at one year was significantly higher with NSTEMI than STEMI and unstable angina (11.1 versus 9.6 percent and 7 percent). A similar finding was noted in a community-based observational study of almost 6000 first MIs over a 23-year period; patients with a NSTEMI had higher two-year mortality than those with an STEMI (20 versus 11 percent)&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Sudden cardiac death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sudden cardiac death (SCD) is the initial mode of presentation in 15 percent of patients with CHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/53\">",
"     53",
"    </a>",
"    ]. In addition, SCD is the most frequent mechanism of death in patients with CHD, accounting for 30 to 50 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Many of these patients do not survive until hospital admission and are therefore not included in most outcomes studies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44361?source=see_link&amp;anchor=H23#H23\">",
"     \"Epidemiology of coronary heart disease\", section on 'Sudden cardiac death'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incidence of SCD after acute myocardial infarction is the same with STEMI and NSTEMI and with symptomatic and silent infarctions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/1,56\">",
"     1,56",
"    </a>",
"    ]. Among patients who have had an MI and are followed for about four years, approximately one-half of sudden deaths occur in the first year and one-quarter in the first three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. The risk is markedly increased in patients with a left ventricular ejection fraction &le;35 percent.",
"   </p>",
"   <p>",
"    Although the risk of SCD is highest in patients with a history of SCD, a prior MI, or heart failure, approximately 80 percent of SCD events occur in asymptomatic patients who do not have a prior history of CHD or MI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/59\">",
"     59",
"    </a>",
"    ]. In both sexes, MI confers twice the SCD risk as angina [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/55,56\">",
"     55,56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SEX DIFFERENCES IN MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following sections discuss similarities and differences in short- and long-term mortality according to gender.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Short-term mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies report higher in-hospital and 30-day mortality after MI in women compared to men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/60-67\">",
"     60-67",
"    </a>",
"    ]. This effect is primarily seen in younger women (less than 55 years), and differences between the sexes progressively decline with age (",
"    <a class=\"graphic graphic_figure graphicRef75056 \" href=\"mobipreview.htm?7/6/7278\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/62,67\">",
"     62,67",
"    </a>",
"    ]. It is thought that the higher early mortality in women may be accounted for by differences in symptoms at presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following observations made in a registry of over 900,000 patients with a confirmed diagnosis of MI (STEMI and NSTEMI) between 1994 and 2006 illustrate these points [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/67\">",
"     67",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The in-hospital mortality rate fell significantly between the time frames 1994 to 1995 and 2004 to 2006 in all age groups and in both women and men.",
"     </li>",
"     <li>",
"      The relative decline was greater for women than men in all age groups. The greatest relative decrease occurred in women younger than 55 years (from 5.1 to 2.4 percent).",
"     </li>",
"     <li>",
"      The mortality reduction was greater for women in the group younger than 55 years (53 percent) compared to any decade above age 55.",
"     </li>",
"     <li>",
"      Changes in comorbidity (risk profile) and clinical severity features at admission accounted for more than 90 percent of the mortality trends. This observation has been confirmed in other studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/61,63,65,69,70\">",
"       61,63,65,69,70",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The issue of why sex differences are present was further evaluated in a study of over 136,000 patients enrolled in randomized trials (1993 to 2006) of therapies for ACS (85 percent STEMI or NSTEMI) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/68\">",
"     68",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The unadjusted 30-day mortality was 9.6 versus 5.3 percent in women and men respectively (odds ratio [OR] 1.91, 95% CI 1.83-2.0). After multivariate analysis (including age, risk factors, history of MI, and angiographic coronary artery disease) the difference was not statistically significant.",
"     </li>",
"     <li>",
"      When examined by type of ACS, worse unadjusted 30-day mortality in women was seen for patients with STEMI (OR 2.29, 95% CI 2.18-2.40) or NSTEMI (OR 1.50, 95% CI 1.28-1.75). After multivariate adjustment, a significant difference remained between men and women with STEMI (adjusted OR 1.15, 95% CI 1.05-1.24); for patients with NSTEMI, women had a lower risk (OR 0.77, 95% CI 0.63-0.95).",
"     </li>",
"     <li>",
"      In a cohort of over 35,000 patients with angiographic data, women more often had non-obstructive disease (15 versus 8 percent) and less often had multivessel disease. After additional adjustment for angiographic disease, the (statistically significant) worse 30-day mortality in women was no longer present irrespective of ACS type, and women with NSTEMI and UA actually had a lower mortality than men.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another factor that may explain the higher short-term mortality in women is a difference in the proportion of men and women who survive to reach the hospital. This was examined in a population-based study of 201,114 patients with a first myocardial infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/71\">",
"     71",
"    </a>",
"    ]. Women, who were on average seven years older than men, were more likely than men to reach the hospital. When deaths before hospitalization were included, the 30-day mortality was lower in women than men (adjusted odds ratio 0.9).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Long-term mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar principles apply to long-term outcomes. Women with an MI have higher long-term mortality after MI than men&nbsp;and the rate is higher in black women compared with white women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/60,66,72-76\">",
"     60,66,72-76",
"    </a>",
"    ]. The difference between women and men tends to disappear when the results are adjusted for age (women tend to be older) and other risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/61,65,72,75,76\">",
"     61,65,72,75,76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, there may be true differences at specific patient ages. This was demonstrated in a report of 6826 patients who survived hospitalization for an acute MI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/77\">",
"     77",
"    </a>",
"    ]. Compared with men of similar age at two-year follow-up, women under age 60 had higher mortality, women between the ages of 60 and 69 had a similar outcome, and women &ge;70 had a lower mortality.",
"   </p>",
"   <p>",
"    Several studies have specifically evaluated the outcomes in women with a non-ST elevation ACS (unstable angina or non-ST elevation [non-Q wave] MI). Despite more comorbidity, such women have a similar [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/78\">",
"     78",
"    </a>",
"    ] or better outcome than men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/72,79,80\">",
"     72,79,80",
"    </a>",
"    ]. In the GUSTO IIb trial, which evaluated 12,142 patients presenting with an ACS, there was no difference in outcome between men and women who had an MI without ST segment elevation, while women with unstable angina had a lower rate of death or reinfarction (odds ratio 0.65) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H190490127\">",
"    <span class=\"h1\">",
"     CHRONIC OBSTRUCTIVE PULMONARY DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD) are not infrequently present in the same patient. The care of such patients may be particularly difficult for a variety of reasons. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/30/17898?source=see_link\">",
"     \"Management of the patient with severe COPD and cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The impact of COPD on the management and outcomes of patients with acute MI was evaluated in a 10-year retrospective, single site study of nearly 6300 patients (17 percent with a history of COPD) cared for between 1997 and 2007 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/81\">",
"     81",
"    </a>",
"    ]. In this study, the following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with COPD were less likely to receive beta blockers, antithrombotic therapies, lipid lowering therapy, or reperfusion strategies. However, the use of these therapies increased in all patients between 1997 and 2007.",
"     </li>",
"     <li>",
"      Short-term mortality was higher for those with COPD both during hospitalization (13.5 versus 10.0 percent) and within 30 days of discharge (18.7 versus 13.2). After multivariable adjustment, the adverse effects of COPD on 30-day post-discharge all-cause mortality persisted (OR 1.31, 95% CI 1.10-1.58). There was a similar trend for in-hospital mortality.",
"     </li>",
"     <li>",
"      During the years under study, in-hospital mortality rates fell for patients without but not those with COPD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     MORBIDITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with mortality, the apparent difference between men and women with regard to morbidity after MI diminishes after correction for age and other risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At six years following a recognized MI, men have a two-fold increase in the age-adjusted risk of a recurrence, a four-fold increase in the risk of developing angina, a five-fold increase in the risk of heart failure, and more than a two-fold increase in the risk of stroke. For women, the age-adjusted outlook is substantially worse for all of the events except angina (",
"    <a class=\"graphic graphic_table graphicRef74255 \" href=\"mobipreview.htm?19/54/20332\">",
"     table 2",
"    </a>",
"    ). However, women who sustain MIs generally have a greater burden of major risk factors; when adjustment is made for these in addition to age, women fare no worse than men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The absolute morbidity risk at six years after an MI is illustrated by the following observations from the Framingham Study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/82\">",
"     82",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent recognized MI occurred in 21 percent of men and 33 percent of women; the long-term risk of recurrence may be greater with an NSTEMI in men under age 65 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/83\">",
"       83",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Heart failure developed in 21 percent of men and 30 percent of women.",
"     </li>",
"     <li>",
"      Stroke was noted in 9 percent of men and 13 percent of women.",
"     </li>",
"     <li>",
"      Following unrecognized MIs, the age-adjusted mortality rate for MI and HF was similar in men and women, but risk ratios were higher in women than men for all events except stroke (",
"      <a class=\"graphic graphic_table graphicRef70290 \" href=\"mobipreview.htm?41/19/42300\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data on the natural history of CHD in middle-aged men have also come from a review of over 7500 patients seen in general practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/84\">",
"     84",
"    </a>",
"    ]. Adjusted to an average age of 50, the cardiovascular event-free survival at 15 years in those with a diagnosed MI was 44 percent; higher cardiovascular event-free survivals occurred in patients with silent MI, angina, silent ischemia, or no coronary heart disease (52, 66, 73, and 79 percent, respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Angina",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study of nearly 2000 patients who sustained an MI in 2003 or 2004 found that angina occurred in nearly 20 percent as early as one year and the determinants were younger age, nonwhite male race and gender, prior angina, angina during the hospital stay, smoking continuation, depression, and CABG surgery history [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/85\">",
"     85",
"    </a>",
"    ]. A similar frequency was found in another report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41769/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/6/37987?source=see_link\">",
"       \"Patient information: Heart attack recovery (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=see_link\">",
"       \"Patient information: Heart attack recovery (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Survivors of a myocardial infarction (MI) face a substantial excess risk of further cardiovascular events, including an increase in mortality. However, the prognosis for an individual varies markedly according to the presence or absence of adverse risk factors. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Predictors of mortality'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The following points summarize what is known about the prognosis after MI:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In-hospital death rates following MI have fallen substantially in the past few decades with improvements in medical care, particularly the widespread use of reperfusion techniques and the adjunctive use of multiple medical therapies. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Short-term mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The bulk of the improvement in 30-day mortality after STEMI has come from increased use of timely primary percutaneous coronary intervention as well as increased use of fibrinolytic therapy,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      , ACE inhibitors, statins, and beta blockers. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Short-term mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among patients with a non-ST elevation acute coronary syndrome (ACS), in-hospital or 30-day mortality has been about 2 percent in major clinical trials, lower than that seen in STEMI. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Short-term mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Similar to short-term outcomes, long-term mortality rates after STEMI have also declined. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Long-term outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The higher early mortality observed in women may be accounted for by differences in baseline comorbidities and clinical presentation. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Sex differences in mortality'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/1\">",
"      Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/2\">",
"      Furman MI, Dauerman HL, Goldberg RJ, et al. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 2001; 37:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/3\">",
"      Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36:2056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/4\">",
"      Heidenreich PA, McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995. Am J Med 2001; 110:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/5\">",
"      Fang J, Alderman MH. Dissociation of hospitalization and mortality trends for myocardial infarction in the United States from 1988 to 1997. Am J Med 2002; 113:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/6\">",
"      Velagaleti RS, Pencina MJ, Murabito JM, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 2008; 118:2057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/7\">",
"      Rogers WJ, Frederick PD, Stoehr E, et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008; 156:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/8\">",
"      Gibson CM, Pride YB, Frederick PD, et al. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008; 156:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/9\">",
"      Krumholz HM, Wang Y, Chen J, et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA 2009; 302:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/10\">",
"      Myerson M, Coady S, Taylor H, et al. Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2009; 119:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/11\">",
"      Krumholz HM, Normand SL. Public reporting of 30-day mortality for patients hospitalized with acute myocardial infarction and heart failure. Circulation 2008; 118:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/12\">",
"      An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993; 329:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/13\">",
"      Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators, Van De Werf F, Adgey J, et al. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 1999; 354:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/14\">",
"      Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283:2941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/15\">",
"      Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/16\">",
"      Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/17\">",
"      Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/18\">",
"      Bahit MC, Cannon CP, Antman EM, et al. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. Am Heart J 2003; 145:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/19\">",
"      Rosamond WD, Chambless LE, Heiss G, et al. Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation 2012; 125:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/20\">",
"      Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 2011; 305:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/21\">",
"      Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010; 362:2155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/22\">",
"      Puymirat E, Simon T, Steg PG, et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA 2012; 308:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/23\">",
"      Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999; 354:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/24\">",
"      Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344:1879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/25\">",
"      Kandzari DE, Roe MT, Chen AY, et al. Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 2005; 149:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/26\">",
"      Liebson PR, Klein LW. The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis 1997; 39:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/27\">",
"      Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 1993; 87:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/28\">",
"      Kerensky RA, Wade M, Deedwania P, et al. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol 2002; 39:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/29\">",
"      Wong GC, Morrow DA, Murphy S, et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation 2002; 106:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/30\">",
"      Armstrong PW, Fu Y, Chang WC, et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation 1998; 98:1860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/31\">",
"      Wang CH, Cherng WJ, Hua CC, Hung MJ. Prognostic value of dobutamine echocardiography in patients after Q-wave or non-Q-wave acute myocardial infarction. Am J Cardiol 1998; 82:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/32\">",
"      Montalescot G, Dallongeville J, Van Belle E, et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 2007; 28:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/33\">",
"      Law MR, Watt HC, Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med 2002; 162:2405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/34\">",
"      Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/35\">",
"      Wiviott SD, Cannon CP, Morrow DA, et al. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation 2004; 109:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/36\">",
"      Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 2005; 111:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/37\">",
"      Wagner S, Burczyk U, Schiele R, et al. The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction. Eur Heart J 1998; 19:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/38\">",
"      Shotan A, Gottlieb S, Goldbourt U, et al. Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era--a national study. Am Heart J 2001; 141:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/39\">",
"      D&ouml;nges K, Schiele R, Gitt A, et al. Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR]). Am J Cardiol 2001; 87:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/40\">",
"      Dorsch MF, Lawrance RA, Sapsford RJ, et al. Poor prognosis of patients presenting with symptomatic myocardial infarction but without chest pain. Heart 2001; 86:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/41\">",
"      Tu JV, Austin PC, Chan BT. Relationship between annual volume of patients treated by admitting physician and mortality after acute myocardial infarction. JAMA 2001; 285:3116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/42\">",
"      Casale PN, Jones JL, Wolf FE, et al. Patients treated by cardiologists have a lower in-hospital mortality for acute myocardial infarction. J Am Coll Cardiol 1998; 32:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/43\">",
"      Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med 1996; 335:1880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/44\">",
"      Thiemann DR, Coresh J, Oetgen WJ, Powe NR. The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med 1999; 340:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/45\">",
"      Ayanian JZ, Landrum MB, Guadagnoli E, Gaccione P. Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction. N Engl J Med 2002; 347:1678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/46\">",
"      Joynt KE, Orav EJ, Jha AK. Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA 2011; 305:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/47\">",
"      Curtis JP, Schreiner G, Wang Y, et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol 2009; 54:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/48\">",
"      Dunlay SM, Weston SA, Killian JM, et al. Thirty-day rehospitalizations after acute myocardial infarction: a cohort study. Ann Intern Med 2012; 157:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/49\">",
"      Behar S, Haim M, Hod H, et al. Long-term prognosis of patients after a Q wave compared with a non-Q wave first acute myocardial infarction. Data from the SPRINT Registry. Eur Heart J 1996; 17:1532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/50\">",
"      Haim M, Behar S, Boyko V, et al. The prognosis of a first Q-wave versus non-Q-wave myocardial infarction in the reperfusion era. Am J Med 2000; 108:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/51\">",
"      Yan AT, Tan M, Fitchett D, et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 2004; 94:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/52\">",
"      Singh M, Reeder GS, Jacobsen SJ, et al. Scores for post-myocardial infarction risk stratification in the community. Circulation 2002; 106:2309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/53\">",
"      Kannel WB, Doyle JT, McNamara PM, et al. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 1975; 51:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/54\">",
"      Gillum RF. Sudden coronary death in the United States: 1980-1985. Circulation 1989; 79:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/55\">",
"      Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998; 136:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/56\">",
"      Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J 1987; 113:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/57\">",
"      Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105:1897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/58\">",
"      Torp-Pedersen C, K&oslash;ber L. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. Lancet 1999; 354:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/59\">",
"      Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992; 85:I2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/60\">",
"      Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation 1991; 83:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/61\">",
"      Gottlieb S, Harpaz D, Shotan A, et al. Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation 2000; 102:2484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/62\">",
"      Vaccarino V, Parsons L, Every NR, et al. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/63\">",
"      Gan SC, Beaver SK, Houck PM, et al. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000; 343:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/64\">",
"      Stone GW, Grines CL, Browne KF, et al. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 1995; 75:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/65\">",
"      Malacrida R, Genoni M, Maggioni AP, et al. A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med 1998; 338:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/66\">",
"      Mak KH, Kark JD, Chia KS, et al. Ethnic variations in female vulnerability after an acute coronary event. Heart 2004; 90:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/67\">",
"      Vaccarino V, Parsons L, Peterson ED, et al. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch Intern Med 2009; 169:1767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/68\">",
"      Berger JS, Elliott L, Gallup D, et al. Sex differences in mortality following acute coronary syndromes. JAMA 2009; 302:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/69\">",
"      Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104:2158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/70\">",
"      White HD, Barbash GI, Modan M, et al. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation 1993; 88:2097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/71\">",
"      MacIntyre K, Stewart S, Capewell S, et al. Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol 2001; 38:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/72\">",
"      Chang WC, Kaul P, Westerhout CM, et al. Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. Arch Intern Med 2003; 163:2476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/73\">",
"      Tofler GH, Stone PH, Muller JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987; 9:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/74\">",
"      Marrugat J, Sala J, Masi&aacute; R, et al. Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. Recursos Empleados en el S&iacute;ndrome Coronario Agudo y Tiempo de Espera. JAMA 1998; 280:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/75\">",
"      Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 1995; 91:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/76\">",
"      K&oslash;ber L, Torp-Pedersen C, Ottesen M, et al. Influence of gender on short- and long-term mortality after acute myocardial infarction. TRACE study group. Am J Cardiol 1996; 77:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/77\">",
"      Vaccarino V, Krumholz HM, Yarzebski J, et al. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med 2001; 134:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/78\">",
"      Hochman JS, McCabe CH, Stone PH, et al. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1997; 30:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/79\">",
"      Roger VL, Farkouh ME, Weston SA, et al. Sex differences in evaluation and outcome of unstable angina. JAMA 2000; 283:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/80\">",
"      Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999; 341:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/81\">",
"      Stefan MS, Bannuru RR, Lessard D, et al. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest 2012; 141:1441.",
"     </a>",
"    </li>",
"    <li>",
"     Thom TJ, Kannel WB, Silbershatz S, et al. Incidence, Prevalence, and Mortality of Cardiovascular Diseases in the United States. In: Hurst's The Heart, 9th ed, Alexander RW, Schlant RC, Fuster V, et al (Eds), McGraw Hill, New York 1998. p.3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/83\">",
"      Berger CJ, Murabito JM, Evans JC, et al. Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA 1992; 268:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/84\">",
"      Lampe FC, Whincup PH, Wannamethee SG, et al. The natural history of prevalent ischaemic heart disease in middle-aged men. Eur Heart J 2000; 21:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41769/abstract/85\">",
"      Maddox TM, Reid KJ, Spertus JA, et al. Angina at 1 year after myocardial infarction: prevalence and associated findings. Arch Intern Med 2008; 168:1310.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1531 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-ED3CA7AB47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41769=[""].join("\n");
var outline_f40_50_41769=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SHORT-TERM MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ST elevation MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Non-ST elevation MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      STEMI versus NSTEMI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Predictors of mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Severity of the event",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Risk scores",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Ischemic MR",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Recurrent MI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - MI with normal coronary arteries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - MI without chest pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H326129\">",
"      - Bundle branch block",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Clinician experience",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Hospital experience",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Off-hour presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1144483338\">",
"      EARLY REHOSPITALIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      LONG-TERM OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      After ST elevation MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      After non-ST elevation ACS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      STEMI versus NSTEMI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SEX DIFFERENCES IN MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Short-term mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Long-term mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H190490127\">",
"      CHRONIC OBSTRUCTIVE PULMONARY DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      MORBIDITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Angina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1531\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1531|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/6/7278\" title=\"figure 1\">",
"      Incidence CHD death over time",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1531|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/59/4027\" title=\"table 1\">",
"      Killip classification of acute MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/54/20332\" title=\"table 2\">",
"      Prognosis after MI men women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/19/42300\" title=\"table 3\">",
"      Deaths MI recognize or not seen",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?27/53/28497?source=related_link\" title=\"calculator 1\">",
"      Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?5/34/5665?source=related_link\" title=\"calculator 2\">",
"      Calculator: Thrombolysis in Myocardial Infarction (TIMI) score for unstable angina or non ST elevation myocardial infarction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/42/5802?source=related_link\">",
"      Cardiac syndrome X: Angina pectoris with normal coronary arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/27/14778?source=related_link\">",
"      Characteristics of fibrinolytic (thrombolytic) agents and clinical trials in acute ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28505?source=related_link\">",
"      Classification of unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/11/4282?source=related_link\">",
"      Conduction abnormalities after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44361?source=related_link\">",
"      Epidemiology of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/24/20874?source=related_link\">",
"      Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/55/18297?source=related_link\">",
"      Ischemic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/30/17898?source=related_link\">",
"      Management of the patient with severe COPD and cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/41/44697?source=related_link\">",
"      Overview of the acute management of ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=related_link\">",
"      Patient information: Heart attack recovery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/6/37987?source=related_link\">",
"      Patient information: Heart attack recovery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/46/16106?source=related_link\">",
"      Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Determinants of outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25754?source=related_link\">",
"      Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/43/2746?source=related_link\">",
"      Risk stratification after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/52/35658?source=related_link\">",
"      Risk stratification for cardiac events after acute ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/36/29257?source=related_link\">",
"      Trials of conservative versus early invasive therapy in unstable angina and non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_50_41770="Evaluation of the adult with abdominal pain in the emergency department";
var content_f40_50_41770=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of the adult with abdominal pain in the emergency department",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41770/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41770/contributors\">",
"     John L Kendall, MD, FACEP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41770/contributors\">",
"     Maria E Moreira, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41770/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41770/contributors\">",
"     Robert S Hockberger, MD, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/50/41770/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/50/41770/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/50/41770/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal pain continues to pose diagnostic challenges for emergency clinicians. In many cases, the differential diagnosis is wide, ranging from benign to life-threatening conditions. Causes include medical, surgical, intraabdominal, and extraabdominal ailments. Associated symptoms often lack specificity and atypical presentations of common diseases are frequent, further complicating matters.",
"   </p>",
"   <p>",
"    The elderly, the immunocompromised, and women of childbearing age pose special diagnostic challenges. Elderly and diabetic patients often have vague, nonspecific complaints and atypical presentations of potentially life-threatening conditions leading to time consuming workups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The immunocompromised patient may suffer from a wide range of ailments, including unusual and therapy-related conditions. Pregnancy leads to physiologic and anatomic changes affecting the presentation of common diseases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/44/36554?source=see_link\">",
"     \"Approach to abdominal pain and the acute abdomen in pregnant and postpartum women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/3/63?source=see_link\">",
"     \"Evaluation of abdominal pain in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will discuss how to assess the adult presenting to the emergency department patient with abdominal pain, and provide a synopsis of important diagnoses to consider. Detailed discussions of specific diagnoses are found separately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal pain comprises 5 to 10 percent of emergency department (ED) visits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. Despite sophisticated diagnostic modalities, undifferentiated abdominal pain remains the diagnosis for approximately 25 percent of patients discharged from the ED and between 35 and 41 percent for those admitted to the hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/4,7-9\">",
"     4,7-9",
"    </a>",
"    ]. Approximately 80 percent of patients discharged with undifferentiated abdominal pain improve or become pain-free within two weeks of presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Older patients with abdominal pain have a six- to eightfold increase in mortality compared to younger patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/1,10\">",
"     1,10",
"    </a>",
"    ]. The elderly (ie, patients over 65 years of age) account for 20 percent of ED visits, of which 3 to 4 percent are for abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/1,10,11\">",
"     1,10,11",
"    </a>",
"    ]. About one-half to two-thirds of these patients requires hospitalization, while one-third requires surgical intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/2,5,12-14\">",
"     2,5,12-14",
"    </a>",
"    ]. Some studies suggest the elderly sustain increased mortality when their diagnosis is not determined in the ED [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of abdominal pain in the HIV patient population ranges from 12 to 45 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Of HIV positive patients presenting with abdominal pain, 38 percent require admission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/17\">",
"     17",
"    </a>",
"    ]. Eleven percent of HIV positive patients requiring surgery had an AIDS associated opportunistic infection. The remaining patients had pathology commonly seen in the immunocompetent population. The most common diagnosis in this group was undifferentiated abdominal pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Immediate life-threatening conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal pain may be caused by the following life-threatening conditions, which are described below:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abdominal aortic aneurysm",
"     </li>",
"     <li>",
"      Mesenteric ischemia",
"     </li>",
"     <li>",
"      Perforation of gastrointestinal tract (including peptic ulcer, bowel, esophagus, or appendix)",
"     </li>",
"     <li>",
"      Acute bowel obstruction",
"     </li>",
"     <li>",
"      Volvulus",
"     </li>",
"     <li>",
"      Ectopic pregnancy",
"     </li>",
"     <li>",
"      Placental abruption",
"     </li>",
"     <li>",
"      Myocardial infarction",
"     </li>",
"     <li>",
"      Splenic rupture (eg, secondary to EBV, leukemia, trauma)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Abdominal aortic aneurysm",
"      </strong>",
"      (AAA) &ndash; An aneurysm is a focal aortic dilation of at least 50 percent compared to normal, with any measurement greater than 3 cm considered abnormal. Most AAAs remain quiescent until rupture, but some manifest as abdominal, back, or flank pain. Aneurysm rupture typically causes exsanguinating hemorrhage and profound, unstable hypotension. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/16/32010?source=see_link\">",
"       \"Clinical features and diagnosis of abdominal aortic aneurysm\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      A number of atypical presentations exist for ruptured AAA, contributing to a misdiagnosis rate of up to 30 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/18\">",
"       18",
"      </a>",
"      ]. AAAs can rupture into the retroperitoneum where they may tamponade, enabling the patient to remain normotensive initially. AAAs can present with back pain and hematuria leading to potential misdiagnosis as nephrolithiasis.",
"      <br/>",
"      <br/>",
"      AAA is most common in men over 60 years, with risk increasing dramatically as patients age beyond 60. Chronic obstructive pulmonary disease, peripheral vascular disease, hypertension, smoking, and a family history are associated with AAA.",
"     </li>",
"     <li>",
"      <strong>",
"       Mesenteric ischemia",
"      </strong>",
"      &ndash; Mesenteric ischemia can be differentiated into four entities: arterial embolism (50 percent), arterial thrombosis (15 percent), nonocclusive mesenteric ischemia (20 percent), and venous thrombosis (15 percent). Mesenteric ischemia is associated with high mortality and prompt diagnosis is crucial albeit often difficult. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44377?source=see_link\">",
"       \"Acute mesenteric ischemia\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Acute mesenteric ischemia is classically said to present with rapid onset of severe periumbilical abdominal pain, often out of proportion to findings on physical examination. Nausea and vomiting are common. Sudden pain associated with few abdominal signs and forceful bowel evacuation in a patient with risk factors should greatly heighten suspicion for the diagnosis. The subset of patients with mesenteric venous thrombosis has a more indolent course and lower reported mortality. Risk factors include advanced age, atherosclerosis, low cardiac output states, cardiac arrhythmias (eg, atrial fibrillation), severe cardiac valvular disease, recent myocardial infarction, and intraabdominal malignancy.",
"     </li>",
"     <li>",
"      <strong>",
"       Gastrointestinal perforation",
"      </strong>",
"      &ndash; Many causes of gastrointestinal perforation exist, but peptic ulcer disease is the most common. Perforation can also complicate appendicitis, diverticulitis, ischemic bowel, and toxic megacolon. Ulcer perforation should be suspected in patients with a history of peptic ulcer symptoms who develop the sudden onset of severe, diffuse abdominal pain. A detailed assessment reveals a history of peptic ulcer disease or ulcer symptoms in the majority of cases, a notable exception being older individuals with NSAID-induced perforation. Perforation is more common and lethal among the elderly. Delays in diagnosis greater than 24 hours substantially increase mortality. Esophageal perforation (Boerhaave syndrome), which can occur with severe retching, can present with severe and progressive epigastric abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/21/40282?source=see_link&amp;anchor=H4460621#H4460621\">",
"       \"Overview of the complications of peptic ulcer disease\", section on 'Perforation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Acute bowel obstruction",
"      </strong>",
"      &ndash; The majority of bowel obstructions involve the small intestine. Mortality from bowel strangulation varies from 8 percent when surgery is performed within 36 hours to 25 percent when surgery is delayed beyond 36 hours. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/38/8807?source=see_link\">",
"       \"Small bowel obstruction: Clinical manifestations and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/46/14058?source=see_link\">",
"       \"Small bowel obstruction: Causes and management\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The most common symptoms of small bowel obstruction (SBO) are abdominal distention, vomiting, crampy abdominal pain, and absence of flatus. In proximal obstruction, nausea and vomiting can be relatively severe compared with distal obstruction, but distention of the abdomen is somewhat less. The colon requires 12 to 24 hours to empty after the onset of bowel obstruction so flatus and even passage of feces may continue after the onset of symptoms. Abdominal pain is frequently described as periumbilical and crampy, with paroxysms of pain occurring every four or five minutes. Pain progresses from crampy to constant and more severe, and some clinicians feel that such progression is a sign of impending strangulation. Focal abdominal pain in the presence of other symptoms of obstruction may be an ominous sign and should not be ignored.",
"      <br/>",
"      <br/>",
"      Previous upper or lower abdominal surgery increases the risk for obstruction. Causes of SBO include: adhesions (50 to 70 percent), incarcerated hernias (15 percent), and neoplasms (15 percent). Gallstone ileus is the cause in up to 20 percent of cases among elderly patients. Patients with Crohn's disease frequently present with obstruction.",
"     </li>",
"     <li>",
"      <strong>",
"       Volvulus",
"      </strong>",
"      &ndash; The majority of patients with cecal volvulus have a similar presentation to those with small bowel obstruction. Symptoms include abdominal pain, nausea, vomiting, and obstipation. The pain is usually steady, with a superimposed colicky component. The abdomen is often diffusely distended. Fever, peritonitis, or hypotension may indicate the presence of intestinal gangrene. Risk factors for cecal volvulus include adhesions, recent surgery, congenital bands, and prolonged constipation. Mortality for cecal volvulus ranges from 12 to 17 percent; mortality in the elderly can be as high as 65 percent. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/29/8663?source=see_link\">",
"       \"Cecal volvulus\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Sigmoid volvulus accounts for the majority of volvulus cases. Most patients present with abdominal pain, nausea, abdominal distension, and constipation; vomiting is less common. Younger patients may have a more insidious presentation with recurrent attacks of abdominal pain and intermittent resolution, presumably due to spontaneous detorsion. Compromise of the blood supply to the sigmoid colon can lead to gangrene with resulting peritonitis and sepsis. Pain is usually continuous and severe, with a superimposed colicky component. The abdomen is usually distended and tympanitic. Risk factors include excessive use of laxatives, tranquilizers, anticholinergic medications, ganglionic blocking agents, and medications for Parkinsonism. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/53/26453?source=see_link\">",
"       \"Sigmoid volvulus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Ectopic pregnancy",
"      </strong>",
"      &ndash; Clinicians must consider the diagnosis of ectopic pregnancy in any female of childbearing age with abdominal pain and should obtain a human chorionic gonadotropin (hCG) test in all such patients. Risk factors include a history of pelvic inflammatory disease, previous tubal pregnancy, previous tubal surgery, history of endometriosis, and an indwelling intrauterine device. Although symptoms of ectopic pregnancy classically include the triad of amenorrhea, abdominal pain, and vaginal bleeding, up to 30 percent of patients do not have vaginal bleeding. The pelvic examination is often nondiagnostic; transvaginal ultrasonography, or serial testing of HCG, is performed to make the diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/9/1178?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/24/34184?source=see_link\">",
"       \"Ultrasonography of pregnancy of unknown location\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20920?source=see_link\">",
"       \"Approach to vaginal bleeding in the emergency department\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Placental abruption",
"      </strong>",
"      &ndash; An acute, clinical abruption classically presents with vaginal bleeding, abdominal or back pain, and uterine contractions. The uterus may be rigid and tender. The amount of vaginal bleeding correlates poorly with the degree of placental separation and in some cases may even be absent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/19\">",
"       19",
"      </a>",
"      ]. In the presence of a severe abruption (&ge;50 percent placental separation), both fetus and mother may be at risk, and acute disseminated intravascular coagulation (DIC) can develop. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29417?source=see_link\">",
"       \"Placental abruption: Clinical features and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/54/34663?source=see_link\">",
"       \"Placental abruption: Management\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20920?source=see_link\">",
"       \"Approach to vaginal bleeding in the emergency department\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In approximately 10 to 20 percent of cases, a woman with placental abruption will present with preterm labor only and no vaginal bleeding. Therefore, even small amounts of vaginal bleeding in the setting of abdominal pain and uterine contractions should prompt careful maternal and fetal evaluation.",
"      <br/>",
"      <br/>",
"      Maternal hypertension is the most common cause of abruption, occurring in 44 percent of cases. Other risk factors include cocaine use, alcohol consumption, cigarette smoking, trauma, and advanced maternal age.",
"     </li>",
"     <li>",
"      <strong>",
"       Myocardial infarction",
"      </strong>",
"      &ndash; Atypical presentations of myocardial infarction are most common in women older than 65 years of age. Abdominal pain is the presenting complaint for an acute myocardial infarction in approximately one-third of atypical cases. Patients with diabetes may also present atypically. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41113?source=see_link\">",
"       \"Clinical features and diagnosis of coronary heart disease in women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/39/25209?source=see_link\">",
"       \"Criteria for the diagnosis of acute myocardial infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=see_link\">",
"       \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Common conditions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Gastrointestinal",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Appendicitis &ndash; The early symptoms and signs of appendicitis are often subtle and nonspecific and examination unrevealing. Nausea and vomiting are generally not the first symptoms. Classically, patients initially experience anorexia along with vague periumbilical discomfort that develops into marked right lower quadrant pain. This progression occurs with an inflamed anterior or pelvic appendix. However, a retrocecal appendix may not cause focal signs of peritonitis. A pelvic appendix can present with urinary symptoms or diarrhea. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31370?source=see_link\">",
"       \"Acute appendicitis in adults: Clinical manifestations and diagnosis\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Patients who have had an appendectomy may still develop a stump appendicitis in which the appendix remnant becomes occluded, edematous, and infected. Presentation, diagnoses, and treatment are similar to that of appendicitis.",
"     </li>",
"     <li>",
"      Clinicians often fail to diagnose appendicitis in elderly patients, in whom mortality can reach 70 percent. The elderly often present without the findings classically associated with appendicitis. Appendicitis is the most common extrauterine cause for abdominal surgery in pregnant women. The right lower quadrant is the most common location of pain regardless of gestational age, despite traditional teaching that the appendix migrates into the right upper quadrant during pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/34/42536?source=see_link\">",
"       \"Acute appendicitis in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Biliary disease &ndash; Patients with acute cholecystitis typically complain of abdominal pain, most commonly in the right upper quadrant or epigastrium. The pain may radiate to the right shoulder or back. Pain is often steady and severe. Associated complaints may include nausea, vomiting, and anorexia. There is often a history of fatty food ingestion about one hour or more before the onset of pain. Patients are usually ill appearing, febrile, and tachycardic, with tenderness in the right upper abdomen. Murphy's sign may be present, although the sensitivity of the test can be diminished in the elderly. Progression to septic shock can occur with ascending cholangitis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29208?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of acute cholecystitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/9/15511?source=see_link\">",
"       \"Treatment of acute cholecystitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pancreatitis &ndash; Acute pancreatitis almost always presents with acute upper abdominal pain. The pain is steady and may be in the midepigastrium, right upper quadrant, diffuse, or, infrequently, confined to the left side. Band-like radiation to the back is common. Pain often reaches maximum intensity within 10 to 20 minutes of onset, but can persist for days. Nausea and vomiting is common. In severe cases, patients can present in shock or coma. Physical findings vary with severity. In mild disease, the epigastrium may be minimally tender; in severe episodes, upper abdominal distention, tenderness, and guarding are common. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20569?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute pancreatitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7738?source=see_link\">",
"       \"Treatment of acute pancreatitis\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Predisposing factors include alcoholism, biliary tract disease, trauma, penetrating ulcer, infection, hypertriglyceridemia, drug reactions (eg, NSAIDS,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      , thiazides, sulfonamides,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/49/2840?source=see_link\">",
"       tetracycline",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      , corticosteroids, estrogens), hypercalcemia, carbon monoxide exposure, and hypothermia.",
"     </li>",
"     <li>",
"      Diverticular disease &ndash; The presentation of diverticulitis depends upon the severity of inflammation and the presence of complications. Left lower quadrant pain is the most common complaint. Pain is often present for several days prior to presentation. Many patients have had one or more similar past episodes. Nausea and vomiting",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a change in bowel habits often accompany the pain. Examination usually reveals abdominal tenderness in the left lower quadrant. Elderly patients are at increased risk for developing diverticula and their complications, which can include diverticulitis, perforation, obstruction, and hemorrhage. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/6/34919?source=see_link\">",
"       \"Clinical manifestations and diagnosis of colonic diverticular disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13450?source=see_link\">",
"       \"Treatment of acute diverticulitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Peptic ulcer disease &ndash; Epigastric pain, indigestion, and reflux symptoms are classically associated with peptic ulcer disease (PUD), but none is sensitive or specific. In the absence of complications, examination findings are unremarkable. Complications include bleeding and perforation. Mortality for perforation is significantly higher in the geriatric population, particularly when the diagnosis is delayed 24 hours or longer. The elderly are often unaware they have PUD until a severe complication develops. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Immediate life-threatening conditions'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/18/13609?source=see_link\">",
"       \"Clinical manifestations of peptic ulcer disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Incarcerated hernia &ndash; Inguinal hernias are most common and often present with mild lower abdominal discomfort exacerbated by straining. Inguinal and incisional hernias are more common in elder patients. Incarcerated hernias can cause severe pain and require immediate surgical consultation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/37/31321?source=see_link\">",
"       \"Classification, clinical features and diagnosis of inguinal and femoral hernias in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gastroenteritis and other infectious causes &ndash; Although common, gastroenteritis is a diagnosis of exclusion in the ED, where the clinician must focus on life-threatening causes of abdominal pain. Infectious gastroenteritis, enteritis, and colitis have many etiologies (viral, bacterial, parasitic, antibiotic associated). Fever, diarrhea,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vomiting may be more prominent symptoms than abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18868?source=see_link\">",
"       \"Prevention and treatment of viral gastroenteritis in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=see_link\">",
"       \"Approach to the adult with acute diarrhea in developed countries\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/29/29145?source=see_link\">",
"       \"Travelers' diarrhea\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29976?source=see_link\">",
"       \"Approach to the adult with acute diarrhea in developing countries\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Foodborne disease &ndash; Foodborne diseases typically manifest as a mixture of nausea, vomiting, fever, abdominal pain, and diarrhea. Vomiting or diarrhea may be more prominent than abdominal pain. Depending upon the nature of the illness, symptoms can develop anywhere from one hour to several days after the contaminated food is ingested. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/44/24265?source=see_link&amp;anchor=H3#H3\">",
"       \"Differential diagnosis of microbial foodborne disease\", section on 'Approach to the patient'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Complications of bariatric (weight loss) surgery &ndash; Complications can occur within weeks or years after bariatric surgery, and many involve abdominal pain as part of the presentation. In addition to such standard complications as bleeding and bowel obstruction, other potential complications (organized by procedure) include the following [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/20-22\">",
"       20-22",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Roux-en-Y gastric bypass: Gastric remnant distension; stomal stenosis; marginal ulceration",
"     </li>",
"     <li>",
"      Gastric banding: Stomal obstruction; port infection; band erosion; band movement causing obstruction",
"     </li>",
"     <li>",
"      Sleeve gastrectomy: Gastric outlet obstruction; gastric leaks (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=see_link\">",
"       \"Complications of bariatric surgery\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflammatory bowel disease &ndash; Acute complications from inflammatory bowel disease can include pain, bleeding, perforation, bowel obstruction, fistula and abscess formation, and toxic megacolon. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=see_link\">",
"       \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11386?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hepatitis &ndash; Hepatitis has a multitude of possible etiologies, including infections (bacterial, viral, parasitic, fungal), toxins, medications, and immunologic disorders. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=see_link\">",
"       \"Approach to the patient with abnormal liver biochemical and function tests\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Spontaneous bacterial peritonitis (SBP) &ndash; SBP involves an acute bacterial infection of ascitic fluid in patients with liver disease. Usually there is no apparent source of infection. SBP occurs in up to a quarter of patients admitted with cirrhosis and ascites. Mortality is high in patients with cirrhosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/0/7172?source=see_link\">",
"       \"Clinical manifestations of spontaneous bacterial peritonitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12296?source=see_link\">",
"       \"Diagnosis of spontaneous bacterial peritonitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/1/4121?source=see_link\">",
"       \"Treatment and prophylaxis of spontaneous bacterial peritonitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Irritable bowel syndrome (IBS) &ndash; Although common, IBS is rarely diagnosed in the ED, where the clinician must focus on life-threatening causes of abdominal pain. Diagnosis of IBS requires persistent symptoms for three months over a one year period. Symptoms include abdominal pain associated with a change in stool frequency or consistency. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/59/22455?source=see_link\">",
"       \"Clinical manifestations and diagnosis of irritable bowel syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Genitourinary",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urinary tract infection",
"      <span class=\"nowrap\">",
"       (UTI)/pyelonephritis",
"      </span>",
"      &ndash; Lower urinary tract infections often present with suprapubic discomfort associated with urinary symptoms such as frequency, urgency, or dysuria. Fever (&gt;38&ordm;C), flank pain, costovertebral angle tenderness, and nausea or vomiting suggest upper tract infection and warrant more aggressive diagnostic and therapeutic measures. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=see_link\">",
"       \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/10999?source=see_link\">",
"       \"Acute complicated cystitis and pyelonephritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nephrolithiasis &ndash; Nephrolithiasis can present with severe abdominal pain, which may mimic that of abdominal aortic aneurysm. Pain is often colicky and radiates to the flank or groin. Hematuria is present in 70 to 90 percent of cases. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=see_link\">",
"       \"Diagnosis and acute management of suspected nephrolithiasis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adnexal torsion &ndash; The most common symptom of adnexal (or ovarian) torsion is sudden onset lower abdominal pain, often associated with waves of nausea and vomiting. Patients with ovarian cysts or other masses are at higher risk. Ovarian torsion is a gynecologic emergency. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23690?source=see_link\">",
"       \"Ovarian and fallopian tube torsion\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ruptured ovarian cyst &ndash; Rupture of an ovarian cyst may be asymptomatic or associated with the sudden onset of unilateral lower abdominal pain. Pain often begins during strenuous physical activity (eg, exercise or sexual intercourse) and may be accompanied by light vaginal bleeding. Significant intraperitoneal bleeding can occur in the absence of vaginal bleeding. Unilateral lower abdominal tenderness is often present. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/40/9863?source=see_link\">",
"       \"Evaluation and management of ruptured ovarian cyst\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20920?source=see_link\">",
"       \"Approach to vaginal bleeding in the emergency department\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Preeclampsia &ndash; Preeclampsia usually occurs in the late stages of pregnancy and is defined by the triad of hypertension, proteinuria, and edema. Liver injury can occur producing right upper or epigastric abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=see_link\">",
"       \"Preeclampsia: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pelvic inflammatory disease (PID) &ndash; PID refers to acute infection of the upper genital tract in women. Lower abdominal pain is the cardinal symptom of PID. Pain that worsens during coitus or with jarring movement may be the only symptom; the onset of pain during or shortly after menses is suggestive. Pain is usually bilateral but may be mild. Abnormal uterine bleeding, new vaginal discharge, urethritis, and fever can be associated with PID but are neither sensitive nor specific. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tubo-ovarian abscess (TOA) &ndash; Infrequently, PID is complicated by TOA. Ultrasound is the preferred study for diagnosing TOA, which may require surgical drainage. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36823?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fitz-Hugh Curtis syndrome &ndash; Approximately 10 percent of patients with PID go on to develop perihepatitis (Fitz-Hugh Curtis Syndrome). Since these patients present with right upper quadrant pain and tenderness, the syndrome can mimic cholecystitis, pneumonia, or pulmonary embolus. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endometriosis &ndash; Endometriosis is defined as endometrial-like tissue located outside the uterine cavity that produces an inflammatory reaction. Common symptoms include pelvic pain (which may be chronic but is often more severe during menses or at ovulation), dysmenorrhea, infertility, and deep dyspareunia. Examination is often unremarkable. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Testicular torsion &ndash; Testicular torsion usually presents with the sudden onset of severe pain following vigorous activity or testicular trauma. Examination often reveals an asymmetrically high-riding, transversely oriented testis on the affected side and loss of the cremasteric reflex. Testicular salvage rates are over 80 percent if treatment is initiated within six hours of symptoms, but fall significantly thereafter. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44360?source=see_link\">",
"       \"Evaluation of the acute scrotum in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3163457\">",
"    <span class=\"h3\">",
"     Trauma-related",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries sustained during trauma may not manifest for days to weeks after the event. Splenic rupture is a common example, but delayed presentations of perforated bowel, pancreatitis, and injuries to the liver, gallbladder, and genitourinary tract have all been reported. Diaphragmatic injury can even be delayed for months to even years and is often difficult to diagnose as the diaphragm is not well visualized by CT scan. Therefore, it is important to ask patients presenting to the ED with abdominal pain about recent and past trauma. Bedside ultrasonography may reveal intraperitoneal free fluid; CT imaging is often necessary in stable patients to make a definitive diagnosis. Immediate surgical consultation is needed for unstable patients in whom abdominal pain is suspected to be trauma-related. The initial evaluation and management of trauma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/35002?source=see_link\">",
"     \"Initial management of trauma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Common extraabdominal diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;A list of extraabdominal causes of abdominal pain is provided (",
"    <a class=\"graphic graphic_table graphicRef60310 \" href=\"mobipreview.htm?12/4/12365\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diabetic ketoacidosis (DKA) &ndash; DKA is the initial presentation for approximately 3 percent of Type I diabetics. DKA can present with severe abdominal pain and vomiting. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/55/4986?source=see_link\">",
"       \"Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Alcoholic ketoacidosis &ndash; Alcoholic ketoacidosis occurs in chronic alcoholics after a recent binge. The binge is followed by vomiting and decreased food intake. Up to 75 percent of patients present with nausea, vomiting, and abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6613?source=see_link\">",
"       \"Alcoholic and fasting ketoacidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pneumonia &ndash; Symptoms of pneumonia may include nausea, vomiting, diarrhea, weight loss, anorexia, and abdominal pain. The abdominal pain stems from pleuritic irritation caused by a basilar infiltrate. The pain is generally sharp and aggravated by cough or deep inspiration. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/26/26026?source=see_link\">",
"       \"Diagnostic approach to community-acquired pneumonia in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary embolus (PE) &ndash; PE can present with a range of nonspecific symptoms and signs, which may include upper abdominal pain and shoulder pain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/23\">",
"       23",
"      </a>",
"      ]. Two possible mechanisms for abdominal pain are pleural irritation of the diaphragm causing an ileus and hepatic congestion from acute right ventricular failure. It seems unlikely that abdominal pain would be the sole manifestation of PE. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/22/4456?source=see_link\">",
"       \"Overview of acute pulmonary embolism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Herpes zoster &ndash; Herpes zoster is a reactivation of a latent varicella-zoster viral infection in a dorsal root ganglion. Pain and a rash develop in a dermatomal pattern, which may involve the abdomen. Pain can precede the rash by days to weeks. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23688?source=see_link\">",
"       \"Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some of the diagnoses listed below will not be made in the emergency department (ED), but are included as a reference and to enable clinicians to access more detailed information easily.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Toxin/drug",
"      </span>",
"      related &ndash; Many toxins and drug ingestions can cause abdominal pain. With corrosives (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      , iron, mercury, acids, and alkali), abdominal pain is from mucosal injury that can result in esophageal or gastric perforation. Anticholinergics and narcotics may cause abdominal pain secondary to ileus or obstruction. Charcoal and drug bezoars can cause mechanical obstruction. Amphetamines, ergotamines, and cocaine can cause abdominal pain from vasoconstriction producing bowel ischemia.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      can cause hepatic injury and ddI (dideoxyinosine) can cause pancreatitis. Heavy metal (eg, lead) intoxication is included in the differential diagnosis of patients with a combination of abdominal pain and anemia. Mushroom poisoning can present with crampy abdominal pain, vomiting, and diarrhea. Abdominal pain can be a prominent symptom in patients withdrawing from opioids. (For discussions of specific toxins see the relevant toxicology topic review, including those listed here). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=see_link\">",
"       \"General approach to drug poisoning in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/38/40551?source=see_link\">",
"       \"Caustic esophageal injury in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43319?source=see_link\">",
"       \"Anticholinergic poisoning\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/39/12922?source=see_link\">",
"       \"Adult lead poisoning\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/47/1786?source=see_link\">",
"       \"Clinical manifestations and evaluation of mushroom poisoning\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/5/28758?source=see_link\">",
"       \"Opioid withdrawal in the emergency setting\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neoplasm &ndash; Abdominal pain may be the presenting symptom for neoplasms. Ovarian cancer can present with abdominal swelling, dyspepsia, indigestion, abdominal distention, flatulence, anorexia, pelvic pressure, back pain, rectal fullness, or urinary urgency, or frequency. Colorectal cancer can present with abdominal pain associated with changes in bowel habits, weight loss, and rectal bleeding. Patients with leukemia can present with symptoms suggestive of an acute abdomen from a functional obstruction, possibly due to autonomic dysfunction, localized vascular derangements, or peritoneal irritation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/6/31849?source=see_link\">",
"       \"Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/33/17946?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Chemotherapy and radiation treatments for neoplasms can produce abdominal pain. As an example,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/29/1498?source=see_link\">",
"       vincristine",
"      </a>",
"      can produce severe colicky abdominal pain for up to 10 days after administration. Patients undergoing chemotherapy for leukemia can present with typhlitis or a necrotizing colitis involving the cecum or cecum and appendix. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/23/42362?source=see_link\">",
"       \"Enterotoxicity of chemotherapeutic agents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sickle cell &ndash; Acute painful episodes associated with sickle cell, formerly called sickle cell crises, result from obstruction of arterioles, which can lead to splenic or mesenteric infarction. Abdominal pain is often a sickle cell patient's typical pain. If the abdominal pain is not typical, the clinician should investigate other causes. Sickle cell patients have a predilection for some common causes of abdominal pain (eg, gallstones). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/11/42170?source=see_link\">",
"       \"Overview of the clinical manifestations of sickle cell disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Toxic megacolon &ndash; Causes of toxic megacolon include inflammatory bowel disease, infectious colitis (eg, Clostridium difficile), ischemic colitis, and obstructive colon cancer. Signs and symptoms of acute colitis, which are frequently resistant to therapy, are often present for at least one week prior to the onset of acute dilatation of the colon. Severe bloody diarrhea is the most common presenting symptom; improvement of diarrhea may herald the onset of megacolon. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/30/18920?source=see_link\">",
"       \"Toxic megacolon\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mesenteric lymphadenitis &ndash; Mesenteric adenitis is a common mimic of appendicitis caused by viral or bacterial inflammation of the mesenteric lymph nodes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/24\">",
"       24",
"      </a>",
"      ]. It is a diagnosis of exclusion in the ED. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41974?source=see_link&amp;anchor=H89479916#H89479916\">",
"       \"Clinical manifestations and diagnosis of Yersinia infections\", section on 'Pseudoappendicitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infectious mononucleosis &ndash; Among patients with infectious mononucleosis, approximately half will have splenic enlargement and a small percentage will develop a self-limited clinical hepatitis. Sudden left upper quadrant pain or generalized abdominal pain should raise concern for spontaneous splenic rupture, although this is rare. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/18/31018?source=see_link\">",
"       \"Infectious mononucleosis in adults and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Toxic shock syndrome &ndash; This syndrome is characterized by fever, rash, hypotension, and multiorgan involvement. Abdominal complaints are common and can include nausea, vomiting, diarrhea, and pain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/52/8010?source=see_link\">",
"       \"Staphylococcal toxic shock syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rocky Mountain spotted fever (RMSF) &ndash; The classic triad of fever, rash, and a history of tick exposure is present in a small percentage of patients during the first three days of illness. Abdominal pain is reported by 30 percent of patients. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/51/14135?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Rocky Mountain spotted fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Porphyria &ndash; Porphyria is a rare autosomal dominant condition where there is a deficiency in the hepatic enzymes responsible for heme synthesis. Porphyria is an unusual cause of abdominal pain, but abdominal pain is the most common finding in acute porphyria attacks. Acute attacks can be precipitated by any drugs or physical states that further interfere with heme synthesis (eg, estrogens, barbiturates,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      , ethanol, sulfonamides, infection, severe dietary restriction, and menstruation). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/16/40198?source=see_link\">",
"       \"Etiology and pathogenesis of acute intermittent porphyria\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Familial Mediterranean fever &ndash; Familial Mediterranean fever is an autosomal recessive disorder characterized by recurring attacks of fever and serosal inflammation of the peritoneum, pleura, or synovium. Attacks begin with fever and peak symptoms occur in the first 12 hours. Abdominal pain is present in over 95 percent of cases. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/31/25078?source=see_link\">",
"       \"Clinical manifestations and diagnosis of familial Mediterranean fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Angioedema &ndash; Both acquired angioedema in the setting of underlying malignancy and hereditary angioedema can cause recurrent abdominal pain and pseudo-obstruction. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19272?source=see_link\">",
"       \"Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rectus sheath hematoma &ndash; Causes may include trauma, anticoagulation therapy, physical exertion, paroxysmal cough, pregnancy, leukemia, and hypertension.",
"     </li>",
"     <li>",
"      Systemic lupus erythematosus (SLE) &ndash; SLE involves the gastrointestinal tract, generally with nonspecific symptoms, in fewer than 50 percent of patients. However, several disorders that cause abdominal pain may be associated with SLE, including peritonitis, peptic ulcer disease, mesenteric vasculitis with intestinal infarction, pancreatitis, and inflammatory bowel disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/50/5928?source=see_link\">",
"       \"Gastrointestinal manifestations of systemic lupus erythematosus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Henoch-Sch&ouml;nlein purpura (HSP [IgA vasculitis (IgAV)]) &ndash; HSP (IgAV) is a hypersensitivity vasculitis most commonly occurring in children, although adults may be affected. It is characterized by palpable purpura, arthralgias, hematuria secondary to glomerulonephritis, colicky abdominal pain, nausea, vomiting, and diarrhea. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/49/40729?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Polyarteritis nodosa &ndash; Polyarteritis nodosa is a systemic disease that includes gastrointestinal symptoms in greater than 50 percent of cases. These may include abdominal pain, nausea, vomiting, diarrhea, and bleeding. Up to a third of patients will develop surgical complications, such as bowel infarction, perforation, or hemorrhage, associated with high mortality. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/26/9641?source=see_link\">",
"       \"Clinical manifestations and diagnosis of polyarteritis nodosa\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Eosinophilic enteritis &ndash; Eosinophilic enteritis is a rare cause of recurrent right lower quadrant pain whose cause is uncertain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43703?source=see_link\">",
"       \"Eosinophilic gastroenteritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypercalcemia &ndash; Patients presenting with hypercalcemia can present with vague abdominal pain. The pain is associated with anorexia, nausea, vomiting and constipation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33669?source=see_link\">",
"       \"Clinical manifestations of hypercalcemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Spider bite (Lactrodectus mactans) &ndash; Venom from this species stimulates release of acetylcholine peripherally and centrally, and symptoms usually begin within one to eight hours. Some patients may develop abdominal pain without physical findings while others present with board-like rigidity, although bowel sounds are normal. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/16/24839?source=see_link\">",
"       \"Approach to the patient with a suspected spider bite: An overview\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Thoracic nerve root dysfunction &ndash; Thoracic nerve root dysfunction can present with severe constant abdominal pain that becomes worse at night. There may be associated loss of pinprick sensation over the abdominal wall.",
"     </li>",
"     <li>",
"      Glaucoma &ndash; Typical symptoms of acute glaucoma include ocular pain and decreased vision. However, abdominal discomfort, nausea, and headache can occur. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15289?source=see_link\">",
"       \"Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pheochromocytoma &ndash; Pheochromocytoma is a rare catecholamine secreting tumor with a classic presentation of headache and hypertension. Nausea is common and epigastric pain may occur. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/14/23786?source=see_link\">",
"       \"Clinical presentation and diagnosis of pheochromocytoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ovarian hyperstimulation syndrome &ndash; This gynecologic emergency occurs in women undergoing ovulation induction. Multiple, large ovarian cysts can precipitate acute fluid shifts with depletion of intravascular fluid and a shock-like syndrome. Consider the diagnosis in women taking fertility medications who present with abdominal pain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/41/35479?source=see_link\">",
"       \"Classification and treatment of ovarian hyperstimulation syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of a careful history and physical examination can often distinguish between organic and nonorganic causes of abdominal pain and is crucial for creating a focused and appropriate differential diagnosis. When trying to determine the etiology of a patient's abdominal pain it is important to consider the patient's age, sex, past medical and surgical history, and medications, and to characterize the pain as precisely as possible (",
"    <a class=\"graphic graphic_table graphicRef68577 \" href=\"mobipreview.htm?31/30/32235\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Characterization of pain'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The elderly are far more likely to have severe disease and \"atypical\" symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/14,25,26\">",
"     14,25,26",
"    </a>",
"    ]. The risk for certain diseases, such as ruptured abdominal aortic aneurysm (AAA), mesenteric ischemia, atypical presentations of myocardial infarction, and colon cancer increases significantly in patients older than 50 years. The clinician must remember that elder patients often present with different symptoms and signs than younger patients and take medications, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , that mask classic symptoms and signs. As an example, elder patients diagnosed surgically with cholecystitis presented far more often with nausea or vomiting than pain, and among those over 65 years, 84 percent had neither epigastric nor right upper quadrant pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16874?source=see_link&amp;anchor=H33#H33\">",
"     \"Differential diagnosis of abdominal pain in adults\", section on 'Older adults'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In women of childbearing age, pregnancy status must be determined. If the patient is pregnant, the differential diagnosis includes complications of pregnancy such as an ectopic gestation and preeclampsia. However, pregnant patients are also at risk for common diseases such as appendicitis and cholecystitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/44/36554?source=see_link\">",
"     \"Approach to abdominal pain and the acute abdomen in pregnant and postpartum women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Genitourinary causes of abdominal pain are numerous and should not be overlooked in nonpregnant women and men. Inquire about vaginal bleeding or discharge, recent changes in menstruation, dysuria or hematuria, penile discharge, and scrotal pain or swelling, and any recent trauma.",
"   </p>",
"   <p>",
"    Clinicians should consider both intra- and extra-abdominal causes of pain (",
"    <a class=\"graphic graphic_table graphicRef60310 \" href=\"mobipreview.htm?12/4/12365\">",
"     table 1",
"    </a>",
"    ). Upper abdominal symptoms may reflect thoracic disease, particularly in elder patients, so it is important to ask about such symptoms as dyspnea, cough, and palpitations.",
"   </p>",
"   <p>",
"    Preexisting medical and surgical conditions and medications can increase a patient&rsquo;s risk for specific diseases. As an example, a history of cardiovascular or peripheral vascular disease corresponds with an increased risk for mesenteric ischemia and AAA. A history of atrial fibrillation or heart failure places patients at risk for mesenteric ischemia from emboli or low-flow respectively. A history of HIV predisposes to opportunistic infection or a medication-related complication (eg, pancreatitis or renal colic). Previous surgery increases the risk for bowel obstruction. A history of NSAID use predisposes to peptic ulceration and bleeding. Concurrent antibiotic or steroid use may mask infections, while some antibiotics increase the risk for Clostridium difficile colitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/3/63?source=see_link\">",
"     \"Evaluation of abdominal pain in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=see_link\">",
"     \"Clostridium difficile in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The social history can be of great importance. Alcohol abuse places patients at risk for pancreatitis, hepatitis, cirrhosis, and spontaneous bacterial peritonitis. Abdominal pain and nausea often figure prominently among the symptoms of patients withdrawing from opioids. Smokers have a greater risk of bladder and other cancers that may cause abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/5/28758?source=see_link\">",
"     \"Opioid withdrawal in the emergency setting\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An occupational and travel history may help to identify unusual causes. Occupational exposures to toxins or chemicals, recent travel, or similar symptoms among family or friends may be important clues indicative of a nonsurgical cause of pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PAIN DESCRIPTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Types of pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal pain can be divided into three types: visceral, parietal (or somatic), and referred. The neurologic basis of abdominal pain is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16874?source=see_link&amp;anchor=H2#H2\">",
"     \"Differential diagnosis of abdominal pain in adults\", section on 'Neurologic basis of abdominal pain'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Visceral pain fibers originate in the walls of hollow organs and the capsules of solid organs and enter the spinal cord bilaterally at multiple levels. Thus, stimulation of visceral nerves produces a dull, poorly localized pain felt in the midline. Pain is perceived in the abdominal region corresponding to the diseased organ's embryonic origin. Visceral pain from structures that originated from the foregut (stomach, pancreas, liver and gallbladder, and proximal duodenum) manifests in the epigastrium; visceral pain from structures of the midgut (remainder of duodenum, small bowel, proximal large bowel) manifests in the periumbilical region; and visceral pain from structures of the hindgut (middle and distal large bowel, pelvic genitourinary organs) manifests in the suprapubic region. Ischemia, inflammation, or distention of hollow organs or capsular stretching of solid organs produces visceral type pain.",
"   </p>",
"   <p>",
"    Parietal pain stimuli are transmitted to specific dorsal root ganglia on the same side and dermatomal level as the origin of the pain. Therefore the pain is more distinct (usually sharper) and localized. Ischemia, inflammation, or stretching of the parietal peritoneum produces parietal pain.",
"   </p>",
"   <p>",
"    Referred pain is felt at a site far from the diseased organ (eg, gallbladder disease experienced as pain in the right subscapular area, a perforated duodenal ulcer causing shoulder pain secondary to diaphragmatic irritation). Shared central pathways for afferent neurons from different locations cause this phenomenon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Characterization of pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate characterization of abdominal pain includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Onset (eg, sudden, gradual)",
"     </li>",
"     <li>",
"      Provocative and palliating factors (eg, does pain decrease after eating?)",
"     </li>",
"     <li>",
"      Quality (eg, dull, sharp, colicky, waxing and waning)",
"     </li>",
"     <li>",
"      Radiation (eg, to the shoulder, back, flank, groin, or chest)",
"     </li>",
"     <li>",
"      Site (eg, a particular quadrant or diffuse)",
"     </li>",
"     <li>",
"      Symptoms associated with pain (eg, fever, vomiting, diarrhea, bloody stool, vaginal discharge, painful urination, shortness of breath)",
"     </li>",
"     <li>",
"      Time course (eg, hours versus weeks, constant or intermittent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A table summarizing high-risk features of abdominal pain is provided (",
"    <a class=\"graphic graphic_table graphicRef68577 \" href=\"mobipreview.htm?31/30/32235\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Location may help to narrow the differential diagnosis (",
"    <a class=\"graphic graphic_table graphicRef70233 \" href=\"mobipreview.htm?19/9/19613\">",
"     table 3",
"    </a>",
"    ). Pain from abdominal viscera often localizes according to the structure's embryologic origin, with foregut structures (mouth to proximal half of duodenum) presenting with upper abdominal pain, midgut structures (distal half of duodenum to middle of the transverse colon) presenting with periumbilical pain, and hind gut structures (remainder of colon and rectum, pelvic genitourinary organs) presenting with lower abdominal pain.",
"   </p>",
"   <p>",
"    Right upper quadrant pain is often associated with the liver or gallbladder, although pain from biliary colic may be poorly localized and patients may complain of lower chest, epigastric, or back discomfort [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/28\">",
"     28",
"    </a>",
"    ]. Other causes of right upper quadrant pain include myocardial infarction, right lower lobe pneumonia, and right sided pulmonary embolus (PE) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/29\">",
"     29",
"    </a>",
"    ]. Left upper quadrant pain can be from pancreatitis, gastric disease, or splenic enlargement. Other causes include left lower lobe pneumonia and myocardial infarction. Both appendicitis and ectopic pregnancy may present with right lower quadrant pain. Diverticulitis usually presents with left lower quadrant pain.",
"   </p>",
"   <p>",
"    However, clinicians should",
"    <strong>",
"     not",
"    </strong>",
"    base the differential diagnosis solely upon the location of pain; diagnosis and pain location often do not correspond [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/30\">",
"     30",
"    </a>",
"    ]. As an example, the diagnosis of appendicitis in patients presenting with right upper quadrant pain may be missed if the clinician fails to consider that retrocecal appendicitis can present in this manner. One study looking at patterns of abdominal pain found that only 60 to 70 percent of patients would be correctly diagnosed based on \"typical\" exam findings alone, yielding a misdiagnosis rate of 30 to 40 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pain location may change over time, reflecting progression of disease. As a classic example, the pain of appendicitis may begin as periumbilical (reflecting its embryologic origin), but move to the right lower quadrant as the inflamed appendix irritates the peritoneum. Another example would be the changing location of pain associated with an extending aortic dissection. Radiation of pain may aid diagnosis (",
"    <a class=\"graphic graphic_figure graphicRef61375 \" href=\"mobipreview.htm?23/54/24419\">",
"     figure 1",
"    </a>",
"    ). As examples, pain from pancreatitis may radiate to the back while pain from gallbladder disease may radiate to the right shoulder or subscapular region.",
"   </p>",
"   <p>",
"    Pain acuity, duration, and intensity can provide clues to disease severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/3,31,32\">",
"     3,31,32",
"    </a>",
"    ]. Pain with maximum intensity at onset is concerning for abdominal or extraabdominal vascular emergencies (eg, aortic rupture or dissection, mesenteric ischemia, PE) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/33\">",
"     33",
"    </a>",
"    ]. The sudden onset of significant pain often reflects a serious underlying disorder, such as organ perforation or ischemia (eg, acute mesentery artery occlusion, ovarian torsion), or obstruction of a small tubular structure (eg, biliary tract or ureter). A more gradual onset of symptoms suggests an inflammatory or infectious process (eg, appendicitis, diverticulitis), or obstruction of a large tubular structure (eg, bowel). Severe pain of sudden onset and constant or worsening pain lasting over six hours (but less than 48 hours) suggest a surgical cause. Nonsurgical causes tend to be less painful.",
"   </p>",
"   <p>",
"    Aggravating and alleviating factors are important. The pain of peptic ulcer disease may improve after meals, whereas biliary colic worsens after meals. Pancreatitis pain may improve when the patient sits upright and increase when the patient reclines. Patients with peritonitis lie still and coughing can worsen their pain, whereas the patient with nephrolithiasis is restless and cannot find a comfortable position. Ask the patient whether going over bumps during the drive to the hospital caused pain. A positive response suggests peritonitis and is roughly 80 percent sensitive, but only 52 percent specific, for appendicitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The character of the abdominal pain is often linked to a specific diagnosis. Burning pain is associated with an ulcer, tearing pain with aortic dissection, and colicky or crampy pain with distention or stretching of a hollow tube, such as with kidney stones in the ureter. Sharp pain develops when inflammation or noxious stimuli (eg, blood, stomach acid, bowel contents) contact parietal peritoneum.",
"   </p>",
"   <p>",
"    Associated symptoms can help narrow the diagnosis, especially with extraabdominal causes. Inquire about fever, cough, dyspnea, and chest pain, since pneumonia, pulmonary embolism, and myocardial infarction can all present with abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/23\">",
"     23",
"    </a>",
"    ]. Though vomiting and nausea are nonspecific, the order of these symptoms may provide a clue to the diagnosis. If vomiting occurs after the onset of pain, the pain is more likely to stem from a surgical process, such as bowel obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/3\">",
"     3",
"    </a>",
"    ]. Vomiting from relatively benign causes is usually self-limited. The type of vomiting may suggest a diagnosis. Bilious vomiting may be caused by an obstruction distal to the duodenum. Causes of coffee-ground or hematemesis include peptic ulcer disease, varices, and, in patients with a history of aortic aneurysm repair, aortoenteric fistula. Diarrhea is often associated with an infectious cause or diverticulitis, but can occur with mesenteric ischemia, in which case it may be bloody, or possibly bowel obstruction.",
"   </p>",
"   <p>",
"    Associated genitourinary symptoms can be important. In women, inquire about vaginal bleeding or discharge and recent changes in menstruation; in men, inquire about penile discharge and scrotal pain or swelling. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20920?source=see_link\">",
"     \"Approach to vaginal bleeding in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Keep in mind that the presentation and characteristics of abdominal pain may be dramatically different in elder patients despite the presence of a life-threatening condition. As an example, a perforated ulcer may present without the sudden onset of pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'History'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Begin the physical examination by assessing the vital signs. Though fever increases the suspicion for infection, there are certain patient populations, such as the elderly and the immunocompromised, that may be unable to mount a fever. Elderly patients with an intraabdominal infection are four times more likely than younger patients to present with hypothermia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/2\">",
"     2",
"    </a>",
"    ]. An oral temperature may be affected by respiratory rate, which is often elevated in those with pain. If there is concern about an inaccurate reading, check a rectal temperature. An elevated respiratory rate may itself be a compensatory reaction and should alert the clinician to the possibility of underlying metabolic acidosis. &nbsp;",
"   </p>",
"   <p>",
"    Next, inspect the patient. While requiring only a few seconds, inspection can provide many clues to the diagnosis. The patient who is restless, curled up, and agitated may suggest renal colic, while a patient lying perfectly still in bed with knees bent raises concern for peritonitis. Inspection may reveal signs of previous surgeries (eg, midline incision scar), abdominal pulsations, or signs of systemic disease (eg, pallor in shock, spider angiomata in cirrhosis), which can be especially important in those who are unable to provide a history.",
"   </p>",
"   <p>",
"    On auscultation, listen for bowel sounds for two minutes. Bowel sounds are normally heard as two to twelve medium-pitched gurgles per minute. The absence of bowel sounds over two minutes suggests peritonitis. Hyperactive medium-pitched bowel sounds are associated with blood or inflammation within the GI track. Periodic rushes of high-pitched \"tinkling\" bowel sounds or the complete absence of bowel sounds, in the presence of abdominal distention, suggests bowel obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/34\">",
"     34",
"    </a>",
"    ]. A bruit may be heard in the presence of an abdominal aortic aneurysm.",
"   </p>",
"   <p>",
"    Palpation of the abdomen enables the clinician to identify the location and degree of tenderness and to detect signs of peritoneal irritation, such as involuntary guarding and rigidity. One approach is to initially perform light palpation in the area away from the site of pain. Palpation can then be extended in either a clockwise or counterclockwise rotation towards the area of maximal pain. Once the area of maximal tenderness is localized, maneuvers to elicit somatic signs can be performed. If a specific area of tenderness is not identified with light palpation, deeper palpation can be performed to identify other abnormalities such as hepatomegaly, splenomegaly, aortic dilatation, or signs of a retrocecal appendix. &nbsp;",
"   </p>",
"   <p>",
"    The few studies that have looked at traditional techniques for assessing rebound tenderness suggest that these tests have limited sensitivity and specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Gentler methods to elicit signs of peritoneal irritation include having the patient cough or drop their heels to the ground after standing on their toes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. The heel test can also be performed by striking a recumbent patient's heel. Studies of these tests are limited and their characteristics remain uncertain. Nevertheless, a rigid abdomen is cause for concern.",
"   </p>",
"   <p>",
"    In patients older than 50 years, it is worthwhile and safe to attempt to palpate the aorta. To do so, have the patient lie supine with their feet on the stretcher and knees bent, thereby relaxing the abdominal wall musculature. Abnormal width of the aortic pulsation suggests the diagnosis of abdominal aortic aneurysm (AAA). Depending upon the patient&rsquo;s body habitus and their aortic anatomy, the accuracy of the physical examination for detecting an AAA may be limited, but it can provide important information.",
"   </p>",
"   <p>",
"    Other examination findings to note include Carnett's sign, Murphy's sign, obturator sign, psoas sign, and Rovsing's sign. In Carnett's sign there is increased tenderness when the abdominal wall muscles are contracted. Tenderness exacerbated by muscular contraction is more likely to be due to pathology within the abdominal wall. In one small study, Carnett's sign was found to be 95 percent accurate at distinguishing abdominal wall pain from visceral pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although insensitive, the psoas, obturator, and Rovsing signs have good specificity for acute appendicitis. A positive psoas sign consists of pain elicited when the examiner passively extends the right hip of the patient, who lies on their left side. A positive psoas sign may be seen with a retrocecal appendix. A patient with a pelvic appendix may have a positive obturator sign. Pain elicited when the clinician performs passive internal rotation of the flexed right thigh represents a positive test. Rovsing's sign consists of pain in the right lower quadrant elicited by palpation of the left lower quadrant. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31370?source=see_link&amp;anchor=H5346477#H5346477\">",
"     \"Acute appendicitis in adults: Clinical manifestations and diagnosis\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Murphy's sign occurs when a patient abruptly stops a deep inspiration during palpation of the right upper quadrant. This test can be useful in some patients with suspected cholecystitis, but its sensitivity may be diminished in the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Perform testicular examinations in men and pelvic examinations in females with pain in the lower half of the abdomen. No preexamination criteria exist that enable the clinician to determine if the pelvic examination will provide useful information [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/6\">",
"     6",
"    </a>",
"    ]. Pain from pelvic inflammatory disease may not be localized to the suprapubic region. The rectal examination may reveal a mass or gastrointestinal bleeding, but its usefulness in patients with undifferentiated abdominal pain and no gastrointestinal bleeding has been questioned [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44360?source=see_link\">",
"     \"Evaluation of the acute scrotum in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42681?source=see_link\">",
"     \"The gynecologic history and pelvic examination\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Physical examination cannot reliably predict or exclude significant disease in the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/12\">",
"     12",
"    </a>",
"    ]. Abdominal tenderness may not localize because of changes in the nervous system affecting pain perception. Rebound or guarding may not be present because of laxity of abdominal wall musculature. In one retrospective study looking at elderly in-patients with peritonitis, only 34 percent manifested guarding or rebound tenderness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical examination can be difficult during pregnancy. Pregnant patients may have fewer clinical findings and may not demonstrate peritoneal signs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/45\">",
"     45",
"    </a>",
"    ]. This may be a result of the gradual growth and stretching of the peritoneal cavity, which desensitizes the pregnant patient to peritoneal irritation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/44/36554?source=see_link&amp;anchor=H2#H2\">",
"     \"Approach to abdominal pain and the acute abdomen in pregnant and postpartum women\", section on 'General principles'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many extraabdominal causes of abdominal pain exist and the clinician should not neglect other parts of the physical examination. Auscultate the heart and lungs. Atrial fibrillation noted on physical exam may increase suspicion for mesenteric ischemia. Localized decreased breath sounds or coarse breath sounds may raise suspicion for pneumonia. Palpate the chest wall, spine, and pelvis. Pain at the costovertebral angles may suggest pyelonephritis. Assess hip range of motion as infectious and inflammatory processes can refer pain to the lower abdomen.",
"   </p>",
"   <p>",
"    The skin exam is important and often overlooked. This is especially true in the elderly, who have a higher incidence of herpes zoster. Ecchymosis of the abdomen (Cullen's sign) or flank (Grey Turner's sign) suggests intraabdominal or retroperitoneal hemorrhage, possibly caused by a ruptured or leaking AAA or hemorrhagic pancreatitis. The skin may be cool and damp in patients with shock. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/20/2378?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a patient with equivocal signs and symptoms, serial examinations can improve diagnostic accuracy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should not rely on ancillary studies to make a diagnosis but should use them as adjuncts. In one small prospective study assessing diagnostic testing for nontraumatic abdominal pain in the emergency department (ED), diagnostic tests led to a change in diagnosis in 37 percent of patients and a change in disposition in 41 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;In an otherwise healthy adult, laboratory tests should generally only be ordered to rule in a clinically suspected diagnosis or to assess a patient with an acute abdomen of unclear etiology. The threshold for ordering a broader range of tests is lower for the immunosuppressed, elderly patients unable to provide a comprehensive history (eg, nonverbal, altered mental status), and those with significant underlying disease (eg, diabetes, cancer, HIV, cirrhosis).",
"   </p>",
"   <p>",
"    A pregnancy test is required in women of child-bearing age. Either a urine or serum qualitative human chorionic gonadotropin (hCG) test may be used. Both tests are extremely sensitive. Patient self-assessment of pregnancy status is not uniformly reliable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/9/1178?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A bedside fingerstick glucose should be performed immediately in seriously ill patients and known diabetics to assess for hyperglycemia and exclude the diagnosis of diabetic ketoacidosis. If the patient is hyperglycemic, basic electrolyte measurements should be obtained to assess the severity of disease.",
"   </p>",
"   <p>",
"    Although often ordered, the complete blood count (CBC) is nonspecific and rarely alters management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/47,49,50\">",
"     47,49,50",
"    </a>",
"    ]. While the white blood cell count may be elevated in up to 80 percent of patients with acute appendicitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/50\">",
"     50",
"    </a>",
"    ], it is also elevated in 70 percent of patients with other causes of right lower quadrant abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/51\">",
"     51",
"    </a>",
"    ]. Of note, older or immunocompromised patients with an acute abdomen can present with normal leukocyte counts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/52\">",
"     52",
"    </a>",
"    ], while healthy pregnant patients can have a leukocytosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16874?source=see_link&amp;anchor=H33#H33\">",
"     \"Differential diagnosis of abdominal pain in adults\", section on 'Older adults'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21703?source=see_link\">",
"     \"Hematologic changes in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with clinically significant upper or mid abdominal pain should have liver and pancreatic enzyme concentrations measured. Elevations in serum amylase concentrations are neither sensitive nor specific for pancreatitis, and may indicate a more ominous process, such as mesenteric ischemia or bowel perforation. Serum lipase is more sensitive and specific than amylase for pancreatitis, but elevations may be caused by a number of diseases. Elevation in the serum total bilirubin and alkaline phosphatase concentrations are",
"    <strong>",
"     not",
"    </strong>",
"    &nbsp;common in uncomplicated cholecystitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20569?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/27/10679?source=see_link\">",
"     \"Approach to the patient with elevated serum amylase or lipase\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=see_link\">",
"     \"Approach to the patient with abnormal liver biochemical and function tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Urinalysis can provide useful information but can also be misleading. The presence of pyuria, proteinuria, and hematuria suggests the diagnosis of urinary tract infection (UTI), but these findings may also be present with acute appendicitis or any inflammatory process occurring adjacent to either ureter. About 20 to 48 percent of patients with appendicitis have blood, leukocytes, or bacteria in their urine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Of note, many elderly patients have chronic, mild pyuria. Hematuria may be present in as many as 87 percent of patients with AAA, which can lead to the misdiagnosis of nephrolithiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=see_link\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31370?source=see_link\">",
"     \"Acute appendicitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Plain x-rays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indiscriminate use of plain radiographs to assess general abdominal pain is an extremely low-yield practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. Only a small percentage is abnormal. Plain x-rays can be helpful when bowel obstruction, bowel perforation, or a radiopaque foreign body is suspected, but cannot be relied upon to exclude these disorders.",
"   </p>",
"   <p>",
"    The diagnosis of bowel perforation can be confirmed by the presence of free intraperitoneal air on an upright chest x-ray (CXR) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83050 \" href=\"mobipreview.htm?0/0/6\">",
"     image 1",
"    </a>",
"    ). The location of the perforation determines the likelihood of detecting free air. With gastroduodenal perforation, free air is present in only two-thirds of cases; with perforation of the distal small bowel or large bowel, free air is present in one-third of cases. Sensitivity decreases further in patients with previous abdominal surgery or a walled off perforation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/58\">",
"     58",
"    </a>",
"    ]. If free air is not seen on a posteroanterior (PA) upright CXR, an upright lateral CXR can be obtained, which is more sensitive for pneumoperitoneum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/59\">",
"     59",
"    </a>",
"    ]. A left lateral decubitus x-ray can be obtained in patients too ill for upright films and may detect free air over the diaphragm above the liver edge (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83043 \" href=\"mobipreview.htm?36/6/36963\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Approximately 5 mL of free air is detected by plain abdominal radiography, while an upright CXR detects as little as 1 to 2 mL after the patient has been upright for 5 to 10 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/58,60\">",
"     58,60",
"    </a>",
"    ]. Detection can be improved by placing a nasogastric tube and injecting 50 mL of air or water soluble contrast.",
"   </p>",
"   <p>",
"    Overall, plain radiographs are up to 69 percent sensitive and 57 percent specific for patients ultimately diagnosed with an obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/61\">",
"     61",
"    </a>",
"    ]. The radiographic finding of a curvilinear array of small gas bubbles (\"string of beads\" sign) is pathognomonic for small bowel obstruction (SBO) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68738 \" href=\"mobipreview.htm?10/15/10481\">",
"     image 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/58\">",
"     58",
"    </a>",
"    ]. This occurs when small gas bubbles collect between the valvulae conniventes floating in a fluid-filled bowel. If the small bowel is dilated more than 2.5 cm, obstruction is likely. Other findings consistent with SBO include gaseous distention and air-fluid levels.",
"   </p>",
"   <p>",
"    Initial radiographs in patients with mesenteric ischemia are often unremarkable. Abnormal findings correlate with increased mortality. Late findings include ileus, \"thumbprinting,\" and intramural air (pneumatosis intestinalis). In one study, patients with these findings had a mortality of 78 percent compared with 29 percent mortality in patients with normal x-rays [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is rapid and can be performed at the bedside. Because of the lack of radiation exposure, it is the study of choice in pregnancy. It is the initial study of choice when abdominal aortic aneurysm (AAA) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83048 \" href=\"mobipreview.htm?27/44/28355\">",
"     image 4",
"    </a>",
"    ) or gallbladder disease (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83042 \" href=\"mobipreview.htm?4/57/5015\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef83107 \" href=\"mobipreview.htm?43/8/44162\">",
"     image 6",
"    </a>",
"    ) is suspected. It can provide useful information about many conditions, such as ectopic pregnancy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53149 \" href=\"mobipreview.htm?31/56/32646\">",
"     image 7",
"    </a>",
"    ), hemoperitoneum (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81382 \" href=\"mobipreview.htm?17/51/18230\">",
"     image 8",
"    </a>",
"    ), renal colic (hydronephrosis may be seen) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57935 \" href=\"mobipreview.htm?15/52/16193\">",
"     image 9",
"    </a>",
"    ), pancreatitis, and venous thrombosis. It is not useful for detecting free air (eg, from a bowel perforation) or retroperitoneal bleeding.",
"   </p>",
"   <p>",
"    One preliminary prospective observational study of 1021 patients with nontraumatic acute abdominal pain presenting to the emergency department found that an imaging strategy in which CT was performed only after a negative or inconclusive ultrasound (performed in all study patients) improved sensitivity for urgent diagnoses and reduced radiation exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/63\">",
"     63",
"    </a>",
"    ]. Further research is needed to confirm the effectiveness of this approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Computed tomography scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is the study of choice in the evaluation of undifferentiated abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/64\">",
"     64",
"    </a>",
"    ]. Approximately two-thirds of patients presenting to the ED with acute abdominal pain have a disease that can be diagnosed by CT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/60\">",
"     60",
"    </a>",
"    ]. One small retrospective study found that CT correctly diagnosed the cause of pain among patients with an \"acute abdomen\" in 90 percent of cases, compared with 76 percent of cases diagnosed correctly by history and physical examination alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/65\">",
"     65",
"    </a>",
"    ]. CT is particularly useful in the elderly, establishing or suggesting the diagnosis in 75 percent of cases and 85 percent of emergent surgical conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/1\">",
"     1",
"    </a>",
"    ], but in the ED population at large, nonenhanced helical CT outperforms plain radiographs in the diagnosis of nontraumatic abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasound is the initial study of choice for unstable patients with suspected abdominal aortic aneurysm (AAA) leak or rupture. However, in stable patients with AAA, CT is an excellent study for defining aortic size and the extent of the aneurysm. Retroperitoneal hemorrhage can also be identified. Hemorrhage can be visualized in nonenhanced scans making IV contrast unnecessary in emergent situations or when IV contrast dye may be contraindicated. CT is not limited by bowel gas or obesity and has a sensitivity of nearly 100 percent in diagnosing AAA. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/16/32010?source=see_link\">",
"     \"Clinical features and diagnosis of abdominal aortic aneurysm\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Imaging is not necessary when the diagnosis of acute appendicitis is clear based upon clinical evaluation. However, CT with oral and IV contrast is a sensitive and specific study for diagnosing acute appendicitis. In some patient populations, CT without contrast demonstrates comparable accuracy. When using noncontrast CT to diagnose appendicitis, the most important findings are the inflammatory changes in the pericecal and periappendiceal fat. Therefore, the diagnosis can be missed in young, slender patients with little retroperitoneal and mesenteric fat. CT, even unenhanced, is extremely useful and sensitive in diagnosing free air [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/64\">",
"     64",
"    </a>",
"    ]. The use of imaging to diagnose acute appendicitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31370?source=see_link&amp;anchor=H5345961#H5345961\">",
"     \"Acute appendicitis in adults: Clinical manifestations and diagnosis\", section on 'Imaging studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One prospective study compared the performance of nonenhanced and enhanced CT in a convenience sample of patients with acute abdominal pain, and found the two modalities had a simple agreement of 79 percent (95% CI 70-87) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with concern for mesenteric ischemia, an accurate and less invasive alternative to standard angiography is CT angiography (CT-A). CT-A allows for visualization of the mesenteric vasculature and shows changes consistent with bowel infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/69\">",
"     69",
"    </a>",
"    ]. In addition, CT-A reveals other abdominal pathology when ischemia is not the cause of abdominal pain and is useful in the evaluation of gastrointestinal bleeding with the ability to detect bleeding rates of 0.3",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44377?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute mesenteric ischemia\", section on 'Radiographic studies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33206?source=see_link\">",
"     \"Chronic mesenteric ischemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiography can be helpful in the diagnosis and treatment of mesenteric ischemia. Injection of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/2/37923?source=see_link\">",
"     papaverine",
"    </a>",
"    into the superior mesenteric artery can help relieve vascular occlusion. However, if the patient is in shock or requiring vasopressors, diagnosis should be made during laparotomy. Angiography has no role in the emergent evaluation of ruptured AAA. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44377?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute mesenteric ischemia\", section on 'Radiographic studies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     APPROACH TO DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Patients over 50",
"    </span>",
"    &nbsp;&mdash;&nbsp;Be wary of older patients with abdominal pain. Many older patients have significant illness and yet may present without signs, symptoms, or laboratory values that reflect the seriousness of their disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/25\">",
"     25",
"    </a>",
"    ]. An algorithm for the management of these patients is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef65734 \" href=\"mobipreview.htm?32/43/33460\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Standard presentations of major diseases provide the initial basis for assessment, even in older patients, but clinicians must remain mindful of so-called \"atypical\" presentations of common diseases and extraabdominal causes of abdominal pain (eg, myocardial infarction). Medications such as beta blockers and glucocorticoids and comorbidities such as diabetes are more common among the elderly, and likely to mask symptoms and signs.",
"   </p>",
"   <p>",
"    The emergency clinician's first priority is to identify life-threatening conditions. Patients presenting in shock or with peritoneal signs require",
"    <strong>",
"     immediate",
"    </strong>",
"    surgical consultation. While resuscitating the patient, perform bedside ultrasound to gain crucial information about aortic diameter, peritoneal fluid, gallstones, and hydronephrosis. A portable left lateral decubitus x-ray may reveal free air.",
"   </p>",
"   <p>",
"    Dangerous and common diagnoses to consider in the elderly include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abdominal aortic aneurysm (AAA)",
"     </li>",
"     <li>",
"      Extended thoracic aortic dissection",
"     </li>",
"     <li>",
"      Mesenteric ischemia",
"     </li>",
"     <li>",
"      Myocardial infarction",
"     </li>",
"     <li>",
"      Bowel obstruction",
"     </li>",
"     <li>",
"      Bowel perforation",
"     </li>",
"     <li>",
"      Gallbladder disease",
"     </li>",
"     <li>",
"      Diverticular disease",
"     </li>",
"     <li>",
"      Volvulus",
"     </li>",
"     <li>",
"      Incarcerated hernia",
"     </li>",
"     <li>",
"      Intraabdominal abscess",
"     </li>",
"     <li>",
"      Splenic rupture or infarct",
"     </li>",
"     <li>",
"      Pyelonephritis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For hemodynamically stable patients, base the approach on the history and physical examination. For patients with risk factors for AAA, pain radiating to the back, a pulsatile abdominal mass, or a known history of AAA, the clinician should perform a bedside ultrasound and obtain surgical consultation. Stable patients can subsequently undergo a CT scan, which provides information on the extent and location of the aneurysm. Early surgical consultation is important in the event the patient deteriorates during evaluation and may be appropriate even if the CT does not clearly show aortic pathology. Chest pain which extends to the abdomen, particularly when associated with neurological symptoms, suggests a thoracoabdominal aortic dissection.",
"   </p>",
"   <p>",
"    Mesenteric ischemia is another life-threatening diagnosis to be considered in patients over age 50 with associated risk factors (eg, atherosclerotic disease, low cardiac output, atrial fibrillation, hypercoagulable states). Pain is often sudden and severe; the pathognomonic finding of \"pain out of proportion to exam\" may be present. In patients at risk for mesenteric ischemia, obtain CT angiography of the abdomen and early surgical consultation. Blood in the stool and elevated serum lactate concentrations may not be present initially. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44377?source=see_link\">",
"     \"Acute mesenteric ischemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An abdominal x-ray series can provide crucial information quickly in patients with diffuse tenderness or distention associated with vomiting or abdominal rigidity. If free air is identified, obtain immediate surgical consultation. If signs of bowel obstruction are identified, perform a CT scan to determine the cause and site of the obstruction. CT is also necessary when plain x-rays are nondiagnostic in these patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13450?source=see_link\">",
"     \"Treatment of acute diverticulitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/21/40282?source=see_link\">",
"     \"Overview of the complications of peptic ulcer disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/38/8807?source=see_link\">",
"     \"Small bowel obstruction: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Obtain a chest x-ray in elderly patients with upper abdominal pain or with symptoms or examination findings suggestive of pneumonia. Obtain an electrocardiogram in both unstable and stable elderly patients with upper abdominal pain. Myocardial infarction can manifest as nausea, vomiting, and epigastric discomfort. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/39/25209?source=see_link\">",
"     \"Criteria for the diagnosis of acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of the above clinical scenarios, the site of abdominal pain helps to guide the workup (",
"    <a class=\"graphic graphic_table graphicRef70233 \" href=\"mobipreview.htm?19/9/19613\">",
"     table 3",
"    </a>",
"    ). The differential diagnosis of",
"    <span class=\"nowrap\">",
"     epigastric/right",
"    </span>",
"    upper quadrant (RUQ) pain includes diseases of the liver and biliary system. Biliary tract disease is among the most common causes of abdominal pain in the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. An ultrasound can help delineate pathology within the gallbladder or liver. Liver function tests (LFTs) and lipase may be helpful in determining the cause of RUQ pain and potential complications of gallstones (eg, pancreatitis). However, LFTs may not be abnormal in elder patients or cases of uncomplicated cholecystitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=see_link\">",
"     \"Approach to the patient with abnormal liver biochemical and function tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with tenderness in the lower quadrants, the differential diagnosis differs depending upon the patient's gender and age. In females, a pelvic examination is essential for diagnosis and to guide the selection of imaging studies. Pelvic pain is best evaluated with ultrasound. The patient with a normal pelvic exam, a negative pregnancy test, and concerning abdominal pain is best evaluated with a CT scan.",
"   </p>",
"   <p>",
"    A testicular and scrotal examination is essential for male patients with lower quadrant abdominal pain. Patients with testicular tenderness or a tender scrotal mass require urologic consultation and a testicular ultrasound. Although more common in younger men, testicular torsion can occur in older patients. Consult a urologist immediately, prior to the performance of any studies, when torsion is suspected. Incarcerated inguinal hernia is more common in elder males. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44360?source=see_link\">",
"     \"Evaluation of the acute scrotum in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with a normal genitourinary examination can be grouped according to the clinician's suspicion for appendicitis. A male patient likely to have appendicitis requires prompt surgical consultation, as he may be taken to the operating room without further studies. If suspicion for appendicitis is not high, the options are to order a CT scan or observe the patient and perform serial examinations. For left lower quadrant pain, a CT scan is useful in diagnosing diverticulitis. While a CT scan is not necessary for all patients with suspected diverticulitis, the test is helpful in confirming the diagnosis in patients without a previous history of diverticular disease, and in assessing for complications (eg, abscess formation) in patients with known disease who present with more than mild to moderate symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31370?source=see_link\">",
"     \"Acute appendicitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/6/34919?source=see_link\">",
"     \"Clinical manifestations and diagnosis of colonic diverticular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation of patients with left upper quadrant tenderness follows the same decision tree as for right upper quadrant tenderness. Perform an ultrasound examination to evaluate for intraabdominal free fluid consistent with splenic rupture in patients with signs and symptoms of infectious mononucleosis, including Kehr's sign. Patients with a positive study require immediate surgical consultation. In the absence of a positive study, a CT scan may be useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Patients under 50",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of patients under 50 years of age is similar to that of those over 50. However, in this age group abdominal aortic aneurysm, mesenteric ischemia, malignancy, and extra-abdominal causes of abdominal pain are much less likely, while common manifestations of disease are more likely. The evaluation for women under 50 is described immediately below. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Women of childbearing age'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Women of childbearing age",
"    </span>",
"    &nbsp;&mdash;&nbsp;First determine whether the patient is unstable and identify peritoneal signs and shock. While resuscitating unstable patients, perform a bedside ultrasound looking for free fluid and signs of pregnancy. Obtain a pregnancy test, a blood type and cross match sample, and immediate surgical or gynecologic consultation. An algorithm for the management of these patients is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef54001 \" href=\"mobipreview.htm?15/17/15632\">",
"     algorithm 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In stable patients, determine whether the patient is pregnant with a qualitative human chorionic gonadotropin (hCG). If so, perform an ultrasound and a sterile pelvic exam to assess for ectopic pregnancy and pelvic disease, and obtain a quantitative hCG. Immediate gynecologic consultation is required for any patient with an ectopic pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/9/1178?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of ectopic pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/24/34184?source=see_link\">",
"     \"Ultrasonography of pregnancy of unknown location\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with an uncomplicated intrauterine pregnancy and concerning abdominal pain need further evaluation. Appendicitis is the most common surgical disease encountered during pregnancy; ultrasound is the diagnostic study of choice to assess for appendicitis during pregnancy. Contrary to common teaching, the area around McBurney's point is the most common location of pain in pregnant patients with appendicitis regardless of gestational age. Changes associated with pregnancy can make the diagnosis difficult. As examples, leukocytosis can be a normal finding and nausea, vomiting, and malaise occur often during the first trimester. Keep in mind that microscopic hematuria and pyuria occur in up to one-third of patients with acute appendicitis. Be wary of attributing concerning abdominal pain to a urinary tract infection (UTI). Obtain surgical and gynecologic consultation for patients with confirmed or suspected appendicitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/34/42536?source=see_link\">",
"     \"Acute appendicitis in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/44/36554?source=see_link\">",
"     \"Approach to abdominal pain and the acute abdomen in pregnant and postpartum women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For nonpregnant patients, further evaluation is guided by history and findings on abdominal and pelvic examination. Keep in mind extra-abdominal causes of pain. As an example, women with acute coronary syndrome are more likely to present with so-called atypical symptoms.",
"   </p>",
"   <p>",
"    Transvaginal ultrasound is helpful to evaluate for ovarian torsion or ruptured ovarian cyst in patients with a consistent history or unilateral adnexal tenderness. Often these entities present with the sudden onset of sharp, lower abdominal pain associated with nausea. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23690?source=see_link\">",
"     \"Ovarian and fallopian tube torsion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/40/9863?source=see_link\">",
"     \"Evaluation and management of ruptured ovarian cyst\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stable patients with pelvic inflammatory disease (PID) by history and examination may need no further studies and can be treated with oral antibiotics and close follow-up as outpatients. For patients with PID and more severe symptoms (eg, persistent vomiting, toxic appearing, unstable vital signs), inpatient treatment with IV antibiotics is appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Differentiating appendicitis from PID may be difficult without imaging, and misdiagnosis increases morbidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/73\">",
"     73",
"    </a>",
"    ]. Clinical factors favoring appendicitis include migration of pain and the presence of nausea, vomiting, or anorexia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/73-75\">",
"     73-75",
"    </a>",
"    ]. Factors favoring PID include pain or tenderness outside the right lower abdomen, vaginal discharge, and cervical motion tenderness.",
"   </p>",
"   <p>",
"    In women without pelvic findings but with predominantly right lower quadrant pain, evaluate for possible appendicitis with either CT scan or ultrasound. Other causes of right lower quadrant abdominal pain to consider include: UTI, nephrolithiasis, endometriosis, and neoplasm. Neoplasm is more common in women over 35 and pain may be accompanied by vaginal bleeding. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/34/42536?source=see_link\">",
"     \"Acute appendicitis in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=see_link\">",
"     \"Diagnosis and acute management of suspected nephrolithiasis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20920?source=see_link\">",
"     \"Approach to vaginal bleeding in the emergency department\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/10999?source=see_link\">",
"     \"Acute complicated cystitis and pyelonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Victims of domestic violence may present to the emergency department with abdominal or pelvic pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Particularly when the diagnosis is unclear in a young woman, clinicians should inquire about violence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86925833\">",
"    <span class=\"h2\">",
"     HIV-infected patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis and evaluation of HIV-infected patients with abdominal pain is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/3/63?source=see_link\">",
"     \"Evaluation of abdominal pain in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ANALGESIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;At one time it was believed that analgesia interferes with the assessment of patients with abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/78\">",
"     78",
"    </a>",
"    ]. Multiple randomized controlled trials have disproved this notion, and patients being evaluated for abdominal pain in the emergency department (ED) should be treated judiciously with appropriate analgesics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/79-83\">",
"     79-83",
"    </a>",
"    ]. According to a systematic review of these studies, opioids can alter the physical examination of patients with acute abdominal pain but they do not increase the number of incorrect management decisions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     Morphine",
"    </a>",
"    in doses of 0.05 to 0.10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV (typical adult dose 2 to 5 mg IV), given approximately every 15 minutes until pain is controlled, is one reasonable approach. If a shorter acting agent is desired,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    , at doses of 0.1 to 0.3",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    IV (typical adult dose 10 to 25 mcg), can be given in five minute intervals until pain is controlled. Careful monitoring of drug effects, particularly respiratory drive, is essential for any patient being treated with opioids. Patients with opioid dependency or chronic pain generally require larger doses.",
"   </p>",
"   <p>",
"    A preliminary randomized trial of 211 adults with abdominal pain treated at an academic urban ED found that patient-controlled analgesia with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    produced greater reductions in pain and no clinically significant differences in adverse events when compared to standard management using the same medication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/84\">",
"     84",
"    </a>",
"    ]. Further study is needed to confirm the efficacy and safety of this approach.",
"   </p>",
"   <p>",
"    When giving analgesics, the goal is to reduce pain to manageable levels, thereby making the patient more cooperative and possibly improving the accuracy of the abdominal examination by minimizing voluntary guarding. The goal is",
"    <strong>",
"     not",
"    </strong>",
"    to eliminate all pain and make the patient somnolent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3163515\">",
"    <span class=\"h1\">",
"     DISPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The elderly are at greater risk of significant disease, are less capable of tolerating such illness, and are more likely not to manifest clear and concerning symptoms and signs. Therefore, elderly patients with abdominal pain should be admitted or undergo prolonged observation if the clinician harbors any doubt about the nature of their disease.",
"   </p>",
"   <p>",
"    Observation and reassessment is useful in the management of abdominal pain of unclear etiology. One retrospective cohort study found that a period of observation increased the certainty of diagnosing appendicitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/46\">",
"     46",
"    </a>",
"    ]. Other retrospective studies support the use of observation periods in unclear cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinicians should consider the likelihood of disease and the comorbidities, reliability, and social supports of the patient when determining whether to observe the patient with abdominal pain of unclear etiology in the emergency department (ED) or allow the patient to be discharged and return to the ED or their primary care clinician in 12 hours for reevaluation. Patients to be discharged must be provided with clear, written instructions about potential danger signs and where and when to return for emergent care or reevaluation.",
"   </p>",
"   <p>",
"    The large majority of patients discharged from the ED, after an appropriate evaluation, with a diagnosis of nonspecific abdominal pain have a benign condition that resolves without further intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/9,86,87\">",
"     9,86,87",
"    </a>",
"    ]. As an example, in a retrospective study of 1411 patients discharged from the ED with nonspecific abdominal pain, 112 patients (7.9 percent) represented with abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/50/41770/abstract/88\">",
"     88",
"    </a>",
"    ]. Of these, 85 were again diagnosed with nonspecific pain while 27 received a more specific diagnosis, including cholelithiasis (30 percent), appendicitis (19 percent), and gastrointestinal cancer (7 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     PITFALLS IN MANAGEMENT",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Failure to conduct a careful and timely evaluation of elderly patients with abdominal pain when overt signs of severe disease are absent.",
"     </li>",
"     <li>",
"      Failure to appreciate high-risk features of abdominal pain (",
"      <a class=\"graphic graphic_table graphicRef68577 \" href=\"mobipreview.htm?31/30/32235\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Failure to perform pelvic and testicular examinations in patients with low abdominal pain.",
"     </li>",
"     <li>",
"      Over-reliance on laboratory studies.",
"     </li>",
"     <li>",
"      Failure to observe and reexamine or to arrange for reassessment of patients with pain of unclear etiology, particularly patients at higher risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/48/8962?source=see_link\">",
"       \"Patient information: Acute abdomen (belly pain) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3163386\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Abdominal pain poses diagnostic challenges for emergency clinicians. Causes include medical, surgical, intraabdominal, and extraabdominal ailments. Associated symptoms often lack specificity and atypical presentations of common diseases are frequent.",
"     </li>",
"     <li>",
"      The elderly, the immunocompromised, and women of childbearing age with abdominal pain pose special diagnostic challenges. Elderly patients often have vague, nonspecific complaints and atypical presentations of potentially life-threatening conditions. Older patients with abdominal pain have a six- to eightfold increase in mortality compared to younger patients. Immunocompromised patients may suffer from a wide range of ailments, including unusual and therapy-related conditions. Pregnancy leads to physiologic and anatomic changes affecting the presentation of common diseases. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/3/63?source=see_link\">",
"       \"Evaluation of abdominal pain in the HIV-infected patient\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/44/36554?source=see_link\">",
"       \"Approach to abdominal pain and the acute abdomen in pregnant and postpartum women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Abdominal pain may be caused by the following life-threatening conditions:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Abdominal aortic aneurysm",
"     </li>",
"     <li>",
"      Thoracoabdominal aortic dissection",
"     </li>",
"     <li>",
"      Mesenteric ischemia",
"     </li>",
"     <li>",
"      Perforation of gastrointestinal tract (including peptic ulcer, bowel, esophagus, or appendix)",
"     </li>",
"     <li>",
"      Acute bowel obstruction",
"     </li>",
"     <li>",
"      Volvulus",
"     </li>",
"     <li>",
"      Splenic rupture",
"     </li>",
"     <li>",
"      Incarcerated hernia",
"     </li>",
"     <li>",
"      Ectopic pregnancy",
"     </li>",
"     <li>",
"      Placental abruption",
"     </li>",
"     <li>",
"      Myocardial infarction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The differential diagnosis for abdominal pain is wide, ranging from benign to life-threatening conditions. A list of important and common causes of abdominal pain, including brief descriptions of their important clinical features and links to more extensive discussions, is provided in the text. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The combination of a careful history, including a precise characterization of the pain, and physical examination can often distinguish between organic and nonorganic causes of abdominal pain and is crucial for creating a focused and appropriate differential diagnosis. High risk features associated with life-threatening causes of abdominal pain are summarized in the accompanying table (",
"      <a class=\"graphic graphic_table graphicRef68577 \" href=\"mobipreview.htm?31/30/32235\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Pain description'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinician should not rely on ancillary studies to make a diagnosis but should use them as adjuncts. Important laboratory and radiographic studies used in the diagnosis of abdominal pain are described in the text. Early consultation with surgery or obstetrics-gynecology can be critical and is discussed in the text. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Ancillary studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The approach to diagnosing the cause of abdominal pain in the emergency department varies by age, gender, and condition. Algorithmic approaches for older and younger patients (",
"      <a class=\"graphic graphic_algorithm graphicRef65734 \" href=\"mobipreview.htm?32/43/33460\">",
"       algorithm 1",
"      </a>",
"      ), women of child-bearing age (",
"      <a class=\"graphic graphic_algorithm graphicRef54001 \" href=\"mobipreview.htm?15/17/15632\">",
"       algorithm 2",
"      </a>",
"      ), and HIV-infected patients are provided. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Approach to diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/3/63?source=see_link\">",
"       \"Evaluation of abdominal pain in the HIV-infected patient\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/1\">",
"      Hustey FM, Meldon SW, Banet GA, et al. The use of abdominal computed tomography in older ED patients with acute abdominal pain. Am J Emerg Med 2005; 23:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/2\">",
"      Cooper GS, Shlaes DM, Salata RA. Intraabdominal infection: differences in presentation and outcome between younger patients and the elderly. Clin Infect Dis 1994; 19:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/3\">",
"      Brewer BJ, Golden GT, Hitch DC, et al. Abdominal pain. An analysis of 1,000 consecutive cases in a University Hospital emergency room. Am J Surg 1976; 131:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/4\">",
"      Powers RD, Guertler AT. Abdominal pain in the ED: stability and change over 20 years. Am J Emerg Med 1995; 13:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/5\">",
"      Sanson TG, O'Keefe KP. Evaluation of abdominal pain in the elderly. Emerg Med Clin North Am 1996; 14:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/6\">",
"      Kamin RA, Nowicki TA, Courtney DS, Powers RD. Pearls and pitfalls in the emergency department evaluation of abdominal pain. Emerg Med Clin North Am 2003; 21:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/7\">",
"      Irvin TT. Abdominal pain: a surgical audit of 1190 emergency admissions. Br J Surg 1989; 76:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/8\">",
"      Jess P, Bjerregaard B, Brynitz S, et al. Prognosis of acute nonspecific abdominal pain. A prospective study. Am J Surg 1982; 144:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/9\">",
"      Lukens TW, Emerman C, Effron D. The natural history and clinical findings in undifferentiated abdominal pain. Ann Emerg Med 1993; 22:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/10\">",
"      Lewis LM, Banet GA, Blanda M, et al. Etiology and clinical course of abdominal pain in senior patients: a prospective, multicenter study. J Gerontol A Biol Sci Med Sci 2005; 60:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/11\">",
"      Kizer KW, Vassar MJ. Emergency department diagnosis of abdominal disorders in the elderly. Am J Emerg Med 1998; 16:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/12\">",
"      Marco CA, Schoenfeld CN, Keyl PM, et al. Abdominal pain in geriatric emergency patients: variables associated with adverse outcomes. Acad Emerg Med 1998; 5:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/13\">",
"      de Dombal FT. The OMGE acute abdominal pain survey. Progress report, 1986. Scand J Gastroenterol Suppl 1988; 144:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/14\">",
"      Bugliosi TF, Meloy TD, Vukov LF. Acute abdominal pain in the elderly. Ann Emerg Med 1990; 19:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/15\">",
"      Feny&ouml; G. Acute abdominal disease in the elderly: experience from two series in Stockholm. Am J Surg 1982; 143:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/16\">",
"      Barone JE, Gingold BS, Arvanitis ML, Nealon TF Jr. Abdominal pain in patients with acquired immune deficiency syndrome. Ann Surg 1986; 204:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/17\">",
"      Yoshida D, Caruso JM. Abdominal pain in the HIV infected patient. J Emerg Med 2002; 23:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/18\">",
"      Marston WA, Ahlquist R, Johnson G Jr, Meyer AA. Misdiagnosis of ruptured abdominal aortic aneurysms. J Vasc Surg 1992; 16:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/19\">",
"      Sinha P, Kuruba N. Ante-partum haemorrhage: an update. J Obstet Gynaecol 2008; 28:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/20\">",
"      Luber SD, Fischer DR, Venkat A. Care of the bariatric surgery patient in the emergency department. J Emerg Med 2008; 34:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/21\">",
"      Ellison SR, Ellison SD. Bariatric surgery: a review of the available procedures and complications for the emergency physician. J Emerg Med 2008; 34:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/22\">",
"      Edwards ED, Jacob BP, Gagner M, Pomp A. Presentation and management of common post-weight loss surgery problems in the emergency department. Ann Emerg Med 2006; 47:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/23\">",
"      Potts DE, Sahn SA. Abdominal manifestations of pulmonary embolism. JAMA 1976; 235:2835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/24\">",
"      Styrud J, Eriksson S, Segelman J, Granstr&ouml;m L. Diagnostic accuracy in 2,351 patients undergoing appendicectomy for suspected acute appendicitis: A retrospective study 1986-1993. Dig Surg 1999; 16:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/25\">",
"      de Dombal FT. Acute abdominal pain in the elderly. J Clin Gastroenterol 1994; 19:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/26\">",
"      Parker LJ, Vukov LF, Wollan PC. Emergency department evaluation of geriatric patients with acute cholecystitis. Acad Emerg Med 1997; 4:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/27\">",
"      Baris D, Karagas MR, Verrill C, et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 2009; 101:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/28\">",
"      McNamara R, Dean AJ. Approach to acute abdominal pain. Emerg Med Clin North Am 2011; 29:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/29\">",
"      Kelso LA, Kugelmas M. Nontraumatic abdominal pain. AACN Clin Issues 1997; 8:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/30\">",
"      Yamamoto W, Kono H, Maekawa M, Fukui T. The relationship between abdominal pain regions and specific diseases: an epidemiologic approach to clinical practice. J Epidemiol 1997; 7:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/31\">",
"      Staniland JR, Ditchburn J, De Dombal FT. Clinical presentation of acute abdomen: study of 600 patients. Br Med J 1972; 3:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/32\">",
"      Purcell TB. Nonsurgical and extraperitoneal causes of abdominal pain. Emerg Med Clin North Am 1989; 7:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/33\">",
"      Hendrickson M, Naparst TR. Abdominal surgical emergencies in the elderly. Emerg Med Clin North Am 2003; 21:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/34\">",
"      Eskelinen M, Ikonen J, Lipponen P. Contributions of history-taking, physical examination, and computer assistance to diagnosis of acute small-bowel obstruction. A prospective study of 1333 patients with acute abdominal pain. Scand J Gastroenterol 1994; 29:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/35\">",
"      Liddington MI, Thomson WH. Rebound tenderness test. Br J Surg 1991; 78:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/36\">",
"      Bemelman WA, Kievit J. [Pysical examination--rebound tenderness]. Ned Tijdschr Geneeskd 1999; 143:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/37\">",
"      Bennett DH, Tambeur LJ, Campbell WB. Use of coughing test to diagnose peritonitis. BMJ 1994; 308:1336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/38\">",
"      Markle GB 4th. A simple test for intraperitoneal inflammation. Am J Surg 1973; 125:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/39\">",
"      Thomson H, Francis DM. Abdominal-wall tenderness: A useful sign in the acute abdomen. Lancet 1977; 2:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/40\">",
"      Singer AJ, Brandt LJ. Pathophysiology of the gastrointestinal tract during pregnancy. Am J Gastroenterol 1991; 86:1695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/41\">",
"      Adedeji OA, McAdam WA. Murphy's sign, acute cholecystitis and elderly people. J R Coll Surg Edinb 1996; 41:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/42\">",
"      Quaas J, Lanigan M, Newman D, et al. Utility of the digital rectal examination in the evaluation of undifferentiated abdominal pain. Am J Emerg Med 2009; 27:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/43\">",
"      Manimaran N, Galland RB. Significance of routine digital rectal examination in adults presenting with abdominal pain. Ann R Coll Surg Engl 2004; 86:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/44\">",
"      Wroblewski M, Mikulowski P. Peritonitis in geriatric inpatients. Age Ageing 1991; 20:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/45\">",
"      Sivanesaratnam V. The acute abdomen and the obstetrician. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/46\">",
"      Graff L, Radford MJ, Werne C. Probability of appendicitis before and after observation. Ann Emerg Med 1991; 20:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/47\">",
"      Nagurney JT, Brown DF, Chang Y, et al. Use of diagnostic testing in the emergency department for patients presenting with non-traumatic abdominal pain. J Emerg Med 2003; 25:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/48\">",
"      Ramoska EA, Sacchetti AD, Nepp M. Reliability of patient history in determining the possibility of pregnancy. Ann Emerg Med 1989; 18:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/49\">",
"      Silver BE, Patterson JW, Kulick M, et al. Effect of CBC results on ED management of women with lower abdominal pain. Am J Emerg Med 1995; 13:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/50\">",
"      Elangovan S. Clinical and laboratory findings in acute appendicitis in the elderly. J Am Board Fam Pract 1996; 9:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/51\">",
"      Calder JD, Gajraj H. Recent advances in the diagnosis and treatment of acute appendicitis. Br J Hosp Med 1995; 54:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/52\">",
"      Berry J Jr, Malt RA. Appendicitis near its centenary. Ann Surg 1984; 200:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/53\">",
"      Paajanen H, Tainio H, Laato M. A chance of misdiagnosis between acute appendicitis and renal colic. Scand J Urol Nephrol 1996; 30:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/54\">",
"      Puskar D, Bedalov G, Fridrih S, et al. Urinalysis, ultrasound analysis, and renal dynamic scintigraphy in acute appendicitis. Urology 1995; 45:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/55\">",
"      Pomper SR, Fiorillo MA, Anderson CW, Kopatsis A. Hematuria associated with ruptured abdominal aortic aneurysms. Int Surg 1995; 80:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/56\">",
"      Eisenberg RL, Heineken P, Hedgcock MW, et al. Evaluation of plain abdominal radiographs in the diagnosis of abdominal pain. Ann Surg 1983; 197:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/57\">",
"      Kellow ZS, MacInnes M, Kurzencwyg D, et al. The role of abdominal radiography in the evaluation of the nontrauma emergency patient. Radiology 2008; 248:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/58\">",
"      Billittier AJ, Abrams BJ, Brunetto A. Radiographic imaging modalities for the patient in the emergency department with abdominal complaints. Emerg Med Clin North Am 1996; 14:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/59\">",
"      Markowitz SK, Ziter FM Jr. The lateral chest film and pneumoperitoneum. Ann Emerg Med 1986; 15:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/60\">",
"      Mindelzun RE, Jeffrey RB. Unenhanced helical CT for evaluating acute abdominal pain: a little more cost, a lot more information. Radiology 1997; 205:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/61\">",
"      Maglinte DD, Reyes BL, Harmon BH, et al. Reliability and role of plain film radiography and CT in the diagnosis of small-bowel obstruction. AJR Am J Roentgenol 1996; 167:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/62\">",
"      Ritz JP, Runkel N, Berger G, Buhr HJ. [Prognostic factors in mesenteric infarct]. Zentralbl Chir 1997; 122:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/63\">",
"      Lam&eacute;ris W, van Randen A, van Es HW, et al. Imaging strategies for detection of urgent conditions in patients with acute abdominal pain: diagnostic accuracy study. BMJ 2009; 338:b2431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/64\">",
"      Stoker J, van Randen A, Lam&eacute;ris W, Boermeester MA. Imaging patients with acute abdominal pain. Radiology 2009; 253:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/65\">",
"      Siewert B, Raptopoulos V, Mueller MF, et al. Impact of CT on diagnosis and management of acute abdomen in patients initially treated without surgery. AJR Am J Roentgenol 1997; 168:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/66\">",
"      MacKersie AB, Lane MJ, Gerhardt RT, et al. Nontraumatic acute abdominal pain: unenhanced helical CT compared with three-view acute abdominal series. Radiology 2005; 237:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/67\">",
"      Nagurney JT, Brown DF, Novelline RA, et al. Plain abdominal radiographs and abdominal CT scans for nontraumatic abdominal pain--added value? Am J Emerg Med 1999; 17:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/68\">",
"      Lee SY, Coughlin B, Wolfe JM, et al. Prospective comparison of helical CT of the abdomen and pelvis without and with oral contrast in assessing acute abdominal pain in adult Emergency Department patients. Emerg Radiol 2006; 12:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/69\">",
"      Dewitte A, Biais M, Coquin J, et al. [Diagnosis and management of acute mesenteric ischemia]. Ann Fr Anesth Reanim 2011; 30:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/70\">",
"      McSweeney SE, O'Donoghue PM, Jhaveri K. Current and emerging techniques in gastrointestinal imaging. J Postgrad Med 2010; 56:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/71\">",
"      Espinoza R, Balbont&iacute;n P, Feuerhake S, Pi&ntilde;era C. [Acute abdomen in the elderly]. Rev Med Chil 2004; 132:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/72\">",
"      G&uuml;rleyik G, G&uuml;rleyik E, Unalmier S. Abdominal surgical emergency in the elderly. Turk J Gastroenterol 2002; 13:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/73\">",
"      Rothrock SG, Green SM, Dobson M, et al. Misdiagnosis of appendicitis in nonpregnant women of childbearing age. J Emerg Med 1995; 13:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/74\">",
"      Webster DP, Schneider CN, Cheche S, et al. Differentiating acute appendicitis from pelvic inflammatory disease in women of childbearing age. Am J Emerg Med 1993; 11:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/75\">",
"      Morishita K, Gushimiyagi M, Hashiguchi M, et al. Clinical prediction rule to distinguish pelvic inflammatory disease from acute appendicitis in women of childbearing age. Am J Emerg Med 2007; 25:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/76\">",
"      John R, Johnson JK, Kukreja S, et al. Domestic violence: prevalence and association with gynaecological symptoms. BJOG 2004; 111:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/77\">",
"      Olson L, Anctil C, Fullerton L, et al. Increasing emergency physician recognition of domestic violence. Ann Emerg Med 1996; 27:741.",
"     </a>",
"    </li>",
"    <li>",
"     Cope Z. Early Diagnosis of the Acute Abdomen, 2nd, Oxford, London 1921.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/79\">",
"      Thomas SH, Silen W, Cheema F, et al. Effects of morphine analgesia on diagnostic accuracy in Emergency Department patients with abdominal pain: a prospective, randomized trial. J Am Coll Surg 2003; 196:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/80\">",
"      Pace S, Burke TF. Intravenous morphine for early pain relief in patients with acute abdominal pain. Acad Emerg Med 1996; 3:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/81\">",
"      Gallagher EJ, Esses D, Lee C, et al. Randomized clinical trial of morphine in acute abdominal pain. Ann Emerg Med 2006; 48:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/82\">",
"      Ranji SR, Goldman LE, Simel DL, Shojania KG. Do opiates affect the clinical evaluation of patients with acute abdominal pain? JAMA 2006; 296:1764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/83\">",
"      Manterola C, Vial M, Moraga J, Astudillo P. Analgesia in patients with acute abdominal pain. Cochrane Database Syst Rev 2011; :CD005660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/84\">",
"      Birnbaum A, Schechter C, Tufaro V, et al. Efficacy of patient-controlled analgesia for patients with acute abdominal pain in the emergency department: a randomized trial. Acad Emerg Med 2012; 19:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/85\">",
"      Graff L, Russell J, Seashore J, et al. False-negative and false-positive errors in abdominal pain evaluation: failure to diagnose acute appendicitis and unnecessary surgery. Acad Emerg Med 2000; 7:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/86\">",
"      Sandhu GS, Redmond AD, Prescott MV. Non-specific abdominal pain: a safe diagnosis? J R Coll Surg Edinb 1995; 40:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/87\">",
"      Gatzen C, Paterson-Brown S, Touquet R, Dudley HA. Management of acute abdominal pain: decision making in the accident and emergency department. J R Coll Surg Edinb 1991; 36:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/50/41770/abstract/88\">",
"      Gunnarsson OS, Birgisson G, Oddsdottir M, Gudbjartsson T. [One year follow-up of patients discharged from the emergency department with non-specific abdominal pain]. Laeknabladid 2011; 97:231.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 290 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-84F2B57B49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41770=[""].join("\n");
var outline_f40_50_41770=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3163386\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Immediate life-threatening conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Common conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Gastrointestinal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Genitourinary",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3163457\">",
"      - Trauma-related",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Common extraabdominal diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PAIN DESCRIPTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Types of pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Characterization of pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Plain x-rays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Computed tomography scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Angiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      APPROACH TO DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Patients over 50",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Patients under 50",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Women of childbearing age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86925833\">",
"      HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ANALGESIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3163515\">",
"      DISPOSITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      PITFALLS IN MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3163386\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/290\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/290|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?32/43/33460\" title=\"algorithm 1\">",
"      Approach to abdominal pain in patients over 50",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?15/17/15632\" title=\"algorithm 2\">",
"      Approach to abdominal pain in female of childbearing age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/290|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?0/0/6\" title=\"diagnostic image 1\">",
"      Chest x-ray intraperitoneal free air",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?36/6/36963\" title=\"diagnostic image 2\">",
"      Decubitus x-ray intraperitoneal free air",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?10/15/10481\" title=\"diagnostic image 3\">",
"      Upright abdominal x-ray of small bowel obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?27/44/28355\" title=\"diagnostic image 4\">",
"      Ultrasound of abdominal aortic aneurysm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?4/57/5015\" title=\"diagnostic image 5\">",
"      Acute cholecystitis with pericholecystic fluid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?43/8/44162\" title=\"diagnostic image 6\">",
"      Ultrasound of acute calculous cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/56/32646\" title=\"diagnostic image 7\">",
"      Tubal pregnancy adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?17/51/18230\" title=\"diagnostic image 8\">",
"      Hemoperitoneum abdomen pelvis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?15/52/16193\" title=\"diagnostic image 9\">",
"      Ultrasound hydronephrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/290|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/54/24419\" title=\"figure 1\">",
"      Patterns of referred abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/290|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/4/12365\" title=\"table 1\">",
"      Extra-abdominal causes abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?31/30/32235\" title=\"table 2\">",
"      Features of high risk abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/9/19613\" title=\"table 3\">",
"      Causes of abdominal pain by location",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31370?source=related_link\">",
"      Acute appendicitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/34/42536?source=related_link\">",
"      Acute appendicitis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/10999?source=related_link\">",
"      Acute complicated cystitis and pyelonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44377?source=related_link\">",
"      Acute mesenteric ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/39/12922?source=related_link\">",
"      Adult lead poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/29/6613?source=related_link\">",
"      Alcoholic and fasting ketoacidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43319?source=related_link\">",
"      Anticholinergic poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/44/36554?source=related_link\">",
"      Approach to abdominal pain and the acute abdomen in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/17/32025?source=related_link\">",
"      Approach to the adult with acute diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29976?source=related_link\">",
"      Approach to the adult with acute diarrhea in developing countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/16/24839?source=related_link\">",
"      Approach to the patient with a suspected spider bite: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/18/34090?source=related_link\">",
"      Approach to the patient with abnormal liver biochemical and function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/27/10679?source=related_link\">",
"      Approach to the patient with elevated serum amylase or lipase",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20920?source=related_link\">",
"      Approach to vaginal bleeding in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/38/40551?source=related_link\">",
"      Caustic esophageal injury in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/29/8663?source=related_link\">",
"      Cecal volvulus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33206?source=related_link\">",
"      Chronic mesenteric ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/41/35479?source=related_link\">",
"      Classification and treatment of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/37/31321?source=related_link\">",
"      Classification, clinical features and diagnosis of inguinal and femoral hernias in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/16/32010?source=related_link\">",
"      Clinical features and diagnosis of abdominal aortic aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/9/41113?source=related_link\">",
"      Clinical features and diagnosis of coronary heart disease in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/55/4986?source=related_link\">",
"      Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/49/40729?source=related_link\">",
"      Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/51/14135?source=related_link\">",
"      Clinical manifestations and diagnosis of Rocky Mountain spotted fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/63/41974?source=related_link\">",
"      Clinical manifestations and diagnosis of Yersinia infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20569?source=related_link\">",
"      Clinical manifestations and diagnosis of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/6/34919?source=related_link\">",
"      Clinical manifestations and diagnosis of colonic diverticular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/31/25078?source=related_link\">",
"      Clinical manifestations and diagnosis of familial Mediterranean fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/59/22455?source=related_link\">",
"      Clinical manifestations and diagnosis of irritable bowel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/26/9641?source=related_link\">",
"      Clinical manifestations and diagnosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/47/1786?source=related_link\">",
"      Clinical manifestations and evaluation of mushroom poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33669?source=related_link\">",
"      Clinical manifestations of hypercalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/18/13609?source=related_link\">",
"      Clinical manifestations of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/0/7172?source=related_link\">",
"      Clinical manifestations of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/0/20490?source=related_link\">",
"      Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/9/1178?source=related_link\">",
"      Clinical manifestations, diagnosis, and management of ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11386?source=related_link\">",
"      Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/33/17946?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/39/29305?source=related_link\">",
"      Clostridium difficile in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41898?source=related_link\">",
"      Complications of bariatric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/39/25209?source=related_link\">",
"      Criteria for the diagnosis of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=related_link\">",
"      Diagnosis and acute management of suspected nephrolithiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12296?source=related_link\">",
"      Diagnosis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16874?source=related_link\">",
"      Differential diagnosis of abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/44/24265?source=related_link\">",
"      Differential diagnosis of microbial foodborne disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/23/42362?source=related_link\">",
"      Enterotoxicity of chemotherapeutic agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43703?source=related_link\">",
"      Eosinophilic gastroenteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23688?source=related_link\">",
"      Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36823?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/6/31849?source=related_link\">",
"      Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/16/40198?source=related_link\">",
"      Etiology and pathogenesis of acute intermittent porphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/40/9863?source=related_link\">",
"      Evaluation and management of ruptured ovarian cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/3/63?source=related_link\">",
"      Evaluation of abdominal pain in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44360?source=related_link\">",
"      Evaluation of the acute scrotum in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/50/5928?source=related_link\">",
"      Gastrointestinal manifestations of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21703?source=related_link\">",
"      Hematologic changes in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/52/19272?source=related_link\">",
"      Hereditary angioedema: Epidemiology, clinical manifestations, exacerbating factors, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/43/15034?source=related_link\">",
"      Initial evaluation and management of suspected acute coronary syndrome in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/35002?source=related_link\">",
"      Initial management of trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15289?source=related_link\">",
"      Open-angle glaucoma: Epidemiology, clinical presentation, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/5/28758?source=related_link\">",
"      Opioid withdrawal in the emergency setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23690?source=related_link\">",
"      Ovarian and fallopian tube torsion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/22/4456?source=related_link\">",
"      Overview of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/11/42170?source=related_link\">",
"      Overview of the clinical manifestations of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/21/40282?source=related_link\">",
"      Overview of the complications of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29208?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of acute cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?8/48/8962?source=related_link\">",
"      Patient information: Acute abdomen (belly pain) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29417?source=related_link\">",
"      Placental abruption: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/54/34663?source=related_link\">",
"      Placental abruption: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=related_link\">",
"      Preeclampsia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18868?source=related_link\">",
"      Prevention and treatment of viral gastroenteritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/53/26453?source=related_link\">",
"      Sigmoid volvulus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/46/14058?source=related_link\">",
"      Small bowel obstruction: Causes and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/38/8807?source=related_link\">",
"      Small bowel obstruction: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/52/8010?source=related_link\">",
"      Staphylococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42681?source=related_link\">",
"      The gynecologic history and pelvic examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/30/18920?source=related_link\">",
"      Toxic megacolon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/29/29145?source=related_link\">",
"      Travelers' diarrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/1/4121?source=related_link\">",
"      Treatment and prophylaxis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/9/15511?source=related_link\">",
"      Treatment of acute cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/8/13450?source=related_link\">",
"      Treatment of acute diverticulitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7738?source=related_link\">",
"      Treatment of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/24/34184?source=related_link\">",
"      Ultrasonography of pregnancy of unknown location",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_50_41771="Counterregulatory response hypoglycemia";
var content_f40_50_41771=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F75618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F75618&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Counterregulatory response to hypoglycemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Condition",
"      </td>",
"      <td class=\"subtitle1\">",
"       Glucose",
"      </td>",
"      <td class=\"subtitle1\">",
"       Insulin",
"      </td>",
"      <td class=\"subtitle1\">",
"       Glucagon",
"      </td>",
"      <td class=\"subtitle1\">",
"       Epinephrine",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nondiabetic",
"      </td>",
"      <td>",
"       &darr;",
"      </td>",
"      <td>",
"       Decreases",
"      </td>",
"      <td>",
"       Increases",
"      </td>",
"      <td>",
"       Increases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1DM",
"      </td>",
"      <td>",
"       &darr;",
"      </td>",
"      <td>",
"       No Decrease*",
"      </td>",
"      <td>",
"       No Increase*",
"      </td>",
"      <td>",
"       Attenuated Increase*&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\" colspan=\"5\">",
"       T2DM",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Early",
"      </td>",
"      <td class=\"sublist_other\">",
"       &darr;",
"      </td>",
"      <td class=\"sublist_other\">",
"       Decreases",
"      </td>",
"      <td class=\"sublist_other\">",
"       Increases",
"      </td>",
"      <td class=\"sublist_other\">",
"       Increases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Late (Absolute endogenous insulin deficient)",
"      </td>",
"      <td class=\"sublist_other\">",
"       &darr;",
"      </td>",
"      <td class=\"sublist_other\">",
"       No Decrease*",
"      </td>",
"      <td class=\"sublist_other\">",
"       No Increase*",
"      </td>",
"      <td class=\"sublist_other\">",
"       Attenuated Increase*&bull;",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Iatrogenic hypoglycemia is the result of the interplay of absolute or relative therapeutic insulin excess and compromised physiological and behavioral defenses against falling plasma glucose concentrations in type 1 diabetes mellitus (T1DM) and advanced type 2 diabetes mellitus (T2DM).",
"    <div class=\"footnotes\">",
"     * Defective glucose counterregulation.",
"     <br>",
"      &bull; Hypoglycemia unawareness.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Philip Cryer.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41771=[""].join("\n");
var outline_f40_50_41771=null;
var title_f40_50_41772="Compare UC Crohns";
var content_f40_50_41772=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74564&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74564&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of ulcerative colitis and Crohn disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Ulcerative colitis",
"      </td>",
"      <td class=\"subtitle1\">",
"       Crohn disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Clinical features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Haematochezia",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"      <td>",
"       Less common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Passage of mucus or pus",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"      <td>",
"       Rare",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Small-bowel disease",
"      </td>",
"      <td>",
"       No (except backwash ileitis)",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Can affect upper-gastrointestinal tract",
"      </td>",
"      <td>",
"       No",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Abdominal mass",
"      </td>",
"      <td>",
"       Rare",
"      </td>",
"      <td>",
"       Sometimes in right lower quadrant",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Extraintestinal manifestations",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Small-bowel obstruction",
"      </td>",
"      <td>",
"       Rarely",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Colonic obstruction",
"      </td>",
"      <td>",
"       Rarely",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fistulas and perianal disease",
"      </td>",
"      <td>",
"       No",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Biochemical features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Anti-neutrophil cytoplasmic antibodies",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"      <td>",
"       Less common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Anti-saccharomyces cerevisiae antibodies",
"      </td>",
"      <td>",
"       Rarely",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Pathological features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Transmural mucosal inflammation",
"      </td>",
"      <td>",
"       No",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Distorted crypt architecture",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cryptitis and crypt abscesses",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Granulomas",
"      </td>",
"      <td>",
"       No",
"      </td>",
"      <td>",
"       Yes (seen in 25 to 40 percent of mucosal biopsies)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Fissures and skip lesions",
"      </td>",
"      <td>",
"       Rarely",
"      </td>",
"      <td>",
"       Common",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    This table describes typical features distinguishing between classic ulcerative colitis and Crohn disease. On occasion, patients with ulcerative colitis may have \"nonclassic\" features, including gastritis and mild perianal disease, as discussed separately.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Baumgert, DC, Sandborn, WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369:1641. Copyright &copy;2007 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41772=[""].join("\n");
var outline_f40_50_41772=null;
var title_f40_50_41773="Differential diagnosis of Marfan syndrome";
var content_f40_50_41773=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59476&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59476&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of Marfan syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Differential diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gene",
"       </td>",
"       <td class=\"subtitle1\">",
"        Features similar to Marfan syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Discriminating features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Loeys-Dietz syndrome (LDS)",
"       </td>",
"       <td>",
"        TGFBR1/2",
"       </td>",
"       <td>",
"        Aortic aneurysm/dissection",
"       </td>",
"       <td>",
"        Bifid uvula/cleft palate, arterial tortuosity, hypertelorism, diffuse aortic and arterial aneurysms, craniosynostosis, clubfoot, cervical spine instability, thin and velvety skin, easy bruising",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shprintzen-Goldberg syndrome (SGS)",
"       </td>",
"       <td>",
"        FBN1 and other",
"       </td>",
"       <td>",
"        Pectus abnormalities, scoliosis, arachnodactyly",
"       </td>",
"       <td>",
"        Craniosynostosis, mental retardation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MASS phenotype*",
"       </td>",
"       <td>",
"        FBN1* and other",
"       </td>",
"       <td>",
"        Mitral valve prolapse, mild aortic dilatation, striae atrophica, and at least one skeletal feature; systemic score &ge;5",
"       </td>",
"       <td>",
"        Aortic root size Z&lt;2; no ectopia lentis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mitral valve prolapse syndrome",
"       </td>",
"       <td>",
"        Several candidate gene loci",
"       </td>",
"       <td>",
"        Mitral valve prolapse, pectus excavatum, scoliosis, mild arachnodactyly",
"       </td>",
"       <td>",
"        Lack of aortic enlargement, lack of ectopia lentis, systemic score &lt;5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital contractural arachnodactyly (CCA)",
"       </td>",
"       <td>",
"        FBN2",
"       </td>",
"       <td>",
"        Marfanoid habitus, arachnodactyly, kyphosis/scoliosis, mild enlargement of the sinuses of Valsalva",
"       </td>",
"       <td>",
"        Crumpled ears (folded upper helix), contractures of major joints (knees and ankles) at birth, flexion contractures of the proximal interphalangeal joints (camptodactyly), absence of aortic dissection or rupture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weill-Marchesani syndrome (WMS)",
"       </td>",
"       <td>",
"        FBN1 and ADAMTS10",
"       </td>",
"       <td>",
"        Ectopia lentis",
"       </td>",
"       <td>",
"        Microspherophakia, brachydactyly, joint stiffness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ectopia lentis syndrome (ELS)",
"       </td>",
"       <td>",
"        FBN1, LTBP2, ADAMTSL4",
"       </td>",
"       <td>",
"        Ectopia lentis, may have mild skeletal findings",
"       </td>",
"       <td>",
"        Lack of aortic root dilatation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Familial thoracic aortic aneurysm and dissection syndrome (FTAAD/FTAA)",
"       </td>",
"       <td>",
"        TGFBR1/2, ACTA2",
"       </td>",
"       <td>",
"        Aortic dilatation and dissection",
"       </td>",
"       <td>",
"        Livedo reticularis, iris flocculi, lack of Marfanoid skeletal features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FTAAD with bicuspid aortic valve",
"       </td>",
"       <td>",
"        ACTA2",
"       </td>",
"       <td>",
"        Aortic aneurysm and dissection",
"       </td>",
"       <td>",
"        Livedo reticularis, iris flocculi, cerebral aneurysm, premature ischemic strokes, Moyamoya disease, premature coronary artery disease, bicuspid aortic valve, patent ductus arteriosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FTAAD with patent ductus arteriosus",
"       </td>",
"       <td>",
"        MYH11",
"       </td>",
"       <td>",
"        Aortic root aneurysm",
"       </td>",
"       <td>",
"        Patent ductus arteriosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Homocystinuria",
"       </td>",
"       <td>",
"        CBS",
"       </td>",
"       <td>",
"        Marfanoid habitus, ectopia lentis",
"       </td>",
"       <td>",
"        Thrombosis, mental retardation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arterial tortuosity syndrome (ATS)",
"       </td>",
"       <td>",
"        SLC2A10",
"       </td>",
"       <td>",
"        Aortic aneurysm",
"       </td>",
"       <td>",
"        Generalized arterial tortuosity, arterial stenosis, facial dysmorphism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ehlers-Danlos syndrome (vascular type)",
"       </td>",
"       <td>",
"        COL3A1",
"       </td>",
"       <td>",
"        Aortic aneurysm/dissection occurs in some",
"       </td>",
"       <td>",
"        Middle sized artery aneurysm, translucent skin, dystrophic scars, intestinal or uterine rupture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ehlers-Danlos syndrome (cardiac valvular subtype)",
"       </td>",
"       <td>",
"        COL1A2",
"       </td>",
"       <td>",
"        Mitral valve prolapse, joint hypermobility",
"       </td>",
"       <td>",
"        Severe aortic and/or mitral valvular regurgitation, atrophic scars, skin hyperelasticity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ehlers-Danlos syndrome (kyphoscoliotic type)",
"       </td>",
"       <td>",
"        PLOD1",
"       </td>",
"       <td>",
"        Aortic dilatation/dissection, kyphoscoliosis, joint laxity",
"       </td>",
"       <td>",
"        Middle sized artery aneurysm/rupture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stickler syndrome (hereditary arthroophthalmopathy)",
"       </td>",
"       <td>",
"        COL2A1, COL11A1",
"       </td>",
"       <td>",
"        Marfinoid habitus, mitral valve prolapse, retrognathia",
"       </td>",
"       <td>",
"        Vitreal degeneration, retinal detachment, myopia, open angle glaucoma, early cataracts, cleft palate, hearing loss, epiphysial changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Klinefelter's syndrome",
"       </td>",
"       <td>",
"        47,XXY (and other X&gt;1 genotypes in men)",
"       </td>",
"       <td>",
"        Marfanoid habitus",
"       </td>",
"       <td>",
"        Small testes and genitalia, cognitive impairment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital bicuspid aortic valve disease with associated aortopathy",
"       </td>",
"       <td>",
"        NOTCH1, KCNJ2, and putative loci on chromosomes 18q, 5q and 13q",
"       </td>",
"       <td>",
"        Ascending aortic aneurysm, some have pectus deformity, scoliosis",
"       </td>",
"       <td>",
"        Bicuspid aortic valve (may occur together with or separately from aortic aneurysm in various family members); lack of ocular and other systemic findings of Marfan syndrome; aortic dilatation is commonly maximal or exclusively above the sinotubular junction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aortic coarctation with associated ascending aortic enlargement",
"       </td>",
"       <td>",
"        NOTCH1, ERBB4, largely unknown",
"       </td>",
"       <td>",
"        Aortic dilatation",
"       </td>",
"       <td>",
"        Coarctation of the aorta",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TGFBR: TGF-beta receptor.",
"     <br>",
"      * An individual with MASS phenotype with an FBN1 mutation may subsequently transition to Marfan syndrome, but the probability of such transition is not known.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted in part from: Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47:476.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41773=[""].join("\n");
var outline_f40_50_41773=null;
var title_f40_50_41774="Contents: Neuropathies";
var content_f40_50_41774=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?0/63/1022\">",
"       Neurology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Neuropathies",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Neuropathies",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cranial neuropathies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/23/36216\">",
"           Bell's palsy: Pathogenesis, clinical features, and diagnosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/27/9655\">",
"           Bell's palsy: Prognosis and treatment in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/10/11431\">",
"           Overview of craniofacial pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/3/34873\">",
"           Trigeminal neuralgia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diabetic neuropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/7/18551\">",
"           Clinical manifestations and diagnosis of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/9/20631\">",
"           Diabetic amyotrophy and idiopathic lumbosacral radiculoplexus neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/46/8938\">",
"           Diabetic autonomic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/25/24985\">",
"           Diabetic autonomic neuropathy of the gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/38/39527\">",
"           Diabetic neuropathic arthropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/34/16934\">",
"           Epidemiology and classification of diabetic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/12/11464\">",
"           Evaluation of the diabetic foot",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/60/41928\">",
"           Pathogenesis and prevention of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/43/12986\">",
"           Treatment of diabetic neuropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/13/27863\">",
"           Clinical neurophysiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/32/8712\">",
"           Differential diagnosis of peripheral nerve and muscle disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/45/3799\">",
"           Evaluation of parasympathetic nervous system function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/12/7369\">",
"           Overview of polyneuropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hereditary peripheral neuropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/37/602\">",
"           Hereditary neuropathies associated with generalized disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/59/35770\">",
"           Hereditary primary motor sensory neuropathies, including Charcot-Marie-Tooth disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/16/43272\">",
"           Hereditary sensory and autonomic neuropathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/60/4038\">",
"           Krabbe disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/27/42421\">",
"           Metachromatic leukodystrophy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/49/27414\">",
"           Neurologic manifestations of Fabry disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/0/20489\">",
"           Overview of Niemann-Pick disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/24/21895\">",
"           Overview of hereditary neuropathies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Mononeuropathies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/15/42230\">",
"           Clinical manifestations and diagnosis of carpal tunnel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/57/22423\">",
"           Clinical manifestations of vasculitic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/53/16215\">",
"           Diagnosis and treatment of vasculitic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/22/23911\">",
"           Etiology of carpal tunnel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/9/39061\">",
"           Meralgia paresthetica (lateral femoral cutaneous nerve entrapment)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/3/32822\">",
"           Surgery for carpal tunnel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/62/44008\">",
"           Treatment of carpal tunnel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/12/38089\">",
"           Ulnar neuropathy at the elbow and wrist",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neuropathy associated with infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/12/27848\">",
"           Diagnosis, treatment and prognosis of HIV-associated neuropathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/1/35864\">",
"           Epidemiology, pathogenesis and clinical features of HIV-associated neuropathies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nondiabetic peripheral neuropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/12/7369\">",
"           Overview of polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/37/2643\">",
"           Uremic mononeuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/27/14773\">",
"           Uremic polyneuropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Orthostatic hypotension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/41/12951\">",
"           Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/2/5161\">",
"           Treatment of orthostatic and postprandial hypotension",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Peripheral nerve disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/33/5655\">",
"           Acute lumbosacral radiculopathy: Prognosis and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/33/40472\">",
"           Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/62/17385\">",
"           Chronic inflammatory demyelinating polyneuropathy: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/19/36152\">",
"           Clinical features and diagnosis of cervical radiculopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/57/22423\">",
"           Clinical manifestations of vasculitic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/53/16215\">",
"           Diagnosis and treatment of vasculitic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/20/20810\">",
"           Lumbosacral radiculopathy: Pathophysiology, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/50/36650\">",
"           Neurofibromatosis type 1 (von Recklinghausen's disease)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/29/11731\">",
"           Overview of schwannomatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/24/23946\">",
"           Peripheral nerve tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/6/21608\">",
"           Postherpetic neuralgia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/47/17144\">",
"           Treatment of cervical radiculopathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Plexopathies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/53/2906\">",
"           Brachial plexus syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/9/20631\">",
"           Diabetic amyotrophy and idiopathic lumbosacral radiculoplexus neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/45/23257\">",
"           Lumbosacral plexus syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/15/42233\">",
"           Overview of lower extremity peripheral nerve syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/44/8906\">",
"           Overview of upper extremity peripheral nerve syndromes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Trauma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/48/26375\">",
"           Burners (stingers): Acute brachial plexus injury in the athlete",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/6/21608\">",
"           Postherpetic neuralgia",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-27B5BB4725-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f40_50_41774=[""].join("\n");
var outline_f40_50_41774=null;
var title_f40_50_41775="ECG changes in paroxysmal SVT after administration of adenosine";
var content_f40_50_41775=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electrocardiographic changes adenosine",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 436px; height: 363px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three sets of simultaneous electrocardiographic rhythms in a two-month-old baby with signs and symptoms of mild heart failure and in whom ice cold wet cloth failed to convert the paroxysmal SVT (PSVT) of 293 bpm (cycle length of 205 msec). Adenosine successfully converted the PSVT to sinus rhythm with an intravenous bolus dose of 150 microgram/kg (panel C) after failure at lower doses. The prediction of an orthodromic reciprocating tachycardia mechanism by noting P waves in the ST-T segments during tachycardia is supported by the finding of Wolff-Parkinson-White syndrome during sinus rhythm after conversion (panel C).",
"    <div class=\"footnotes\">",
"     SVT: supraventricular tachycardia; HR: heart rate; bpm: beats per minute.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kugler JD, Danford DA. Management of infants, children, and adolescents with paroxysmal supraventricular tachycardia. J Pediatr 1996; 129:324. Copyright &copy; 1996 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_50_41775=[""].join("\n");
var outline_f40_50_41775=null;
